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Abstract Approved:
Pyoluteorin is a chlorinated, mixed polyketide metabolite produced by
Pseudomonas fluorescens Pf-5. Pyoluteorin exhibits antifungal activity against
Pythium ultimum, the causal agent of preemergence damping-off disease.
Biosynthesis of this compound was studied using an approach that integrated
nucleotide sequence analysis of a region required for pyoluteorin production
and isotopic labelling studies of proposed pathway intermediates. ['COOK-
L-Proline was demonstrated to be the primary precursor of the chlorinated
pyrrole moiety within pyoluteorin. Hypothetical pathway intermediates were
synthesized and tested in vivo for their incorporation into pyoluteorin. The
results of these studies, however, were equivocal and definitive conclusions
regarding the biochemical pathway leading to pyoluteorin could not be made.
Nucleotide sequencing of the region required for pyoluteorin production
identified several clustered biosynthetic genes. pltB and pltC encode a Type I
polyketide synthase required for pyoluteorin biosynthesis. A pathway for
resorcinol ring formation is proposed based on the catalytic domain
organization of the polyketide synthase. The deduced peptide sequences of
pltA, pltD, and a partial open reading frame, orf-S, exhibit similarity to the
halogenases that are involved in tetracycline and pyrrolnitrin biosynthesis.
Although halogenases are a poorly characterized class of enzymes, some
aspects of their catalytic mechanism regarding pyoluteorin biosynthesis are
discussed based on peptide sequence analysis. The regulatory gene pltR was
also identified and appears to encode a transcriptional activator protein with
similarity to the LysR family of transcriptional regulators.
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Chapter 1. Biological Control of Plant Pathogens: 
A Paradigm for Understanding Bacterial Physiology 
and the Ecological Role of Secondary Metabolites 
1.1 INTRODUCTION 
Traditionally, research in plant pathology and plant physiology has 
focused on two types of microbial interactions, namely parasitism/predation 
and mutualism (symbiosis). Because both types of interactions generally 
involve a plant host, and since the respective disciplines often emphasize 
agricultural applications, the importance of microbe-microbe  interactions 
within agricultural systems is often overlooked. Nevertheless,  an astounding 
number of interactions, both direct and indirect, inevitably occur among the 
individual populations within any microbial community  and can affect 
microbe-plant interactions. It is possible within certain agricultural systems 
to exploit the microbial interactions in order to biologically control plant 
pathogenic organisms that are not managed adequately by current control 
practices. 
Biological control is defined as the reduction in the amount of inoculum 
or the virulence of a pathogen accomplished by one or more organisms, 
excluding humans (Cook and Baker, 1983). Biological control of plant pathogens 
can be accomplished through modifying cultural practices to increase or 
maintain native antagonistic populations  or by artificially introducing 
antagonists or hypovirulent strains of the pathogen  either into the 
environment or onto the plant host. Therefore, successfully  implementing a 
biological control program requires an understanding of not only the agonist-
antagonist relationship, but also the environmental influences affecting the 
establishment of antagonist populations. Many ecologists advocate that 
homeostasis of very diverse communities is generally maintained via negative 
feedback, wherein an environmentally induced change in one population 2 
elicits a response within other communal populations so as to reduce the 
severity of the initial environmental stimulus (Bull and Slater, 1982). Because 
environmentally induced changes within microbial populations  are 
manifested as observable phenotypes, biological control systems serve as useful 
paradigms for physiological processes that occur in response to environmental 
conditions. As a result, biological control research provides a forum for 
understanding biochemical processes as well as the ecological mechanisms 
regulating these processes. 
Biological control organisms utilize a variety of mechanisms to inhibit 
their target pathogens. Competitive exclusion of a pathogen by a biocontrol 
antagonist results when the ecological niches occupied by both organisms 
overlap. The extent of ecological overlap may be nearly complete as in the 
competition between a virulent and a hypovirulent strain of  a pathogen 
(Paulitz et al, 1987; MacDonald and Fulbright, 1991; Chen  et al, 1994). 
Alternatively, two unrelated organisms may compete for limiting resources 
such as available iron (Loper and Buyer, 1991) or carbon sources (Nelson and 
Maloney, 1992; Pau litz, 1990). Other mechanisms that have also been implicated 
in biological control include parasitism (Adams, 1990), cross protection (Fulton, 
1986), and antibiosis (Fravel, 1988). Details of biocontrol systems utilizing 
these mechanisms are described within the  many comprehensive reviews 
that have been published (Weller, 1988; DeFago and Haas, 1990; Gould,  1990; 
Gutterson, 1990; Nelson and Maloney, 1992; O'Sullivan and O'Gara,  1992; 
Loper et al, 1994; Thomashow and Weller, 1995). It should be emphasized 
that in many systems, several biocontrol mechanisms concertedly contribute 
to the total biological control activity observed for a single antagonist. 
1.2 ANTIBIOSIS AS A MECHANISM IN BIOLOGICAL CONTROL 
Antibiotics are relatively small organic compounds produced by 
microorganisms via secondary metabolic pathways. Their production generally 
is not considered essential for survival of the producing organism, and the 
ecological importance of secondary metabolites has been debated for many 
years (Gottlieb, 1976; de Lorenzo and Aguilar, 1984; Williams and Vickers, 
1986; Maplestone et al, 1992; Stone and Williams, 1992; Vining, 1992). Research 3 
with biological control systems has demonstrated that, in some instances, 
antibiotics contribute to the ecological competence of the producing organism 
(Mazzola et al, 1992). Nevertheless, their production is  not an absolute 
requirement for survival of bacteria in natural habitats. 
Historically, it has been difficult to establish a role for antibiotic production 
in the biological control of plant diseases. Although antibiotics produced by 
biocontrol agents in vitro clearly supressed growth of target pathogens, there 
was little evidence for in situ antibiotic production by biocontrol organisms 
inhabiting soil or plant surfaces. Recently, molecular genetic techniques have 
been used to construct mutants that are deficient in antibiotic production. 
Comparison of the biocontrol activities of the isogenic mutant and the parental 
strains has provided further correlations between antibiotic production and 
the biocontrol activity of a microorganism in natural habitats.  Unfortunately, 
selection of the mutants generally has relied upon in vitro screening for 
pathogen inhibition without biochemical characterization. Mutations affecting 
antibiotic production are not limited to lesions within  biosynthetic loci; 
antibiotic production is mediated by global regulatory loci as well as genes 
closely linked to the biosynthetic gene cluster. Furthermore, lesions within 
genes affecting antibiotic precursor biosynthesis can also result in a non-
producing phenotype. Mutants selected for loss of antibiotic  production 
commonly have pleiotropic phenotypes (Kraus and Loper, 1992; Laville et al, 
1992; Haas et al, 1993; Lam et al, 1993; Willis et al, 1994).  Therefore, 
demonstrating the dependence of biocontrol activity through  a molecular 
genetic approach requires thoroughly characterized  mutants with genetic 
lesions in structural genes for antibiotic biosynthesis. 
The following examples highlight several secondary metabolites (Figure 
1-1) that are produced by organisms exhibiting biological  control activity. 
Although some of these compounds have not been definitively established 
as contributing factors to biological control, they nevertheless serve to illustrate 
the importance of molecular genetics in biological control  research as well as 
the requirement for rigorously characterizing the mutants used in these studies. 4 
Agrocin 84. Agrocin 84 is a bacteriostatic antibiotic  produced by the 
biological control organism Agrobacterium radiobacter K84 that inhibits DNA 
synthesis in A. tumefaciens, the causal agent of crown gall disease (Moore 
and Warren, 1979; Kerr, 1980; Farrand, 1990). Agrocin 84 production  is a 
plasmid determined phenotype of A. radiobacter K84. Curing A. radiobacter 
of the plasmid required for agrocin 84 production significantly reduces the 
biocontrol activity of this bacterium, but non-producing strains  partially 
suppress crown gall formation when introduced onto the plant host prior to 
infection by A.  tumefaciens. Although agrocin 84 production is  a major 
determinant of biocontrol activity, other factors also contribute to disease 
suppression. Increasing the agrocin 84 biosynthetic  gene dosage, however, 
does not further improve biocontrol activity (Shim et al, 1987). 
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Figure 1-1. Antibiotics with inhibitory activity against plant pathogens.
The antifungal metabolite oomycin A has been omitted because its molecular 
structure is unknown. 5 
Gliovirin. Gliocladium virens is a soil fungus with a demonstrated ability 
to parasitize Rhizoctonia  solani (Tu and Vaartaja, 1980; Tu,  1980; Howell, 
1982). Although G. virens also is able to inhibit the plant pathogenic fungus 
Pythium ultimum, initial evidence suggested that a non-parasitic mechanism 
was responsible for this activity (Howell, 1982). Subsequently, the  antifungal 
metabolite gliovirin was isolated and structurally characterized from G. virens 
culture extracts (Howell and Stipanovic, 1982).  Gliovirin inhibits only 
oomycete fungi, such as P. ultimum and Phytopthora species (Stipanovic and 
Howell, 1983). Mutagenesis of G. virens has allowed the isolation of gliovirin 
non-producing and over-producing strains. Gliovirin non-producing mutants 
were significantly less effective at controlling preemergence damping-off in 
Pythium infested soils, but the over-producing mutants did not increase disease 
suppression as compared to the parental strain. Although it is tempting to 
conclude that gliovirin is a contributing factor to the biocontrol activity of G. 
virens against P.  ultimum, these studies have not  demonstrated in situ 
gliovirin production. Furthermore, the non-producing and over-producing 
mutants have not been thoroughly characterized  to ascertain if the genetic 
lesions affect only gliovirin production. Therefore, further studies are necessary 
before the role of gliovirin in the biological control of P. ultimum can be 
unequivocally demonstrated. 
Oomycin A. Pseudcmonas fluorescens Hv37a exhibits in vitro antifungal 
activity against P.  ultimum (Gutterson et al, 1986) and produces  several 
antifungal metabolites (James and Gutterson, 1986). Although none of the 
compounds produced by this strain have been structurally characterized, one 
metabolite, oomycin A, is the major contributing factor for biocontrol activity 
(Howie and Sus low, 1991). Genetic analysis within Hv37a has identified at 
least four unlinked loci required for oomycin A production (Gutterson et al, 
1988; Gutterson, 1990). Several of these loci are responsible for induction of 
the biosynthetic genes by the oxidation of glucose via glucose dehydrogenase. 
The in situ expression of an oomycin A biosynthetic gene was demonstrated 
using a lacZ transcriptional fusion in both an oomycin A producing and 
non-producing strain (Howie and Sus low, 1991). Additional evidence for the 
ecological role of oomycin A production within Hv37a was obtained by placing 6 
a constitutive tac promoter upstream of the oomycin A biosynthetic gene 
cluster (Howie et al, 1989; Gutterson, 1990). By introducing the unregulated 
loci into the Hv37a chromosome, an increase in oomycin A  production 
correlated with a significant increase in biological control of P.  ultimum as 
compared to the wild-type strain. Furthermore, transcriptional fusions of the 
tac-derived promoter to a lux reporter gene revealed an increase of biosynthetic 
gene expression in situ (Gutterson, 1990). Demonstrating biosynthetic  gene 
expression in situ, however, does not necessarily establish antibiotic production 
because other regulatory mechanisms may ultimately control  antibiotic 
biosynthesis. 
Phenazine-1-carboxylic acid. Suppression of the phytopathogenic fungi 
Gaeumannomyces graminis var. tritici has been correlated to the production 
of phenazine-1-carboxylic acid by the biocontrol organisms Ps. fluorescens 
2-79 (Thomashow and Weller, 1988) and Ps. aureofaciens 30-84 (Pierson and 
Thomashow, 1993). The production of phenazine-1-carboxylic acid is one of 
the few cases in which a direct correlation has been demonstrated between in 
situ antibiotic production and biological control activity (Thomashow et al, 
1990). Phenazine-1-carboxylic acid biosynthesis also has a long term, positive 
influence on the ecological fitness of producing strains (Mazzola et al, 1992). 
Furthermore, the efficacy of Ps. fluorescens 2-79 as a biocontrol agent is a 
function of the target pathogen sensitivity to phenazine-l-carboxylic acid 
(Mazzola et al, 1995). Antibiotic production, therefore,  is not the sole 
determinant of biocontrol activity since non-producing  mutants partially 
suppress disease (Thomashow and Weller, 1988). 
The in situ production of phenazine-1-carboxylic acid is influenced by 
several edaphic factors such as the proportions of sand, organic matter, silt, 
and clay, soil pH, metal ions, and total carbon (Thomashow  and Weller, 
1995). Although these factors affect antibiotic production, it is likely that their 
influence is indirect, exerted through complex interactions between the host, 
pathogen, biocontrol agent, and soil. Phenazine-l-carboxylic acid  production 
also is regulated directly in response to cell density (reviewed in Pierson and 
Pierson, 1996). Two loci, phzR and phzl, have been identified via  nucleotide 
sequence analysis and are linked to genes encoding the biosynthetic enzymes 7 
of the phenazine pathway (Pierson et al, 1995). PhzR and PhzI belong to the 
LuxR/LuxI family of cell-density dependent regulatory proteins and are 
required for antibiotic production in Ps.  aureofaciens 30-84. PhzI shares 
sequence similarity to several N-acyl-L-homoserine lactone synthases. PhzR 
is presumably a transcriptional activator that induces phenazine-1-carboxylic 
acid production in response to the N-acyl-L-homoserine lactone derivative 
produced by PhzI. It is hypothesized that fungal infection is actually required 
for the Ps. aureofaciens population to reach the threshold density required 
for phenazine production as a result of an increase in root exudates released 
from root lesions. 
Pyrrolnitrin. Pyrrolnitrin is produced by  many Pseudomonas spp. 
(Leisinger and Margraff, 1979) and was identified initially as a contributing 
factor to biological control in Ps. fluorescens Pf-5 (Howell and Stipanovic, 
1979). Pyrrolnitrin inhibits several phytopathogenic fungi; however, it is most 
effective in situ against Rhizoctonia solani. Although the severity of R. solani 
infection as measured by seedling emergence was reduced by treating seeds 
with purified pyrrolnitrin, greater protection was afforded when Pf-5 itself 
was used as a seed treatment (Howell and Stipanovic, 1979). These results 
suggest that other biocontrol mechanisms may contribute to the inhibition of 
R. solani by Pf-5. 
Further evidence for the role of pyrrolnitrin production in biological 
control has been obtained in studies of Ps. fluorescens BL915 (Ligon et al, 
1996). A 6.2-kb genomic region within BL915 is required both for pyrrolnitrin 
production and for biological control activity (Hill et al, 1995). Nucleotide 
sequence analysis and pyrrolnitrin production in heterologous strains 
containing the cloned 6.2-kb region is compelling evidence for the existence 
of pyrrolnitrin biosynthetic genes within this region (Ligon et al, 1996; GenBank 
accession no. U74493). These results suggest that pyrrolnitrin is  a major 
contributing factor to the biological control activity of BL915. Pyrrolnitrin 
production does not appear to increase the ecological  competence of BL915 
(Hill et al, 1994); however, the duration of this competition study was relatively 
short (12 days) and may not have been sufficient to detect slight differences 
between the ecological competence of non-producing and wild-type strains. 8 
2,4-Diacetylphloroglucinol. 2,4-Diacetylphloroglucinol is produced by 
many isolates of fluorescent pseudomonads and exhibits activity against  a 
variety of plant pathogenic fungi (Thomashow and Weller, 1995). Production 
of this antifungal metabolite is globally regulated by the GacA/ApdA two 
component regulatory system within Ps. fluorescens (Laville, et al, 1992; Corbell 
and Loper, 1995) as well as by the sigma factors RpoS and RpoD (Schnider et 
al, 1995; Sarniguet et al, 1995). In independent studies using two Ps. fluorescens 
strains, antibiotic non-producing mutants  were obtained by transposon 
mutagenesis (Vincent et al, 1991; Fenton et al, 1992). In both cases, the isolated 
mutants were less suppressive against P. ultimum or G. grorninis var. tritici 
than were the wild-type strains. Subsequently,  a genomic DNA region 
conferring 2,4-diacetylphloroglucinol production was cloned from both strains 
and when transferred into heterologous hosts, significantly increased their 
biocontrol activity against the target pathogens (Fenton et al, 1992; Bangera 
and Thomashow, 1996). Four open reading frames that encode biosynthetic 
enzymes required for 2,4-diacetylphloroglucinol production have been 
identified within a 6.5-kb fragment from Ps. fluorescens Q2-87 (Thomashow 
et al, 1996; GenBank accession no. U41818). Since the  genes expressed 
heterologously in the previous studies were specifically involved in 2,4­
diacetylphloroglucinol biosynthesis, it is very likely that this antibiotic is a 
major contributing factor of biological control. 
Pyoluteorin. Pyoluteorin is produced by the biological control agent Ps. 
fluorescens Pf-5 and is active against the plant pathogenic fungus P. ultimum 
(Howell and Stipanovic, 1980). Treatment of  cotton seeds with either 
pyoluteorin or Pf-5 cultures prior to planting in Pythium infested soils results 
in similar levels of disease suppression and  was initially the basis for 
demonstrating the contribution of pyoluteorin towards the biocontrol activity 
of Pf-5 (Howell and Stipanovic, 1980). In a later study, Tn5 mutagenesis of 
Pf-5 was used in an attempt to further correlate pyoluteorin production in 
the biocontrol of P. ultimum on cucumber (Kraus and Loper, 1992). Seven 
pyoluteorin non-producing mutants were isolated; however, they were just 
as effective in disease suppression as the wild-type strain. More recently a 
study using Ps. fluorescens CHAO has demonstrated  that pyoluteorin 9 
contributes to biological control on cress but not on cucumbi, leading to the 
conclusion that the plant host appears to affects pyoluteorin's contribution to 
biological control (Maurhofer et al, 1994). Subsequent characterization of the 
Pf-5-derived Tn5 mutants localized all seven of the  transposon insertions to 
within a 21-kb genomic region (Kraus and Loper, 1995). Since it is generally 
accepted that biosynthetic genes are closely linked, it was assumed that this 
region encoded pyoluteorin biosynthetic enzymes. The expression of this 
region in situ was assessed on cotton and cucumber using an ice nucleation 
transcriptional reporter gene fusion. Although gene expression occurred on 
both plant hosts, expression on cucumber occurred after the infection period 
required by P. ultimum (Nelson et al, 1986). In light of the carbon source 
effects on pyoluteorin production within Pf-5 (Kraus and Loper, 1992; Nowak-
Thompson et al, 1994), differences in seed exudates could account for the 
plant host-dependent pattern of gene expression. 
1.3 STATEMENT OF RESEARCH OBJECTIVES 
The research described within this treatise represents an integrated 
approach to understanding the biosynthesis of pyoluteorin  within Ps. 
fluorescens Pf-5. Pf-5, originally isolated from a cotton rhizosphere, is effective 
at controlling Pythium damping-off of cotton (Howell and Stipanovic, 1980) 
and cucumber (Kraus and Loper, 1992), Rhizoctonia damping-off  of cotton 
(Howell and Stipanovic, 1979), and ascocarp formation by Pyrenophora tritici­
repentis on wheat straw residue (Pfender et al, 1993). In addition to producing 
pyoluteorin, Pf-5 also produces pyrrolnitrin (Howell and  Stipanovic, 1979), 
2,4-diacetylphloroglucinol (Nowak-Thompson et al, 1994; See Appendix 1), 
hydrogen cyanide (Kraus and Loper, 1992), and a pyoverdine siderophore 
(Kraus and Loper, 1992). 
Because of the importance of pyoluteorin in biological control (Section 
1.2), characterization of the genomic region required for  pyoluteorin 
production has been undertaken. Furthermore, pyoluteorin is  a structurally 
interesting metabolite due to the halogenated pyrrole moiety,  a relatively 
rare functionality found in terrestrial natural products. Therefore,  two 
principle objectives guided the research described within this treatise: the 10 
elucidation of the pyoluteorin biosynthetic pathway using  an isotope feeding 
methodology, and the nucleotide sequence analysis of the genomic region 
required for pyoluteorin production. Although the results herein  do not 
provide a complete understanding of pyoluteorin biosynthesis,  they 
nevertheless have revealed several interesting aspects of this pathway and 
have established a solid framework for future studies concerning both  the 
biochemical pathway and the regulation of pyoluteorin biosynthesis. 11 
Chapter 2. Biochemical Analysis of the Pyoluteorin Pathway 
2.1 INTRODUCTION 
The polyketide origin of natural products  was originally proposed by 
Collie (1907) based on the observation that successive  condensations and 
dehydrations of a few simple aldehydes or ketones can give rise to more 
complex structures. However, the biological significance of this proposal was 
not demonstrated until the introduction of radioisotopes in the 1950's. 14C_ 
labelling studies provided the  necessary evidence for Collie's original 
proposal, and also lead to an expansion of the biosynthetic hypothesis as an 
aid in the structural elucidation of natural products (Birch,  1957). Many 
polyketide biosynthetic pathways have since been probed using a variety of 
techniques, and many reviews have highlighted the recent developments 
within the realm of polyketide natural products (Robinson,  1991; Fenical, 
1993; Plater and Strohl, 1994; Rohr, 1995; Simpson, 1995; O'Hagan, 1995; Khos la 
and Zawada, 1996). The structural diversity of the polyketides  makes it 
necessary to limit this discussion to a few thoroughly characterized metabolic 
pathways, some of which represent "mixed" polyketide pathways (i.e. not 
solely acetate-derived). Although the polyketides described herein possess 
relatively simple molecular structures when compared to higher molecular 
weight polyketides, they nevertheless serve to illustrate the biochemical 
transformations often encountered in polyketide biosynthesis.  The 
biochemical reactions required for polyketide chain assembly and their analogy 
to fatty acid synthesis have been reviewed (Hopwood and Sherman,  1990), 
and will not be presented here. 
2.1.1 Rudimentary polyketide pathways: the tetraketides 
One of the most thoroughly studied polyketide systems in which both 
the genetic and biochemical aspects are understood, is the 6-methylsalicylic 
acid (6MSA) pathway found within various Penicillium  species. Several 12 
independent isotope labelling studies have firmly established the polyketide 
origin of 6MSA, 2.1 (Scheme 2-1; Birch 1967; Spencer and  Jordan, 1990). 
6MSA biosynthesis is processive and requires  an NADPH-dependent 
reduction before addition of the final malonyl-CoA unit (Dimroth et al, 
1970; Scott et al, 1974). Furthermore, elimination of the C-2 malonyl-CoA 
methylene hydrogens required for aromatization of the carbocyclic ring occurs 
stereospecifically (Spencer and Jordan, 1990; Jordan and Spencer, 1990). 6MSA 
synthase has been isolated and characterized (Dimroth et al, 1970; Scott et al, 
1974; Spencer and Jordan, 1992a). The gene encoding the 6MSA synthase has 
been cloned and sequenced (Beck and Ripka, 1990). The deduced polypeptide 
sequence exhibits similarity to several bacterial polyketide synthases and 
contains discrete catalytic domains required for polyketide assembly (see 
Chapter 3). 
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Orsellinic acid (OA; see Scheme 2-4, pg. 20) is a metabolite produced by 
Penicillium spp. that is structurally related to 6MSA, but contains an additional 
C4 hydroxyl moiety. OA synthase has been purified, and although it does 
not require exogenous NADPH for catalysis, it exhibits properties similar to 
6MSA synthase (Gaucher and Shepherd, 1968). The OA synthase gene sequence 13 
has not been reported. With the exception of the NADPH-dependent reduction 
at C4 of the aromatic ring, OA and 6MSA biosynthesis appear to occur via 
identical reaction pathways (Gatenbeck and Mosbach, 1959; Spencer and 
Jordan, 1992b). 
The bacterial metabolite 2,4-diacetylphloroglucinol (DAPG), 2.2, is 
produced by many fluorescent Pseudomonas species (Nowak-Thompson et 
al, 1994 and references therein; see Appendix 1). Although the DAPG structure 
certainly suggests that it is acetate derived (Birch, 1967; Mann, 1987), this  has 
never been experimentally proven. Nevertheless, two pieces of experimental 
evidence support this hypothesis. The identification of monoacetyl­
phloroglucinol (MAPG), 2.3, and the detection of enzyme activity converting 
MAPG to DAPG in a Pseudomonas species argues in favor of DAPG originating 
as a simple tetraketide (Shanahan et al, 1993). Furthermore, the biosynthetic 
gene required for DAPG production exhibits sequence similarity to several 
chalcone synthases (Thomashow et al, 1996), plant enzymes that utilize three 
malonyl-CoA equivalents in precursor formation for flavonoid phytoalexins 
(Kreuzaler and Halbrock, 1975; Hrazdina et al, 1976). Therefore,  DAPG 
biosynthesis most likely occurs as depicted in Scheme 2-2. 
Scheme 2-2 
0 
0 C H3 
CO2  SEnz  CH  HO  OH 
EnzS.C H3 
IT
0  0  0 
C H3  C H3 JP" 
OH 0  OH 0 
C H3 
2.3  2.2 
DAPG represents a fundamentally different ring structure from  6MSA 
due to the folding of the extended polyketide chain prior to cyclization (Scheme 
2-3). Cyclization of 6MSA requires C-C bond formation between C2 and C7 of 
the polyketide chain, whereas Cl and C6  are involved in bond formation 14 
within DAPG. Differences in cyclization regiospecificity are also apparent in 
naringenin chalcone, 2.4, and resveratrol, 2.5, plant-specific polyketide 
metabolites required for flavonoid and stilbene production, respectively 
(Mann, 1987; Kindl, 1985). Oxygenation patterns on the phenol ring highlight 
the similarity of naringenin chalcone to DAPG; however, the relationship of 
resveratrol to 6MSA is somewhat obscured by an apparent decarboxylation 
(Scheme 2-3). Although both chalcone and resveratrol synthase catalyze 
polyketide biosynthesis via successive condensations of malonyl-CoA, these 
enzymes are distinct from the polyketide synthases (Schroder et al, 1988; 
Lanz et al, 1991). 
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Although only two different ring systems are possible for any of the 
tetraketides, applying this same principle to larger polyketides greatly increases 
the structural variability within this class of natural products. Structural 
variation is an important consideration in biocombinatiorial design of novel 
compounds (McDaniel et al, 1995). It has also been suggested that folding 
patterns may represent biosynthetic and evolutionary relationships within 
the multicyclic polyketides (Rohr, 1992). 15 
2.1.2 Unusual polyketide starter units 
For many years, the contribution of starter units to polyketide structural 
variability has been an understated aspect of polyketide biosynthesis. However, 
recent proposals regarding biocombinatorial engineering of polyketide natural 
products have suggested manipulating the starter unit specificity of the 
polyketide synthase as a means of introducing novel structural variations 
(Katz and Donadio, 1993; Hutchinson and Fugii, 1995; Rohr, 1995; Khosla 
and Zawada, 1995). Alternative starter units  can sometimes be introduced 
into polyketide structures through precursor-directed biosynthesis (reviewed 
by Thiericke and Rohr, 1993). 
Of the naturally occurring polyketide starter units, acetate and propionate 
are, by far, the most widely used, but some structures exhibit alternative 
starter units (Table 2.1; also see Scheme 2-3 for starter units within naringenin 
chalcone and resveratrol.). Nevertheless, polyketide natural products 
possessing a non-acetate starter unit are encountered relatively infrequently. 
Starter units generally can be identified within the polyketide structure except 
in  cases of extensive post-assembly modifications or structural 
rearrangements. Only precursors that have been experimentally demonstrated 
as polyketide starter units are listed in Table 2.1. Although this list is extensive, 
it should not be considered complete. 
The existence of amino acid polyketide starter units is especially 
interesting in light of the similar thiotemplate mechanisms used in polyketide 
and non-ribosomal peptide biosynthesis (Kleinkauf and von Dohren, 1995 
and 1996). The substrates recognized by polyketide synthases and peptide 
synthetases are the activated CoA thioester and acyl adenylated amino acids, 
respectively. Since the activated amino acids eventually form  a thioester 
linkage with a 4'-phosphopantetheine prosthetic group in both the synthases 
and synthetases, it is tempting to speculate on the possibility of substrate 
competition within an organism possessing both biosynthetic pathways. It is 
likely that these activation strategies serve to channel substrates to the 
individual pathways and avoid direct competition between both pathways. 
Nevertheless, the activating enzymes offer a potential point for  the 
coordinated regulation of polyketide and non-ribosomal peptide biosynthesis. 16 
Table 2.1	  Non-acetate compounds that incorporate into the starter units of 
polyketide natural products. The location of each starter unit is 
indicated by darkened bonds within each structure. 
Amino Acids 
proline 
OH 0  H 
Pyoluteorin 
a 
if.  0 
C H3 
Pyralomicin 
a 
02N 
OHO H 
Dioxapyrrolomycin 
o-acetyl-L-serine 
3C. _ pN
O%
 
Rhizoxin 
glycine 
0  H3C H3C 
H3C) rk''')Y1 
C F13  C H3 
Tolytoxin 
13phenylalanine 
Hitachimycin 
(B.N-T., J. Loper, and S. Gould, 
unpublished results; Cuppels 
et al, 1986) 
(Kawamura et al, 1996) 
(Carter et al, 1989) 
(Kobayashi et al, 1986) 
(Carmeli et al, 1993) 
(Omura et al, 1982) 17 
Glycerol 
Linear Carboxylic Acids 
malonate 
hexanoate 
hexadecanoate 
Table 2.1 (cont'd) 
000 
(Lee et al, 1987)
0
 
Aplasmomycin
 
(Jeffs and McWilliams, 1981) 
H 
Cycloheximide 
, 
OH  NK4e2al 7 
Nit  (Thomas and Williams, 1983) OH 0H0 0 0 
Oxytetracycline 
(Bockholt et al, 1994) 
F1300  N  0 
H3 
Lysolipin 
OH 0  OH 
(Townsend et al, 1984; 110111 
C H3  Brobst and Townsend, 1994)
0
 
Averfulvin
 
(Walters et al, 1990) 
Anacardic Acid 18 
Table 2.1 (cont'd) 
Branched and Cyclic
 
Carboxylic Acids
 
2-methylpropionatel 
2-methylbutanoatel 
1-0  0 
Lathodoratin 
3-hydroxycyclo­
hexanoate2
 
Asukamycin 
3,4-dihydroxy­
cyclohexanoate
 
C H3 
CH 
Rapamycin 
Aromatic Carboxylic Acids 
benzoate3 
OH 0 
0 
3 
C H3 
Squalistatins 
(Tsou et al, 1989) 
(Al-Douri and Dewick, 1988) 
(Thiericke et al, 1990) 
(Lowden et al, 1996) 
(Burns et al, 1979) 
(Jones et al, 1992) 19 
Table 2.1 (cont'd) 
Aromatic Carboxylic Acids (cont'd) 
o-hydroxybenzoate 
(Aragozzini et al, 1988) 
cD2H 
Thermorubin 
m-hydroxybenzoate 
(Bennett and Lee, 1988) R= yy 
Mangostin 
3-amino-5-hydroxy­
benzoate4 
(Kibby et al, 1980; Lee et al, 1993; 
Ghisalba and Nuesch, 1981) 
1 Identical starter units are incorporated into several avermectin antibiotics (Chen et al, 1989;
Schulman et al, 1986). 
2 Ansatrienin A is a related antibiotic utilizing this precursor as the polyketide starter unit 
(Moore et al, 1993). 
3 Benzoate also serves as the starter unit for vulgamycin biosynthesis (Seto et al, 1976). 
4 The me ta-C7N unit is also used in other ansamycin antibiotics; see Staley and Rinehart,
1991. 20 
2.1.3 Post-assembly modifications of polyketide metabolites 
Post-assembly modification of polyketide structures greatly expands the 
structural variability of simple polyketides such as 6MSA or OA. The extent 
of these modifications range from simple transformations  of functional 
groups (i.e. methylations or oxidations/reductions) to complex oxidative 
cleavages and carbon skeleton rearrangements. Methylation by  S-adenosyl 
methionine and oxidative decarboxylation of the OA  sub-structure are 
required for biosynthesis of the fungal benzoquinone,  shanorellin, 2.6, 
(Scheme 2-4; Wat et al, 1971). Because the carbon skeleton of OA is found 
within a variety of fungal metabolites (Simpson, 1991), OA is a likely precursor 
to shanorellin. Nevertheless, this possibility has not been tested. 
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[Ox]  *CH3 -AdoMet 
OH  OH C H3 
C 02H  C 02H  C 02H 
OA 
*C H3-AdoMet  H3C  *C H3  -C 02 -Nap.
OH HO 
C 02H 
Two well known examples of an oxidative C-C bond cleavage followed 
by a structural rearrangement are found in the pathways leading to patulin, 
2.7, and penicillic acid, 2.8 (reviewed by Zamir, 1980 and Mann, 1987). Both 
patulin and penicillic acid are carcinogenic Penicillium metabolites derived 
from 6MSA and OA, respectively. Patulin biosynthesis requires ring cleavage 
at the C2-C3 bond of the aromatic ring. The epoxide intermediate was isolated 
from a patulin non-producing mutant and shown to efficiently incorporate 21 
into patulin (Scheme 2-5). In contrast, ring cleavage required for  penicillic 
acid biosynthesis occurs between the C4-05 bond of the aromatic ring (Scheme 
2-6). In light of the reaction pathway leading to patulin, it has been suggested 
that an epoxyquinone may serve as a penicillic acid precursor (Zamir, 1980). 
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Oxidative coupling of phenolic compounds is another post-assembly 
modification found in many natural products and is not limited to polyketide 
derived structures. Because oxidative coupling has been discussed extensively 
elsewhere (Brown, 1967; Geismann and Crout, 1969), it will only be mentioned 22 
briefly as it applies to usnic acid biosynthesis. Usnic acid, 2.9, is produced by 
several lichen species and labelling studies have established the biosynthetic 
pathway (Scheme 2-7; Taguchi et al, 1969). Although 4-methyl-MAPG, 2.10, 
is a precursor to 2.9, MAPG itself does not incorporate into usnic acid. It was 
therefore concluded that the aromatic methyl group is introduced prior to 
cyclization. It is possible that the 4-methyl moiety actually originates  via a 
propionate extender unit incorporated by the bacterial symbiont of the lichen. 
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2.2 BIOSYNTHETIC ANALYSIS OF PYOLUTEORIN 
It is apparent from the oxygenation pattern of pyoluteorin, 2.11, that the 
resorcinol moiety most likely results from the condensation of three malonyl-
CoA equivalents with proline, or a derivative thereof, serving as the starter 
unit for polyketide assembly. The specific incorporation of [1,2-13C2] acetate 
into pyoluteorin has demonstrated that pyoluteorin is indeed a polyketide 
metabolite (Cuppels et al, 1986) as evidenced by the labelling pattern found 
within the resorcinol moiety (Scheme 2-8). Furthermore, the  non-uniform 23 
labelling of the dichloropyrrole suggested that this moiety originated from a 
tricarboxylic acid cycle intermediate, a conclusion that is consistent with a 
proline derived starter unit (Scheme 2-9; Cuppels et al, 1986). 
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While the assembly of the resorcinol ring is by no means atypical, the 
use of an unusual starter unit by the presumed pyoluteorin polyketide 
synthase (PKS) justified further study of this system. The rapamycin synthase 
is the only PKS utilizing an unusual starter unit that has been characterized 
(Aparicio et al, 1996). Considering the current advances in PKS molecular 
genetics, a combinatorial approach to drug design is possible, and the ability 
to introduce diverse starter units into a polyketide offers an additional variable 
for drug design. The basis for starter unit selection by a PKS, however, is 
unknown. Therefore, the concurrent genetic  characterization of the 
pyoluteorin PKS and identification of the required starter unit substrate may 
reveal factors influencing starter unit fidelity. 
Further justification for this study focuses  on formation of the 
pyoluteorin dichloropyrrole ring. Over 2000 halogenated natural products 
have been reported (Gribble, 1996), but despite the  proliferation of these 
compounds, little is known regarding the halogenation reactions involved 
in their synthesis. Because halogenation is known  to increase the 
pharmacological effects of many compounds (Neidelman and Geigert, 1987), 
it is conceivable that a mechanistic understanding of biohalogenations could 
be exploited for the synthesis of new or otherwise costly antibiotics. 24 
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A considerable amount of effort has been directed, therefore, towards 
the isolation and characterization of haloperoxidases, enzymes that are capable 
of forming carbon-halogen bonds in the presence of halide ions and hydrogen 
peroxide (van Pee, 1996). However, it has yet to be demonstrated that any of 
the haloperoxidases so far characterized are responsible for the in  vivo 
halogenation of known natural products. It is quite likely that elucidating 
the pyoluteorin biosynthetic pathway will identify  a substrate for the 
halogenating enzyme(s) involved. Such  a discovery would allow the 
development of a specific assay required for the isolation and subsequent 
characterization of this unknown class of enzymes. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Preliminary studies: pyoluteorin production and isolation 
Pyoluteorin production was evaluated in a variety of liquid culture 
media. HPLC and TLC analysis of culture extracts indicated that pyoluteorin 
production was greatest in cultures grown on either modified King's medium 
B (King et al, 1954) or Bacto Peptone medium (Difco, 1984). Pyoluteorin 
production did not differ between these two media, and  modified King's 
medium B was chosen for further studies. 
By varying the peptone source within King's medium B, it was discovered 
that phytone resulted in approximately  a two-fold increase in pyoluteorin 
production as compared to proteose peptone #3. Several carbon sources were 
also used in an attempt to further improve production. The addition of 
glucose to the production medium appeared to increase DAPG production at 
the expense of pyoluteorin. The differential production of these antibiotics 
in response to carbon source parallels previous results demonstrating that 
transcriptional activity of a promoter within the pyoluteorin gene cluster is 
repressed in cultures containing glucose, but  induced in cultures 
supplemented with glycerol (Loper and Kraus, 1995). 
Aeration effects were examined by varying the flask size to medium 
volume ratio. In general, flasks containing  a smaller volume of medium 26 
result in elevated pyoluteorin production, presumably due to an increase in 
aeration rate. This result contrasts with an earlier report that pyoluteorin is 
produced only in non-aerated flask cultures (Bencini  et al, 1983). Lower 
temperatures (18 °C vs 27 °C) also supported greater metabolite production. 
Although it is not obvious why temperature would  serve to increase 
production, it is possible that the lower temperature more closely approximates 
the native habitat of Pf-5. 
A previously developed purification method for pyoluteorin required 
the fractionation of a crude extract by both column  and thin layer 
chromatography followed by derivatization and further purification (Cuppels 
et al, 1986). Several alternative solvent systems (see Section 2.5) therefore 
were developed that provided pyoluteorin of sufficient purity after  a single 
silica column chomatography for NMR spectroscopic analysis. 
2.3.2 Incorporation of proline into pyoluteorin 
In light of the previous biosynthetic study (Cuppels et al, 1986), the 
initial objective was to establish if proline is the primary precursor of the 
dichloropyrrole moiety. Therefore, an initial study was conducted in which 
R  L-proline was administered to growing cultures of Pf-5. After isolation 
and recrystallization to a constant specific activity, 19% of the total radioactivity 
added to the culture was detected in pyoluteorin. Although it was possible 
that proline may have been catabolized and the labelled products subsequently 
incorporated into pyoluteorin, the high level of radioactivity in the final 
product argued against this possibility. Nevertheless, [1-13C] -L-proline was 
administered to Pf-5 cultures in order to demonstrate the specific incorporation 
of proline into pyoluteorin. Purification and 13C-NMR analysis of pyoluteorin 
revealed a specific enrichment of 5.7% over and above the natural abundance 
carbonyl resonance for the 13C spectrum and provided definitive evidence 
that the dichloropyrrole is derived from proline (Scheme 2-10). 27 
Scheme 2-10 
0 H  CH 0 H 
2.11 
Based on the results of these simple feeding experiments,  several 
biosynthetic pathways could be envisioned in which proline serves as the 
primary precursor to pyoluteorin (Scheme 2-11). The proposed pathways all 
involve a pyrrolidine to pyrrole oxidation, the subsequent chlorination  of 
the pyrrole, and polyketide assembly of the resorcinol moiety.  Differences 
among the proposed pathways reside in the temporal order of the 
transformations. It was expected that biosynthetic feeding studies  would 
demonstrate involvement of deschloropyoluteorin, 2.12, and either pyrrole­
2-carboxylic acid, 2.13 or tetrahydrodeschloropyoluteorin, 2.14, and provide 
evidence for the intermediates in the metabolic pathway leading to 
pyoluteorin. 
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2.3.3 Involvement of deschloropyoluteorin 
Deschloropyoluteorin (DCP) was a logical target compound for the 
subsequent feeding studies because two of the three proposed pathways 
converge at this putative intermediate. Furthermore, DCP was readily 
synthesized (Scheme 2-12) by Friedel-Crafts aroylation of pyrrole with  2,6­
dimethoxybenzoyl chloride, 2.15, (Rao and Reddy, 1990) followed  by 
deprotection of 2.16 with aluminum bromide (Cue et al, 1981).  The 
intermediacy of DCP in the pyoluteorin pathway was first examined using a 
radioisotope trapping method. [1-14C]-Acetate was added to cultures of Pf-5 
with the expectation that pyoluteorin pathway intermediates would  be 
radiolabelled. Shortly after adding the labelled precursor, the cells were 
collected, lysed, and unlabelled synthetic DCP was added to the cell lysate. 
DCP was subsequently re-isolated from the lysate, but no radioactivity could 
be detected in the purified sample. 
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This unexpected result unlikely was due to insufficient labelling of 
pathway intermediates since approximately 3% of the total radioactivity was 
detected in pyoluteorin. Other explanations, however, could account for the 
lack of evidence from this experiment. The metabolic flux  through the 
pyoluteorin pathway may have been rapid enough to prevent accumulation 
of pathway intermediates. Addition of unlabelled carrier  DCP could 
sufficiently dilute the radiolabel to render it undetectable. Alternatively, it is 
also possible that DCP was not a pyoluteorin pathway  intermediate. 
Nevertheless, the outcome of this experiment does not allow for any definitive 
conclusions regarding the role of DCP in the pyoluteorin pathway. 29 
In light of the unsuccessful result from the isotope trapping experiment, 
the involvement of DCP in pyoluteorin biosynthesis was further investigated 
by isotope labelling studies. Treatment of DCP with 2H-trifluoroacetic acid 
afforded the deuterated compound, 2.17 (Scheme 2-13). Greater than  90% 
proton-deuterium exchange occurred on the pyrrole ring and approximately 
70% proton-deuterium exchange occurred at two of the three positions on 
the resorcinol moiety. 
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Higher reaction temperatures resulted in low yields of the  desired 
product, and this was likely the result of an acid-catalyzed rearrangement of 
the acylpyrrole (Carson and Davis, 1981). Attempts to deuterate DCP using 
2H20 and BF3-Et20 (McGeady and Croteau, 1993) were unsuccessful. Compound 
2.17 was subsequently fed to cultures of Pf-5 and pyoluteorin analyzed for 
deuterium enrichment by 2H NMR spectroscopy. Based on the amount of 
2.17 used in this feeding experiment (50 mg; 240 gmole) and a minimal 
NMR detection limit of 1 gmole 2H-pyoluteorin, the detectable limit for 
incorporation of DCP was approximately 0.5%. However, no deuterium was 
detected in the pyoluteorin sample isolated. Therefore, no valid conclusions 
regarding the intermediacy of DCP in the pyoluteorin pathway could be 
made on the basis of this experiment. 
Two observations made during the  course of the deuterium feeding 
experiment offer some insight to the limitations occasionally encountered 
in biosynthetic labelling studies. Since DCP is only sparingly soluble in water 
and the majority of 2.17 administered to the cell culture was recovered (98% 30 
with no loss of the label), it is possible that an insufficient amount of DCP 
was able to cross the cell membrane. The outer membrane structure of Gram-
negative bacteria is an effective barrier to macromolecules and allows limited 
diffusion of hydrophobic compounds (see references within Vaara, 1992). 
Several polycationic agents and divalent cation chelators are reported 
to decrease antibiotic resistance in Gram-negative bacteria by increasing the 
permeability of the outer membrane (Brown and Richards, 1965; Leive, 1967; 
Viljanen et al, 1986; Vaara, 1990; Vaara, 1992). Therefore, several cationic 
detergents, polylysine, and polymyxin B nonapeptide (PMBN) were tested 
for their effects on pyoluteorin production and DCP utilization by Pf-5 cultures. 
In addition, the organic solvents toluene and dimethylsulfoxide (DMSO) 
were also examined for their peameabilizing properties. It was expected that 
by increasing cell permeability to DCP, an increase in pyoluteorin production 
would be accompanied by a corresponding decrease in the concentration of 
exogenous DCP. Cell pellets from the detergent- and toluene-amended Pf-5 
cultures were visibly different from the control culture, and no pyoluteorin 
was detected in the corresponding culture extracts. Both PMBN and polylysine 
negatively affected pyoluteorin production in MgC12-containing  cultures. 
However, the suppressive effect of PMBN was not apparent in  a culture 
medium lacking MgC12 and amended with ethylenediaminetetraacetic acid 
(EDTA). Interestingly enough, DMSO did not affect pyoluteorin production 
when compared to the control culture. Nevertheless,  no changes in 
pyoluteorin production were observed when DCP was added to cultures. 
In spite of the negative evidence resulting from this study, it was reasoned 
that including either PMBN or DMSO in the culture medium may increase 
the chances for a obtaining a positive result. Since there was no apparent 
change in pyoluteorin production when DCP was added to the cultures 
however, the use of radioisotopes to increase sensitivity in future analysis 
was considered prudent. A semi-synthetic strategy was initially considered 
to obtain radiolabelled DCP by reductive dechlorination of labelled pyoluteorin 
obtained from "C-acetate fed cell cultures (Takeda, 1958; Birch et al, 1964). 
However, catalytic hydrogenation of pyoluteorin  on platinum oxide or 
palladium metal was unsuccessful. A total synthesis of 14C -DCP was therefore 
undertaken based on the Friedel-Crafts aroylation shown in Scheme  2-12. 
Labelled [14C0] -2,6- dimethoxybenzoic acid, 2.18, was readily available (Scheme 31 
2-14) by direct metalation of 1,3-dimethoxybenzene, 2.19, followed by treatment 
of the organolithium species with 14CO2 generated from Na214CO3  (Gilman 
and Ess, 1933; Gilman et al, 1940). Despite  reports that addition of 
tetramethylenediamine (TMEDA) to the reaction mixture  increases the 
overall yield and affects the regiospecificity of metalation (Slocum and 
Jennings, 1976; Cabiddu et al, 1979; Cabiddu et al, 1981), use of this reagent 
resulted in yields of <5%. However, reaction yields were increased ten-fold 
when TMEDA was omitted and THF was used as the reaction solvent instead 
of diethyl ether; a similar observation has been reported previously (Meyers 
and Avila, 1980). Conversion of 2.18 to the acid chloride, 2.15, was achieved 
with thionyl chloride (Bosshard et al, 1959), and the labelled product was 
used directly for the Friedel-Crafts aroylation without purification. 
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The labelled DCP thus synthesized was administered to Pf-5 cultures 
grown in medium lacking MgC12 and amended with EDTA and PMBN. 
Isolation of pyoluteorin from the culture  supernatant followed by 
recrystallization to constant specific activity revealed that none of the labelled 
DCP was incorporated. The lowest detectable limit of incorporation was 
calculated as 0.005% based on the amount of pyoluteorin produced (17.1 mg; 
62.6 pimole), a weighing accuracy of ± 0.10 mg, and a specific activity of at 
least 103 dpm mg-1 for the recovered pyoluteorin. 
Despite the considerable amount of effort focused  on the possible 
involvement of DCP in the pyoluteorin biosynthetic pathway, no evidence 
was obtained suggesting that DCP is a pyoluteorin precursor. Although it is 
tempting to refute the intermediacy of DCP, such a conclusion based solely 32 
on a lack of evidence would be unsound. Therefore, none of the proposed 
pathways leading to pyoluteorin could be discounted from these studies and 
other putative intermediates were considered. 
2.3.4 Involvement of pyrrole-2-carboxylic acid 
The putative intermediate pyrrole-2-carboxylic acid (PCA) lies at a branch 
point in the hypothetical biosynthetic routes leading to pyoluteorin (Scheme 
2-11) and therefore was chosen as the next target for further study. Although 
synthesis of PCA is feasible by reacting pyrrole with methyl chloroformate 
(Hodge and Rickards, 1963) or with trifluoroacetic anhydride in the presence 
of an acid scavenger followed by base hydrolysis (Sonnet, 1971), isotopic 
labelling of PCA is not convenient using either of these strategies. [13CO2H]­
PCA, 2.20, was synthesized instead (Scheme 2-15) from pyrrole and 13CO2 via 
pyrrylmagnesium bromide (Letellier and Bouthillier, 1957). Subsequently, 
2.20 was added to Pf-5 cultures as an aqueous solution, and pyoluteorin was 
isolated and analyzed for isotopic enrichment. However, no enrichment of 
the carbonyl resonance in the 13C NMR spectrum was observed. The lowest 
detectable limit for incorporation of 2.20 into pyoluteorin was calculated as 
0.3% based on the amount of pyoluteorin isolated (46.1  mg; 171 limole), a 13C 
NMR enrichment of at least 1.1% over natural abundance, and the amount 
of 2.20 administered to the culture (75 mg; 681 1.tmole). 
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Failure to detect incorporation of the free acid into pyoluteorin provoked 
consideration of the initial PKS substrate required for  biosynthesis. If the 
pyrrole is the actual starter unit for polyketide biosynthesis, it may be 
recognized by the PKS only as the ACP-CoA thioester.  The use of N­
acetylcysteamine (NAC) thioester derivatives to mimic the  ACP-bound 
substrate allows recognition of an advanced intermediate by active-sites within 
the PKS. This method has been used on occassion to incorporate postulated 
polyketide intermediates into several natural products (Yue et al, 1987; Cane 
and Ott, 1988; Brobst and Townsend, 1994; Dutton et al, 1994; Hai les et al, 
1994a; Hai les et al, 1994b; Cane et al, 1995 and references therein). 
Therefore, 2.20 was converted to the NAC thioester 2.21 (Scheme 2-16) 
by treatment with dicyclohexaneylcarbodiimide (Brobst and Townsend, 1994). 
The labelled product was dissolved in DMSO and administered to a 1 L 
culture of Pf-5. Generally, 40-55 mg of pyoluteorin can be recovered from a 1 
L culture, however in this instance, only 15 mg was isolated. Nevertheless, 
based on the amount of pyoluteorin produced (15 mg; 54.9 umole), a 13C 
NMR enrichment of at least 1.1% over natural abundance, and the amount 
of 2.21 administered to the culture (93 mg; 440.8 umole), the lowest detectable 
limit for incorporation of 2.21 into pyoluteorin was calculated to be 0.1%. 
The isolated pyoluteorin, however, was not labelled. 
Scheme 2-16 
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The absence of any positive results from these feeding experiments 
again obviates any definitive conclusion regarding the role of PCA in the 
pyoluteorin pathway. As was the case for results described in Section 2.3.3, 
none of the proposed pathways leading to pyoluteorin could be discounted. 34 
2.3.5 Involvement of tetrahydrodeschloropyoluteorin
 
The involvement of the proposed biosynthetic intermediate tetrahydro­
deschloropyoluteorin (THDCP, 2.14 in Scheme 2-11) was examined via isotopic 
feeding studies in a final attempt to elucidate the biosynthetic route leading 
to pyoluteorin. While the feeding study itself did not present any particular 
difficulty, synthesis of labelled THDCP was not as readily accomplished as 
was the syntheses of either DCP or PCA. Direct hydrogenation of 2.16  over 
palladium or platinum catalysts was unsuccessful, presumably due to the 
aromatic resonance stabilization of the pyrrole. However, N protection of 
the pyrrole as the tert-butoxycarbonyl derivative 2.22 (Scheme 2-17) provided 
sufficient delocalization of the nitrogen electron pair for reduction to occur 
(Kaiser and Muchowski, 1984). Although this methodology looked promising, 
complete deprotection of 2.23 was unsuccessful despite the variety of 
conditions examined (Greene and Wuts, 1991). 
Scheme 2.17 
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19% overall) 35 
An alternative protection strategy  was attempted via catalytic 
hydrogenation of an N,0,0-tri-tert-butoxycarbonyl  derivative of 2.12. 
Although complete characterization of the product  was not undertaken, 
resonances in the 1H NMR spectrum of the isolated product suggested only a 
partial reduction of the pyrrole. It is very likely that steric constraints of the 
tert-butoxycarbonyl protecting groups  were responsible for incomplete 
reduction of the pyrrole. Therefore, protection of the resorcinol ring with a 
less sterically demanding protecting group was examined within this synthetic 
strategy. 
Treatment of 2.12 with benzyl bromide resulted in protection of a single 
phenolic group as the benzyl aryl ether 2.24 (Scheme 2-18).  Conversion of 
this ether to 2.25 was afforded by treatment with base and di-tert-butyl 
dicarbonate. Catalytic hydrogenation allowed full reduction of the pyrrole to 
the pyrrolidine, presumably due to the loss of the benzyl protecting group, 
thereby relieving the steric effects limiting pyrrole  reduction. Removal of 
the remaining tert-butoxycarbonyl groups with trifluoroacetic acid resulted 
in THDCP as the desired product. The reaction scheme was then repeated 
using a mixture of [13CO]- and [14CO] -DCP. 
Scheme 2-18 
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Extremely low levels of radioactivity were found in the pyoluteorin 
purified from Pf-5 cultures that had been fed [1300/140-j u THDCP. Within the 
parameters generally accepted for biosynthetic feeding studies, the permissible 
error in determining radiochemical purity of the final product is + 3% of the 
specific molar radioactivity over the  course of three recrystallizations. The 
total disintegrations per minute (dpm) that were counted for the purified 
samples were in the range of 150-400 dpm. The specific activity of each 
sample from the last three recrystallizations fell within the permissible error 
range (969.39 ± 15.63 dpm mg-1 = 1.6% error) and corresponded to an observed 
incorporation of 0.1%. However, due to the low levels of radioactivity  for 
each counted sample, the specific activities were recalculated taking into 
account background radioactivity of -30 dpm. The standard deviation of the 
adjusted specific activities was more than twice the acceptable range (768.01 
± 59.52 dpm mg-1 = 7.5% error). It should also be noted that approximately 
90% of the total radioactivity added to the culture remained in the supernatant 
following extraction of the pyoluteorin and could not be recovered. 
Despite the presence of a 13C label in THDCP administered to the Pf-5 
culture, no evidence of enrichment was detected in the isolated pyoluteorin 
sample. However, in light of the low incorporation of radioactivity, this 
result was expected since the minimum detectable incorporation of ['CO]­
THDCP for this experiment was approximately 0.8%. 
Developing definitive conclusions from these results is difficult due to 
the inconsistency of the two interpretations of the radioisotope incorporation 
data. On one hand, it appears that THDCP is, in fact, incorporated into 
pyoluteorin, suggesting that it is a pathway intermediate. Furthermore, since 
90% of the radiolabel remained in the culture supernatant, the cell membrane 
may not be permeable to THDCP, thus preventing efficient utilization of 
this putative intermediate. If this is the case, the actual incorporation of 
THDCP into pyoluteorin was approximately 1%. Without  a complete 
characterization of the labelled compound remaining in the  supernatant, 
however, this point is merely speculation. The other possible interpretation 
of the described result is that THDCP is not a pathway intermediate. While 
this conclusion is supported by the lack of evidence implicating DCP as a 
pathway intermediate, both of these statements are based on negative evidence 
and, therefore, are suspect. 37 
2.4 CONCLUSION 
Although this study has demonstrated that proline is the  primary 
precursor leading to formation of the dichloropyrrole moiety of pyoluteorin, 
the results regarding postulated advanced intermediates  within the 
pyoluteorin biosynthetic pathway are inconclusive. No evidence was obtained 
for the involvement of either DCP or PCA within the pathway despite the 
various approaches used. Although isotope labelling data suggests that THDCP 
is a pathway intermediate, this evidence is tenuous at best since the extent of 
incorporation is low, given the level of background  radioactivity. 
Furthermore, if THDCP is a pathway intermediate, DCP should have been 
incorporated into pyoluteorin. The lack of evidence resulting from this study 
has forestalled identification of the starter unit required for polyketide 
assembly as well as the intermediate preceding halogenation. This is rather 
unfortunate since these points were the basis of justification for this approach. 
The limited success of these isotope feeding experiments brings into 
question the usefulness of this approach for future work with this organism. 
An isotopic labelling methodology will most likely be successful only if used 
in conjunction with a cell free extract or purified recombinant proteins. 
Because several genes within the pyoluteorin biosynthetic gene cluster have 
been cloned and sequenced (see Chapter 3), purified recombinant proteins 
can be obtained for use in future studies. 
2.5 EXPERIMENTAL METHODS 
Chromatographic analysis of pyoluteorin. Production of pyoluteorin 
was routinely assayed from a crude extract preparation of bacterial cultures. 
A 5-10 mL aliquot was removed from  a bacterial culture and cells were 
removed by centrifugation. The supernatant was then acidified to pH < 2 
with 1 N HC1. The solution was subsequently extracted with ethyl acetate 
(10% vol, 3x), the pooled organic layers back extracted with water (5% vol, 
3x), and the solvent removed by rotary evaporation.  The pyoluteorin 
contained within the crude extract was assayed using either thin layer or 38 
high performance liquid chromatography (TLC and HPLC, respectively). 
TLC analysis: Efficient resolution of pyoluteorin from the culture extract 
dissolved in Me0H was observed on aluminum backed, normal phase silica 
gel plates (Merck Kieselgel 60 F254) developed using  any one of the solvent 
systems listed below. Pyoluteorin was visualized  as an orange-brown 
derivative upon treatment with aqueous diazosulfanilic acid  (1 vol. of 5% 
NaNO2, 2 vol. of 0.9% sulfanilate in 1M HC1, and 3 vol. of 20% K2CO3). 
Solvent Mixture  Rf Value 
CHC13 / Me0H  0.32 
CHC13 / EtOAc  0.34 
CHC13 / Acetone  0.34 
Toluene/ Acetone  0.38 
It was also possible to resolve pyoluteorin (Rf 0.32) on reverse phase C18 
silica TLC plates (Whatman KC18F) developed with a mixture of 50% 0.5 M 
NaCl and 50% Me0H. 
HPLC analysis: Pyoluteorin was analyzed using a Waters C18 Nova-pak 
column (8 x 100 mm, 4p) eluted with 45% H20/25% Me0H/30% ACN at 1.5 
ml miri 1. Samples were dissolved in Me0H for injection onto the column 
and the eluant was monitored by UV absorbance at 310 nm. The retention 
time for pyoluteorin was 3.25 min. 
Pyoluteorin could also be assayed by normal phase HPLC (Nova-pak, 8 
x 100 mm, 414 with 75% hexane/25% EtOAc at 1.5 ml min-1 (retention time 
6.3 min). This method was not routinely used, however. 
Optimization of pyoluteorin production. Duplicate 5 mL cultures of 
Pseudomonas fluorescens Pf-5 (JL4092) were grown in 523 media (Kado and 
Heskett, 1970), King's medium B modified to contain 0.5% wt/vol glycerol 
(King et al, 1954), B10 medium (Nowak-Thompson and Gould, 1994), Nutrient 
Broth supplemented with 1% glycerol (Difco Laboratories,  Detroit, MI), and 
Bacto Peptone (Difco). Samples taken from each fermentation at 24 h, 48 h, 
and 70 h, were assayed by TLC and HPLC for relative pyoluteorin production. 
Peptone source: To investigate the effect of  peptone sources on 
pyoluteorin production, equal weights of Bacto Peptone (Difco Laboratories, 39 
Detroit, MI), phytone peptone (Becton-Dickinson, Cockeysville, MD), soytone 
peptone (Difco), neopeptone (Difco), and proteose peptone #3 (Difco) were 
substituted in the modified King's medium B formulation. In addition, two 
flasks containing proteose peptone #3 were supplemented with either Bacto 
yeast extract (Difco) or Amberex yeast extract (Red Star Specialties, Milwaukee, 
WI). Extractions and analysis for metabolites were performed as above. 
Carbon source: Equal weights of glycerol, sucrose, glucose, fructose, and 
gluconate were substituted as carbon sources into modified King's medium 
B formulation containing phytone peptone. Filter-sterilized solutions of 
glucose and fructose were added to the sterile medium aseptically. Extractions 
and analysis for metabolites were performed as above. 
Flask size: Medium to flask volume ratio effects  on pyoluteorin 
production were examined using cultures of a pyoluteorin over-producing 
Tn5 mutant of Ps. fluorescens Pf-5 (JL4239). Cultures were grown in 2-500 
mL flasks containing either 160 or 80 mL of modified  King's medium B 
containing phytone peptone, and in 2-250 mL flasks containing either 80 or 
40 mL of the same medium at 20 °C for 48 h. Pyoluteorin production was 
also examined under oxygen-limiting conditions. Cultures in 2-250 mL flasks 
containing either 80 or 40 mL of the modified medium were incubated 
without aeration at 20 °C for 48 h. Cultures maintained without shaking 
grew poorly and were not analyzed. 
Temperature effect: The temperature effect on pyoluteorin production 
was investigated for both strains JL4092 and JL4239. Strains were grown in 
modified King's medium B containing phytone peptone and either fructose 
or glycerol at 18 °C, 22 °C, and 28 °C for 48 h. Extractions and analysis for 
metabolites were performed as above. 
Production of pyoluteorin by Pf-5 in culture. For feeding studies and 
routine isolation of pyoluteorin, cultures of Ps. fluorescens Pf-5 were grown 
in a modified King's medium B (referred to hereafter as phytone medium) 
formulated as follows: 40 
phytone peptone  2.0% 
Glycerol  0.5% 
K2HPO4  0.15% 
MgSO4  7 H2O  0.15% 
All percentages are mass/volume. Medium was made to volume with 
deionized water and adjusted to between pH 7.0-7.2. Production was optimal 
in 40 mL cultures contained in 250 mL Erlenmeyer flasks;  however, large 
scale cultures were grown in 100 mL of phytone medium contained in 1 L 
Erlenmeyer flasks. All cultures were incubated at 19-22 °C  at 150 RPM for 
42-48 h. 
Isolation of pyoluteorin. Cells were removed from a 1 L culture of Ps. 
fluorescens Pf-5 (10-1 L flasks containing 100 mL phytone medium) by 
centrifugation and the supernatant was acidified to pH < 2 with 6N HC1. The 
solution was extracted with ethyl acetate (10% vol, 3x) and the pooled organic 
layers back extracted with water (5% vol, 3x). The organic layer was dried 
over anhydrous MgSO4 and the solvent was subsequently removed by rotary 
evaporation. The crude extract was adsorbed onto a small amount of silica 
gel and applied to a 2.5 x 15 cm silica gel (Silica Gel 60, 40-63  EM Science, 
Gibbstown, NJ) column equilibrated in either 3:1 toluene/acetone  or 4:1 
CHC13/acetone and fractionated by flash chromatography (Still et al, 1978) 
with the equilibrating solvent. The material thus isolated was further purified 
by recrystallization from hot CHC13 and was spectroscopically identical to 
pyoluteorin. 
1H NMR (300 MHz; d6-acetone) 8 9.02 (br s, exchangeable), 7.15 (t, 1H, J = 
8.2 Hz), 6.80 (s, 1H), 6.47 (d, 2H, J = 8.2 Hz), and 3.00 (br s, exchangeable). 13C 
NMR (75 MHz; d6-acetone) 8 183.1, 157.2, 132.5, 130.9, 119.5, 117.3, 113.0, 110.5, 
and 107.5. 
L-14C1  feeding study. Phytone medium (40 mL in 250  mL 
shake flask) was inoculated with Ps. fluorescens Pf-5 (over-producing mutant 
JL4239). The culture was grown under standard conditions (see above) for 24 41 
h. One milliliter of this culture was used to inoculate 100 mL phytone medium 
in each of two, 1-L shake flasks. After 16 h, 9.99 ptCi (2.20 E 7 dpm) of [U -14C]­
L-proline (ICN, Irvine, CA) dissolved in 18 mL H2O was divided into two 
equal portions and added aseptically to each 100 mL culture. Both cultures 
were combined 44 h after inoculation and pyoluteorin was extracted from 
the culture supernatant. Authentic, unlabelled pyoluteorin (20 mg) was added 
to the crude extract, and the combined samples purified by flash 
chromatography yielding 56 mg (207 1.unol) of pyoluteorin. The sample  was 
recrystallized to within 1% of constant specific radioactivity (1.18 E 5 ± 1.05 E 
3), indicating a 19 % incorporation of proline into pyoluteorin. 
[1-"a-L-Proline feeding study. A 40 mL seed culture of Ps. fluorescens 
Pf-5 (wild-type strain JL4239) was grown under standard conditions (see above) 
for 24 h. One milliliter of this culture was used to inoculate 100 mL phytone 
medium in each of ten 1-L shake flasks. Sixteen milligrams of [1-13C] -L-proline 
(CIL, Cambridge, MA) was dissolved in 10 mL H2O and equal portions added 
aseptically to each of the culture flasks 13 h after inoculation. 48 h after 
culture inoculation, pyoluteorin was isolated (47  mg; 173 innol) from the 
combined cultures and recrystallized from hot CHC13. An enrichment of 
5.7% over natural abundance of the pyoluteorin carbonyl resonance (8 183.0) 
was observed in the 13C NMR spectrum (75 MHz; d6-acetone). 
Synthesis of deschloropyoluteorin (2-(2',6'-dihydroxybenzoy1)-1H­
pyrrole; DCP; Scheme 2-12). 2,6-Dimethoxybenzoyl chloride (2.0 g; 9.97 mmol) 
and pyrrole (1 mL; 14.4 mmol) were combined in 20 mL dichloroethane  and 
cooled to 5 °C in an ice/water bath. A slurry of A1C13 (1.5 g; 11.25 mmol) 
suspended in 20 mL anhydrous CH2C12 was added to the mixture over 30 
min with stirring under an inert atmosphere. The reaction was allowed to 
warm to room temperature and stirred for 1 h. Work up of the reaction and 
purification of the desired compound was as described (Rao and Reddy, 
1990). Purification yielded 820 mg (40% yield) of 2,6-dimethoxy-DCP: mp 
197-198 °C [lit. (Cue et al, 1981) mp 192-195 °C[;1H NMR (300 MHz; d6 -DMSO) 
8 11.85 (br s, exchangeable), 7.34 (t, 1H, J = 8.5 Hz), 7.08 (m,41-1), 6.70 (d, 2H, J = 42 
8.5 Hz), 6.29 (m, 1H), 6.10 (m, 1H), 3.65 (s, 6H); 13C NMR (75 MHz; d6-acetone) 
8 184.5, 158.7, 136.9, 131.3, 125.6, 119.4, 118.6, 110.8, 105.1, and 56.2; EI HRMS 
m/z 231.0896 (calc. exact mass for C13H13NO3 231.0895). 
The 2,6-dimethoxy derivative (800  mg, 3.46 mmol) was subsequently 
dissolved in 115 mL of benzene and added to a vigorously stirred solution of 
A1Br3 (3.0 g; 11.28 mmol in 30 mL benzene). The bright  orange reaction 
mixture was stirred for 5 h at room temperature. The reaction was then 
added to a 1 L flask containing 130 mL of 3 N HCl and 30 mL EtOAc and 
stirred for 30 min. The aqueous layer was extracted with EtOAc (3 x 30 mL) 
and the combined organic layers dried over anhydrous MgSO4. The  crude 
extract was concentrated to dryness and fractionated on a flash silica gel 
column (5 x 15 cm) eluted in CHC13 and Me0H (9:1) yielding 510 mg of DCP 
(72% yield): mp 143-145 °C [lit. (Takeda, 1958) mp 142-145 °C]; UV. (HPLC 
solvent) 298 nm; 11-1 NMR (300 MHz; d6-DMS0) 8 11.76 (br s, 1H), 9.34 (s, 2H), 
7.06 (m, 1H), 6.98 (t, 1H, J = 8.1 Hz), 6.39 (m, 1H), 6.35 (d, 2H, J= 8.2 Hz), and 
6.11 (m, 1H); 13C NMR (100 MHz; d6 -DMSO) 8 183.6, 155.6, 133.3, 129.6, 125.1, 
118.1, 116.1, 109.6, and 106.4; EI HRMS m/z 203.0583 (calc. exact mass for 
CI IH9N03203.0582). 
Deschloropyoluteorin "C-isotope trapping experiment. Two  sets of 
duplicate production cultures (a total of 4-40 mL cultures in 250 mL flasks) 
were used in this experiment. One set was comprised of two flasks containing 
phytone medium and the two flasks within the other set contained phytone 
medium in which glucose was substituted for glycerol  (phytone / glucose 
medium). Each of the production cultures were inoculated with 400 JAL of a 
Ps. fluorescens Pf-5 (JL4092) seed culture  grown for 24 h. After 9.5 h, an 
aqueous solution of [1-14C1-sodium acetate (10 liCi) was added to each of the 
production cultures. The cells were collected by centrifugation from one 
phytone and one phytone/glucose culture at 14.5 h and  18.5 h following 
inoculation. The cells were then resuspended in 3-5 mL of  the culture 
supernatant and an equal weight of micro glass beads. The suspension was 
sonicated on ice using a probe-type sonicator for 15 min at 90% full power. 
The sample was then centrifuged to remove cell debris and glass beads. 
Approximately 60 mg of DCP (in Me0H) was added to each lysate solution. 43 
The DCP was isolated from the cell lysate using the methodology described 
for pyoluteorin with one important addition. Since DCP and pyoluteorin 
co-elute from the flash silica gel column, it was necessary to further purify 
the sample by reverse phase chromatography. The DCP/pyoluteorin mixture 
was applied to a 1.5 x 15 cm C18 reverse-phase silica gel column (Bakerbond; 
40 gm; JT Baker, Phillipsburg, NJ) and eluted with 50%  aqueous Me0H. 
Repeated recrystallization from benzene of the recovered DCP resulted  in 
complete loss of detectable radioactivity. 
The combined fractions containing pyoluteorin recovered from the C18 
silica column were determined to contain approximately 2.8% of the total 
radioactivity that had been added to the cultures. Unlabelled pyoluteorin 
was added to these fractions, but it was not possible to recrystallize pyoluteorin 
to determine accurate levels of incorporation. Therefore,  a sample of the 
recovered pyoluteorin was resolved from impurities by 2D-TLC (silica gel; 
4:1 toluene-acetone; 9:1 CHC13-Me0H) and subjected to scintillation counting. 
Deuterium exchange of deschloropyoluteorin with 21-1-trifluoroacetic acid 
(Scheme 2-13). DCP (64 mg; 315 gmol) was dissolved in 1 mL of 2H­
trifluoroacetic acid and 700 gL of 21120. The solution was placed in a thick 
walled, glass tube fitted with a telfon stopcock and frozen in a dry ice bath. 
The tube was repeatedly evacuated and flushed with N2 (4 x). After the final 
flush, the tube was sealed and heated in an oil bath at 75 °C overnight. 
Solvent was removed under high vacuum and the crude product was eluted 
on a flash silica gel column with 9:1 CHC13 -MeOH yielding 50 mg of purified 
product (76% yield). The extent of labelling was estimated as >90% for the 
pyrrole ring and -70% for the m eta-positions of the resorcinol ring, based on 
the integration of resonances within the 1H NMR spectrum. Since the carbon 
resonance corresponding to the pa ra-position within the resorcinol ring 
exhibited limited isotopic splitting, it was presumed that limited deuterium 
exchange occurred at this position. Therefore proton  integrations were 
normalized to the para-proton resonance. 44 
2H- Deschloropyoluteorin feeding study. Phytone  production medium 
(5 x 100 mL in 1 L shake flasks) was inoculated with 800 'IL of an overnight 
culture of Ps. fluorescens Pf-5 (JL4092). 400 piL of a 2H-DCP solution (50 mg in 
2 mL EtOH) was added aseptically to each of the production cultures at 20 h 
after inoculation. Cultures were incubated until 48 h after inoculation when 
the supernatant was extracted as described above. The crude  extract was 
fractionated on a 2 x 20 cm C 18 reverse-phase silica column (Bakerbond; 40 
gm; JT Baker, Phillipsburg, NJ) and eluted with a 3:2 Me0H-water mixture. 
Both DCP and pyoluteorin were recovered (52.2 mg and 15.5 mg, respectively). 
2H NMR analysis of pyoluteorin showed no evidence of 2H-DCP incorporation. 
The 1H NMR spectrum for the recovered DCP  was identical to authentic 
material and indicated the exchange of the label had not occurred during the 
course of the experiment. 
Cell permeability study. Cultures (5 mL) of Ps. fluorescens Pf-5 (JL4092) 
were grown in phytone medium for 15 h at which time individual cultures 
received one of the following: 100 pit toluene, 100 pil DMSO, 50 mg mixed 
alkyltrimethylammonium bromide (primarily C14), 50 mg cetylpyridinium 
bromide, 50 mg methyltrioctylammonium chloride, PMBN  to 1 pig mL-1 and 
3 pig mL-1, or poly-L-lysine (MW 4000-15000) to 8  pig mL-1 and 16 lig mL-1. 
Additional 5 mL cultures were prepared in which MgC127H20 was omitted 
from the phytone medium and replaced with EDTA to a final concentration 
of 6.5 pig mL-1. The phytone/EDTA cultures were amended with either PMBN 
to 1 pig mL-1 and 3 pig mL-1 or poly-L-lysine to 8 pig mL-1 and 16 pig mL-1, 15 h 
after inoculation. All of the cultures also received 10 pit of a stock DCP 
solution (24 mg dissolved in 1.2 mL) at the same time point. Cultures were 
allowed to grow for an additional 26 h. Pyoluteorin production and changes 
in DCP concentration were analyzed qualitatively by HPLC as described above. 
Synthesis of 2,6-dimethoxy-['4C0]-benzoyl chloride (Scheme 2-14). 1,3­
Dimethoxybenzene (261 piL; 276 mg; 2 mmol) and n-butyl lithium (1.25 mL 
of a 1.6 M hexaneane solution; 2 mmol) were combined in a round bottom 
flask (25 mL) containing a stir bar and 5 mL anhydrous THF. The solution 45 
was refluxed for 4 h under Ar, after which time the condenser was removed 
and the flask fitted with a rubber septum. A mixture of 220 mg Na213CO3 
(CIL, Cambridge, MA) and 250 gCi Na214CO3 (ARC, St. Louis, MO) was placed 
in a separate round bottom flask (10 mL) containing a stir bar and fitted with 
a rubber septum. Both flasks were frozen in liquid N2, evacuated, and flushed 
with Ar (3x). Upon final evacuation, the two flasks were connected via 
candula needle and allowed to warm to room temperature. Concentrated 
H2SO4 (5 mL) was added to the Na2CO3 mixture and the organolithium reagent 
was again frozen in liquid N2 until CO2 evolution ceased. The candula needle 
was removed, and the reaction was warmed to room temperature and stirred 
for 24 h. The residue remaining in the reaction flask was dissolved in 10% 
NaHCO3 and extracted with Et20. The  aqueous phase was subsequently 
acidified to pH 2 with 6 N HC1 and the reaction product extracted into Et20. 
The organic layer was dried over anhydrous MgSO4 and evaporated, yielding 
209 mg of [14C0] -2,6- dimethoxybenzoic acid (0.055 gCi mg-1; 78% yield): mp 
183-185 °C [lit (Aldrich, 1997) mp 186-187 °C]; 1H NMR (300 MHz; CDC13) 
7.33 (t, 1H, J = 8.4 Hz), 6.60 (d, 2H, J = 8.4 Hz), and 3.88 (s, 6H); 13C NMR (75 
MHz; CDC13) 8 170.6, 157.8, 131.8, 111.5, 104.0, and 56.1; EI HRMS m/z 182.0579 
(calc. exact mass for C9H1003 182.0579). 
The entire sample of the labelled benzoic acid derivative was dissolved 
in a minimal volume of SOC12 and 1 drop of dimethylformamide was then 
added. The reaction was stirred overnight at room temperature under Ar. 
The solvent was subsequently removed under high vacuum and the material 
used directly in the Friedel-Crafts reaction as described above yielding 95.5 
mg of labelled 2,6-dimethoxy-DCP, approximately half (48 mg) of which was 
subsequently converted to labelled DCP (38 mg, sp. act. 0.982 tiCi 
P4C01-deschloropyoluteorin feeding study. Ps. fluorescens Pf-5 (JL4092) 
cultures (3 x 90 mL in 1 L shake flasks) grown in phytone medium lacking 
MgC127H20 under standard conditions were started from one milliliter of 
an overnight culture. Cultures were amended with PMBN (3 pg mL-1) and 
EDTA (6.5 pg mL-1) 14 h after inoculation. The labelled DCP (14.73 mg in 3 
mL DMSO) was simultaneously added to the cultures and growth continued 46 
until 50 h after initial inoculation. Pyoluteorin was isolated using the method 
described for the 2H-DCP feeding study. Following three recrystallizations of 
the recovered pyoluteorin from hot CHC13, no radioactivity was detected. 
rOD21-1)-Pyrrole-2-carboxylic acid synthesis (PCA; Scheme 2 -15). In a 
round bottom flask fitted with a rubber septum and stir bar, 20 mL of Et20 
was cooled to -10 °C followed by addition of 10 mL of EtMgBi (3.0 M ethereal 
solution). A solution of 2.08 mL pyrrole (2.0 g; 29.9 mmol) in 15 mL Et20 was 
added drop-wise and the reaction stirred for 15 min. The reaction mixture 
was frozen in liquid N2, evacuated, and allowed to thaw in an ice bath (3x). 
Upon final thawing, the reaction flask was connected via a candula needle 
to a second flask containing 2.05 g Na213CO3 (CIL, Cambridge, MA) and a stir 
bar under Ar. Concentrated H2SO4 (10 mL) was added to the Na213CO3 and the 
Grignard reagent was immediately immersed in liquid N2 until CO2 evolution 
ceased. The candula needle was removed, and the reaction warmed to room 
temperature over 3 h. The mixture was then poured into an ice slurry of 3 
M H2SO4 and the reaction product partitioned into Et20. The organic layer 
was dried over anhydrous MgSO4, treated with activated charcoal, and filtered. 
Crystallization was induced by partial evaporation of  the solvent and 
refrigeration, yielding 975 mg of while crystals: mp 204-207 °C (dec) [lit. (Letellier 
and Bouthillier, 1957) mp 204-207 °C]; 1H NMR (400 MHz; d6-acetone) 8 10.89 
(br s), 9.25 (br s), 7.06 (m, 1H), 6.87 (m, 1H), and 6.23 (m, 1H); 13C NMR (100 
MHz; d6-acetone) 8 162.9, 124.5, 123.5, 116.2, and 110.6; EI HRMS for [12CO2H] -PCA 
m/z 111.0320 (calc. exact mass for C5H5NO2 111.0320); EI LRMS for [13CO2F1] -PCA 
m/z 112.1. Calculated 13C-enrichment of the synthetic sample was 96% based 
on LRMS data. 
FI313211]-Pyrrole-2-carboxylic acid feeding study. Phytone medium (3 x 
100 mL in 1 L shake flasks) was inoculated with one milliliter of an overnight 
culture ofPs. fluorescens Pf-5 (over-producing mutant JL4239). Cultures were 
grown under standard conditions. Labelled PCA (75 mg) was dissolved in 18 
mL of 0.1 M NaHCO3 and administered in equal portions to the cultures at 
14 h and 21 h after inoculation. After 46 h of growth, pyoluteorin was isolated 47 
from the culture supernatant as described above. The sample (47 mg) was 
recrystallized from hot benzene and analyzed by 13C  NMR. Comparison of 
13C line intensities for the isolated sample to those of an identical, unlabelled 
pyoluteorin sample did not reveal any evidence of isotopic enrichment. 
(13C0]-Pyrrole-2-carboxylic acid N-acetylcysteamine thioester (NAC­
PC0]-PCA; Scheme 2-16). N,S-Diacetylcysteamine (2.4  g; 14.8 mmol) was 
hydrolyzed in 80 mL aqueous KOH (2.8 g, 49.9 mmol) for 2 h. The reaction 
pH was adjusted to 5.0 with 2 N HCl and the mixture  was saturated with 
NaCl. The brine solution was subsequently extracted with dichloromethane 
yielding N-acetylcysteamine as a clear oily residue: 1I-1 NMR (300 MHz; CDC13) 
8 7.03 (br s, 1H), 3.28 (q, 2H, J = 6.6 Hz), 2.53 (dt, 2H, J= 6.6 Hz and 8.4 Hz), 1.89 
(s, 3H), and 1.36 (t, 1H, J = 8.4 Hz). 
An aliquot of the N-acetylcysteamine preparation (800 A) was combined 
with [13CO2H] -PCA (250 mg, 2.23 mmol) and 4-dimethylaminopyridine  (27.5 
mg, 0.23 mmol) in 15 mL of anhydrous dichloromethane. The mixture was 
cooled to 0 °C and the flask flushed with Ar. 1,3-Dicyclohexaneylcarbodiimide 
(460 mg, 2.71 mmol) was added and the reaction was maintained at 0 °C with 
stirring. The reaction flask was subsequently removed from  the ice bath, 
allowed to warm to room temperature, and stirring continued for 4 h. The 
reaction mixture was then filtered through celite and placed under high 
vacuum overnight. Purification of the NAC-thioester was afforded by flash 
silica chromatography (2.5 x 15 cm column, 4:1 EtOAc- hexane) followed by 
recrystallization from 1,1,1-trichloroethane. A total of 195 mg of pure thioester 
was obtained: mp 110-111 °C ; UVmax (Et0H) 296 nm; IR (neat) 3304, 2930, 
2353, 1628, and 1598 cm-1;11 NMR (300 MHz; d6-acetone) 8 7.31 (br s), 7.11 (m, 
1H), 6.91 (m, 1H), 6.19 (m, 1H), 3.32 (q, 2H J= 6.5 Hz), 3.06 (t, 2H, J = 6.5 Hz), 
2.82 (s, 1H), and 1.82 (s, 3H); 13C NMR (75 MHz; d6-acetone) 8  180.1, 169.5, 
130.2, 124.8, 115.2, 110.3, 39.5, 27.6, and 22.2; EI HRMS for NAC-P2CORCA 
m/z 212.0619 (calc. exact mass for C9H12N202S 212.0619); EI LRMS for [13CO21-1]­
PCA m/z 213.1. Calculated 13C-enrichment of the synthetic sample was 96% 
based on LRMS data. 48 
(13C0]-Pyrrole-2-carboxylic acid N-acetylcysteamine thioester feeding 
study. Ps. fluorescens Pf-5 (JL4092) cultures (10 x 100 mL in 1 L shake flasks) 
grown in phytone medium under standard conditions were started from 800 
!IL of an overnight culture. NAC-[13C0]-PCA (92.3 mg) was dissolved in 4 
mL DMSO and equal portions were administered to the cultures at 13.5, 15.5, 
18, and 20 h after inoculation. Pyoluteorin (15 mg) was isolated from the 
combined culture supernatants 48 h after inoculation as described above. No 
enrichment was observed for the 13C carbonyl resonance in the NMR spectrum 
of the isolated pyoluteorin sample. 
Synthesis of protected tetrahydrodeschloropyoluteorin (242-hydroxy­
6'-methoxybenzoy1)-1H-pyrrolidine; Scheme 3-17). 2,6-dimethoxy-DCP  (203 
mg, 0.88 mmol) potassium-tert-butoxide (100 mg, 0.89 mmol), and di-tert-butyl 
dicarbonate (225  210.9 mg, 0.97 mmol) were refluxed in 30 mL anhydrous 
THE under Ar for 2 h. The reaction was washed twice with saturated NaCI. 
The reaction was fractionated on a silica gel flash column (1 x 15 cm) eluted 
with 3:7 EtOAc- hexane, yielding 218 mg of the N-protected compound: mp 
66-68 °C; UVmax (MeOH) 212, 248, and 286  nm; IR (CHC13) 2975, 2944, 1753, 
1673, 1605, and 1475 cm-1; 1H NMR (300 MHz; CDC13) 8 7.40 (dd, 1H, J = 3.4 
and 1.5 Hz), 7.29 (t, 1H, J = 8.4 Hz), 6.58 (dd, 1H, J = 3.4 and 1.5 Hz), 6.54 (d, 2H, 
J = 8.4 Hz), 6.10 (dd, 1H J = 3.4 and 1.5 Hz), 3.74 (s, 6H), and 1.60 (s, 9H); 13C 
NMR (75 MHz; CDC13) 6 182.6, 157.9, 149.3, 134.9, 130.7, 128.9, 124.3, 118.8, 
109.8, 104.0, 84.5, 55.9, and 27.4; EI HRMS m/z 331.1418 (calc. exact mass for 
C18H21N05 331.14197). 
The N-protected pyrrole (164  mg, 0.495 mmol) was catalytically 
hydrogenated over 10% Pd/C (77 mg) in MeOH (2 mL)  containing 2 drops 
conc. HC1 under 1 atm H2 for 36 h with vigorous stirring. The suspension 
was then filtered through glass wool and the filtrate triturated with CHC13 
forming a white solid. The precipitate was chromatographed on silica gel 
with 1:1 EtOAc- hexane yielding 138 mg of the 2,6-dimethoxy-tBoc-pyrrolidine 
as an oily residue: UV. (MeOH) 257 (shoulder) and 276 nm; IR (CHC13) 
2970, 2933, 2884, 1726, 1707, 1605, and 1473 cm-1;1H NMR (300 MHz; d4 -MeOH) 
8 7.37 (t, 1H, J = 8.4 Hz), 6.71 (d, 2H, J = 8.4 Hz), 4.94 (t, 1H, J= 5.7 Hz), 3.80 (s, 
6H), 3.43 (m, 2H), 2.04 (m, 1H), 1.89 (m, 2H), and 1.41  (s, 9H); 13C NMR (75 49 
MHz; CDC13) 8 200.8, 157.5, 154.5, 131.0, 117.9, 103.9, 79.1, 66.2, 55.7, 46.2, 28.5, 
28.1, and 22.9; EI FIRMS m/z 336.1786 (calc. exact mass for Ci8H25N05336.18110). 
The t-Boc protecting group was removed by treatment of the pyrrolidine 
(138 mg, 0.412 mmol) with 1.5 mL trifluoroacetic  acid under an inert 
atmosphere at 0 °C for 40 min. Evaporation of the solvent under high vacuum 
yielded the 2,6-dimethoxy-pyrrolidine derivative as an oily residue: UVmax 
(MeOH) 214 and 274 nm; IR (CHC13) 2966, 2842, 2768, 1790, 1722, 1673, and 
1592 cm-1; 11-1 NMR (300 MHz; CDC13) 8 9.59 (br s), 7.40 (t, 1H, J = 8.4 Hz), 6.60 
(d, 2H, J = 8.4 Hz), 5.21 (br s, 1H), 3.80 (s, 6H), 3.53 (m, 2H), 2.13 (m, 1H), 2.11 
(m, 2H), and 2.07 (m, 1H); 13C NMR (75 MHz; CDC13) 8 197.1, 158.1, 133.8, 
113.4, 104.2, 66.9, 56.0, 47.0, 27.9, and 23.9; EI FIRMS m/z 236.1287 (calc. exact 
mass for C13H18NO3 236.1287). 
The 2,6-dimethoxy pyrrolidine derivative (18  mg, 0.52 mmol) was 
dissolved in 2 mL anhydrous dichloromethane,  was cooled to -70 °C and 
BBr3 (510 !IL of 1.0 M solution) was added drop-wise. The reaction was removed 
from the dry ice bath and allowed to warm to room temperature and stirred 
for 2 h. The reaction mixture was poured into an ice slurry (20 mL), stirred 
for an additional 20 min, saturated with NaC1, and subsequently extracted 
into dichloromethane. Reaction work up yielded 6.5 mg of product. 1H NMR 
analysis revealed that only a single methyl group was removed and therefore, 
complete characterization of the compound was not undertaken. 1F1 NMR 
(300 MHz; CDC13) 8 8.36 (br s), 7.45 (t, 1H, J = 8.4 Hz), 6.61 (d, 1H, J = 8.4 Hz), 
6.42 (d, 1H, J = 8.4 Hz), 5.50 (br s, 1H), 3.95 (s, 3H), 3.63 (m, 2H), 2.64 (m, 1H), 
2.12 (m, 2H), and 1.91 (m, 1H). 
Synthesis of labelled tetrahydrodeschloropyoluteorin (2-(2',6'-dihydroxy­
13CO/4C01-benzoy1)-1H-pyrrolidine; [13C0114C0]-THDCP;  Scheme 2-18). 
Labelled DCP (63 mg, 0.310 mmol) was dissolved in 7 mL dimethylformamide 
containing Na2CO3 (72 mg, 0.683 mmol) and benzyl bromide (81 III., 116 mg, 
0.683 mmol). The reaction flask was charged with Ar and heated for 3 h at 
60-65 °C. Solvent was removed overnight under vacuum and the residue 
dissolved in 5-10 mL of EtOAc. The solution was subsequently washed with 
1N HCl (2x) followed by saturated NaCl (2x). Benzylated product was purified 
via flash silica chromatography (1  x 15 cm, 7:13 EtOAc- hexane) as an oily 50 
residue: UV,.. (EtOH) 295 nm; IR (CHC13) 3393, 2965, 2365, 1604, and 1551 
cm-1; 1H NMR (300 MHz; CDC13) 5 9.98 (br s), 7.28 (m, 4H), 7.17 (m, 2H), 7.01 
(m, 2H), 6.67 (d, 1H, J = 8.0 Hz), 6.57 (d, 1H, J = 8.1 Hz), 6.24 (m, 1H), and 5.06 
(s, 2H);13C NMR (75 MHz; CDC13) 8 184.7, 159.4, 157.6, 136.2, 133.4, 132.6, 128.3, 
127.7, 126.9, 125.6, 120.7, 113.8, 111.0, 110.5, 104.3, and 70.6; EI HRMS m/z 
293.1045 (calc. exact mass for C18H15NO3 293.1052). 
O-Benzyl-DCP (98 mg, 0.334 mmol) was combined with potassium  tert­
butoxide (93.8 mg, 0.836 mmol) and di- tert-butyl dicarbonate (192  182.4 
mg, 0.836 mmol) and the mixture refluxed in 25 mL anhydrous THE under 
Ar for 2.5 h. The reaction products were fractionated on a silica gel column 
(2 x 15 cm, 1:4 EtOAc- hexane) and the fully protected product was recrystallized 
from 1,1,1-trichloroethane and hexane yielding a white crystalline compound: 
mp 119-120 °C; UVmax (EtOH) 254 and 287 nm; IR (CHC13) 2977, 2936, 2876, 
2359, 1759, and 1720 cm-1; 1H NMR (300 MHz; CDC13) 8 7.42 (m, 1H), 7.35 (t, 
1H, J = 8.2 Hz), 7.26 (m, 3H), 7.26 (m, 2H), 6.86 (d, 1H, J = 8.2 Hz), 6.84 (d, 1H, J 
= 8.2 Hz), 6.58 (m, 1H), 6.11 (m, 1H), 5.03 (s, 2H), 1.49 (s, 9H), and 1.40 (s, 9H); 
13C NMR (75 MHz; CDC13) 8180.5, 157.2, 151.4, 149.3, 149.0, 136.2, 134.6, 130.8, 
128.4, 128.3, 127.7, 126.9, 124.1, 123.4, 115.5, 110.2, 110.0,  84.6, 83.4, 70.6, 27.4, 
and 27.3; EI HRMS m/z 493.2098 (calc. exact mass for C28H31N07 493.2101); 
Elemental analysis: found C 68.10, H 6.42, N 2.78, 0 22.70 (anal. calc. for 
C28H31N07: C 68.18, H 6.34, N 2.84, 0 22.64). 
Hydrogenation of the protected pyrrole derivative (114 mg, 0.231 mmol) 
was accomplished over 10% Pd/C (20 mg) in 3 mL EtOH under 1 atm 112 for 
5 h. The catalyst was removed by filtering the reaction through glass wool 
and the products fractionated by flash silica chromatography (1.5 x 15 cm, 
3:17 EtOAc- hexane) yielding 85 mg of N,O- t- Boc- pyrrolidine as an oily residue: 
U Vmax (EtOH) 210 (shoulder), 254, and 312  nm; IR (CHC13) 3150, 2977, 2936, 
2882, 2246, 1770, 1711, and 1693 cm-1; 1H NMR (300 MHz; CDC13) 8 12.44 (s, 
1H), 11.80 (br s, 1H), 7.43 (t, 1H, J = 8.3 Hz), 7.36 (t, 1H, J= 8.3 Hz), 6.88 (dd, 1H, 
J = 1.0 and 8.3 Hz), 6.85 (dd, 1H, J = 1.0 and 8.3 Hz), 6.73 (dd, 1H, J = 1.0 and 8.3 
Hz), 6.70 (dd, 1H, J = 1.0 and 8.3 Hz), 5.13 (m, 2H), 3.67 (m, 2H), 3.47 (m, 2H), 
2.38 (m, 1H), 2.24 (m, 1H), 1.93 (m, 6 H), 1.56 (s, 9H), 1.53 (s, 9H), 1.45 (s, 9H), 
and 1.23 (s, 9H); 13C NMR (75 MHz; CDC13) 8 205.6, 203.6, 163.8, 161.5, 154.9, 
153.6, 150.9, 150.8, 150.6, 150.0, 135.4, 134.2, 116.1, 116.0, 114.9, 113.5, 113.3, 
112.4, 84.6, 84.1, 80.4, 79.7, 64.9, 64.7, 46.9, 46.6, 30.3, 29.7, 29.5, 28.3, 27.9, 27.6, 51 
23.8, and 22.9; EI HRMS m/z 407.1944 (calc. exact mass for C211-129N07 407.1944). 
Full deprotection of the N,O- t- Boc- pyrrolidine intermediate (84 mg, 0.206 
mmol) occurred upon treatment with trifluoroacetic acid at 0 °C for 20 min. 
Solvent was removed under high vacuum and the residue  recrystallized 
from EtOAc and pentane, yielding 35 mg of [13C0/14C0] -THDCP (sp. act. 0.982 
m.Ci mg-1): mp 186-190 °C (dec); UVmax (EtOH) 278 and  356 nm; IR (CHC13) 
2995, 2757, 2365, 1670, 1634, and 1610 cm-1; 111 NMR (300 MHz; d4-Me0H) 8 
7.35 (t, 1H, J = 8.2 Hz), 6.43 (d, 2H, J = 8.2 Hz), 5.50 (dd, 1H, J= 5.5 and 9.3 Hz), 
3.42 (m, 2H), 2.67 (m, 1H), 2.09 (m, 2H), and 1.98 (m, 1H); 13C NMR (75 MHz; 
d4 -MeOH) 8 202.6, 166.3, 142.1, 111.2, 110.9, 70.1, 50.0, 33.2, and 26.9; EI HRMS 
m/z 207.08950 (calc. exact mass for C11H13NO3 207.08954). 
[13COP4C0]-Tetrahydrodeschloropyoluteorin feeding study.  Ps. 
fluorescens Pf-5 (JL4092) cultures (7 x 100 mL in 1 L shake flasks) inoculated 
from a common seed culture were grown in phytone medium under standard 
conditions. Labelled THDCP (35 mg, 12.9 liCi) was dissolved in 14 mL H20, 1 
mL of which was added to each culture 13 h and 16 h after inoculation. 
Cultures were grown until 42 h after inoculation. Pyoluteorin was isolated 
using standard methods and analyzed by 13C NMR. No enrichment above 
natural abundance was detected; therefore, the sample was recrystallized to 
constant specific radioactivity from hot CHC13. Specific activity was calculated 
with and without background correction (31.6 dpm). 52 
Chapter 3. Nucleotide Sequence Analysis of Loci Required 
for Pyoluteorin Biosynthesis 
3.1 INTRODUCTION 
A genomic region was identified previously within Ps. fluorescens Pf-5 
that is required for pyoluteorin production (Kraus and Loper, 1995; see Chapter 
1). Based on the fact that this region spanned approximately 21-kb and that 
transposon insertions within this region appeared to only affect pyoluteorin 
production, it was suggested that the structural genes encoding the pyoluteorin 
biosynthetic enzymes were localized within this 21-kb  fragment. Because 
pyoluteorin is a polyketide-derived metabolite (see Chapter 2), it was likely 
that genes encoding a polyketide synthase could be identified via nucleotide 
sequence analysis of the 21-kb genomic region. Although the principal 
objective of this study was to identify the pyoluteorin polyketide synthase, 
other loci also were identified that are likely responsible for chlorination of 
a pyoluteorin biosynthetic intermediate(s). The identification of  genes 
encoding the polyketide synthase and the halogenases required for pyoluteorin 
biosynthesis is intriguing in that the polyketide synthases  have been 
characterized extensively whereas halogenases are an almost unknown class 
of enzymes. 
3.1.1 Genetic organization of polyketide synthases 
The biochemical pathways as well as the biosynthetic enzymes required 
for fatty acid and polyketide biosynthesis share many similarities (Hopwood 
and Sherman, 1990; Katz and Donadio, 1993). Both  processes involve the 
serial condensation of short chain CoA-thioesters  (usually acetate-derived) 
and the subsequent reductive modification of the extended carbon chain. 
These reductive modifications involve the same types of transformations, 
namely, carbonyl reduction, dehydration, and enoyl reduction. Whereas fatty 
acid synthases (FASs) redundantly catalyze each one of these reactions and 53 
generally recognize only malonyl-CoA as a substrate, PKSs exhibit remarkable 
control over the extent to which each newly added carbon unit is modified. 
Furthermore, PKSs can utilize a variety of carboxylic acid.,  (e.g. acetate, 
propionate, or butyrate) as starter units (see Table 2.1) or for extending the 
carbon chain. Therefore, polyketides generally possess an elaborate carbon 
skeleton containing several oxidized functionalities. 
The protein structures of fatty acid and polyketide synthases are also 
similar, and these enzymes are classified as either Type I or Type II proteins. 
Like the Type I FASs present in vertebrates, Type I  PKSs are large 
multifunctional proteins containing several catalytic domains required for 
polyketide assembly. These domains are organized into one or more enzymatic 
modules, each containing a minimal  core set of domains: a ketosynthase 
(KS), an acyltransferase (AT), and an acyl carrier protein (ACP). Additional 
enzymatic domains, such as a ketoreductase (KR), may also be present within 
an individual Type I PKS module and are located between the AT and the 
ACP domains. In Type I PKSs possessing several modules, each module is 
responsible for the addition and modification of a single extender unit. In 
addition, these enzymes are processive and typically  require f3-carbonyl 
modification prior to addition of the next carbon unit. 
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Figure 3-1. Genetic organization and part of the reaction pathway catalyzed
by a Type I PKS. For this example, a single enzymatic module is encoded by a
single ORF. Only the reduction, dehydration, and the final  condensation 
within the pathway are presented to illustrate the processive mechanism of
the Type I PKSs. Abbreviations  are as follow: KS, ketosynthase; AT, 
acyltransferase; DH, dehydrase; KR, ketoreductase; ACP, acyl carrier protein;
SEnz, thioester linkage to the enzyme. 54 
The genes encoding several Type I PKSs have been characterized  from 
both bacterial and fungal sources. Fungal Type I PKSs generally are encoded 
by a single ORF containing one module and are responsible for biosynthesis 
of an aromatic metabolite, as exemplified by the 6-methyl salicylate synthase 
(6MSAS) from Penicillium patulum (Figure 3-1; Beck et al, 1990). Bacterial 
Type I PKSs, however, often contain multiple modules distributed  among 
several proteins and generally synthesize non-aromatic, macrolide antibiotics. 
Examples of bacterial Type I PKSs exist in which 2, 4, 5, or 6 modules are 
present within a single peptide (Cortes et al, 1990; Donadio et al, 1991; Aparicio 
et al, 1996). 
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Figure 3-2. Genetic organization and part of the reaction pathway catalyzed
by a Type II PKS. Only the first reduction and cyclization within the pathway
are presented to illustrate the non-processive mechanism of the Type II 
PKSs. ORFs are indicated by open boxes. Abbreviations are as follow: KS, 
ketosynthase; AT, acyltransferase; CLF, chain length determining factor; KR, 
ketoreductase; ACP, acyl carrier protein; SEnz, thioester linkage to the enzyme. 
In contrast to the multifunctional protein Type I systems, the Type II 
PKSs are multienzyme complexes comprised of a few, principally mono-
functional proteins (Figure 3-2). Three essential proteins (a  bifunctional 
KS/AT, a chain length-determining factor (CLF), and an ACP) are present in 
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all of the Type II PKSs described to date (Hutchinson and Fujii,  1995). The 
KA/AT, CLF, and ACP comprise a minimal PKS, which is necessary and 
sufficient for polyketide biosynthesis (McDaniel et al, 1994). Unlike the 
processive mechanism of the Type 1 PKSs, active sites within the  minimal 
Type II PKS are used iteratively to form an extended poly -(3- ketone chain 
prior to any reductive modifications of the carbonyls (i.e. a non-processive 
mechanism). The regiospecificity of the cyclization process is dependent upon 
several cyclases and, in some instances a ketoreductase, that function in 
concert with the minimal PKS (Hutchinson and Fujii, 1995). Other proteins 
within the Type II PKSs are thought to be required for starter unit specificity 
or post assembly modifications of functional groups present within the 
polyketide structure. 
Although the resveratrol and chalcone synthases are distinct from the 
polyketide synthases, they nevertheless are responsible for the formation of 
polyketide natural products. These synthases are single, homodimeric proteins 
that do not require the 4'-phosphopantetheinyl prosthetic group necessary 
for the PKSs (Kreuzaler et al, 1979; Schroder et al, 1988), and they possess a 
single cysteine residue that is required for activity (Lanz  et al, 1991). 
Furthermore, the dissimilarity between the peptide  sequences of the 
resveratrol/chalcone synthases and the PKSs suggests that these two classes 
of enzymes have convergently evolved to utilize  a similar catalytic 
mechanism (J. Schroder, personal communication). 
Within the fluorescent pseudomonads, only  two PKSs have been 
previously reported. The PKS required for 2,4-diacetylphloroglucinol 
biosynthesis in Ps. fluorescens Q2-87 exhibits similarity  to the chalcone 
synthases (Thomashow et al, 1996). A Type II PKS has been identified within 
Ps. syringae and is responsible for biosynthesis of the coronafacic acid moiety 
of the phytotoxin coronatine (Penfold et al, 1996). 
3.1.2 Halogenating enzymes in microorganisms 
Despite the existence of a few thousand halogenated secondary metabolites 
(Gribble, 1996), practically nothing is known about the enzymes responsible 
for the halogenation of these compounds. Historically, a non-specific enzyme 56 
assay based on the halogenation of monochlorodimedone in the presence of 
hydrogen peroxide and halide ion (Hewson and Hager, 1980) has been the 
principal method used in the isolation of known haloperoxidases.  Recently, 
however, gene disruption experiments have demonstrated that  several of 
the proteins thus isolated are not required for halo-metabolite production in 
the pathways to which they have been assigned (reviewed by van Pee, 1996). 
Furthermore, halogenation by many of these halogenating proteins  is non­
regiospecific, suggesting the protein has a negligible role in directing the 
reaction. Sequence comparison of these haloperoxidases has revealed 
structural  similarities  to  several serine-hydrolases  (Pelletier and 
Altenbuchner, 1995). The halogenations catalyzed by these  proteins are 
presumed to involve hydrogen peroxide hydrolysis of the serine ester within 
the hydrolase catalytic triad. The peracid thus formed reacts with halide ion 
generating the reactive halogenating species (van Pee, 1996). In light of these 
observations, it is quite possible that the halogenating activity of these proteins 
is an experimental artifact and not representative of their biological function. 
Genes encoding halogenases participating in secondary  metabolic 
pathways have been identified only recently. The encoded enzymatic activities 
have been experimentally verified by either complementation  or gene 
disruption. Therefore, the discovery of several loci within the pyoluteorin 
gene cluster that may encode halogenases is significant. Although data 
concerning the catalytic mechanism of these  enzymes is presently not 
available, it is possible that alignment of the deduced amino acid  sequences 
will identify invariant residues that may be required for catalytic activity. 
3.2 RESULTS AND DISCUSSION 
3.2.1 Nucleotide sequencing of the pyoluteorin region 
Nucleotide sequence analysis was initiated  on genomic DNA of Pf-5 
flanking each of the Tn5 insertions. One of the Tn5 inverted repeats and the 
flanking Pf-5 genomic DNA was cloned from each of five Tn5 mutants 
(Figure 3-3, insertions 4236, 4296, 4128, 4274, and 4175). The nucleotide sequence 57 
of the genomic DNA flanking each Tn5 insertion  was obtained via an 
oligonucleotide primer complementary to nucleotides  18-37 of the Tn5 
inverted repeat sequence (Gen Bank accession no. L19385). One of these 
sequences (insertion 4274) showed significant similarity to genes encoding 
the erythromycin polyketide synthase (PKS) of Saccharopolyspora  erythraea. 
Because pyoluteorin is a polyketide-derived metabolite (Cuppels et al, 1986; 
see Chapter 2), a PKS should be required for pyoluteorin biosynthesis. 
Therefore, initial sequence data was consistent with the hypothesis that 
insertion 4274 was within a pyoluteorin biosynthesis gene. Sequence analysis 
was continued with wild-type DNA of Pf-5 subdoned from cosmid pJEL1938, 
which contained the 18.4 kb region depicted in Figure 3-3. 
4236  4296  4128  4274  4175  4366 Hind111
 
EcoRl
 t EcoRl  Hind!!! EcoR1 EcoRl  I  EcoRl 
I  t  1 
orf-S  pitA  p/tB  pltC  pltD 
1.3 kb 
Figure 3-3. Genomic region required for pyoluteorin production and the
biosynthetic genes identified by nucleotide analysis. All transposon insertions
are numerically labelled. Tn5 insertion locations are designated by black 
diamonds. The orientation of a Tn3nice reporter insertion (4366) is is indicated 
by the open flag. Loci names are below the corresponding ORFs. 
Four complete ORFs in addition to a partial ORF were identified by 
codon preference analysis (West and Iglewski, 1988). The inferred peptide 
sequences of the two largest ORFs (pltB and pitC) exhibit extensive similarity 
to several PKSs. The identification of several functional  domains within 
P1tB and P1tC that are required for polyketide assembly is convincing evidence 
for the assigned function of these proteins. The inferred  gene products of 
pltA, pltD, and orf-S share sequence similarity to other halogenases. Because 
halogenases are a poorly characterized class of enzymes, however, enzyme 
function cannot yet be predicted from sequence similarity alone. 58 
3.2.2 Identification and sequence analysis of the pyoluteorin PKS 
Nucleotide sequence analysis of pltB and pltC. Two ORFs, pltB (7.4 kb) 
and pltC (5.3 kb), which encode proteins 2458 and 1774 amino acids in length, 
respectively, were identified within the pyoluteorin biosynthesis gene cluster 
and share sequence similarity to known PKSs (nucleotide sequence data for 
pltB and pltC are in Appendices 2 and 3, respectively). The translation initiation 
sites for both pltB and pltC were assigned based on the existence of postulated 
Shine-Dalgarno sequences 8 and 6 bp, respectively, upstream from the 
identified start codons. It is unlikely that an alternative translation initiation 
site exists upstream of the identified pltB start codon since it is immediately 
preceded by an in-frame stop codon. Although it appears that pltB and pltC 
are separated by 48 nucleotides (nt), a possible alternative pltC start codon 
exists 12 by downstream of pltB. A pltC gene initiated from this alternative 
start codon would encode 12 additional amino acid residues on the N-terminus 
of P1tC. However, no convincing Shine-Dalgarno sequence exists immediately 
preceding this alternative start site. Nevertheless it is possible that the two 
ORFs may be translationally coupled, given the short distance between the 
end of pltB and this possible pltC initiator codon (McCarthy and Gualerzi, 
1990). 
Comparison of pltB and pltC nucleotide sequences with entries in either 
the EMBL or Gen Bank databases revealed that these ORFs  exhibited 
similarities to several known Type I PKSs. At both the nucleotide and amino 
acid level, the most significant alignments of pltB and pltC were found with 
the eryA gene of S. erythraea, which encodes the PKS required for erythromycin 
production (Cortes et al, 1990; Donadio et al, 1991). Conserved amino acids 
found in the catalytic sites of several PKSs are also present in the deduced 
amino acid sequences of PltB and PltC and define catalytic domains within 
these proteins. These results suggest that both PltB and PltC possess enzymatic 
functions necessary for polyketide assembly. 59 
Modular organization of the pyoluteorin PKS  catalytic domains. The 
genetic organization of the Pf-5 pyoluteorin PKS exhibits features common 
to both bacterial and fungal Type I PKSs. Three KS, AT, and ACP catalytic 
domains and a single functional KR domain are present in P1tB and PDC 
(Figure 3-4). Two modules are present within P1tB. Of these, module 1 (1013 
aa) is located at the N-terminus of P1tB and contains only a core set of 
domains. Module 2 (1424 aa), located in the C-terminus of P1tB, contains an 
apparently non-functional KR domain in addition to a core set of domains. 
A single module (1774 aa) is present within PDC and contains the only 
functional KR domain identified within the this PKS as well as a presumed 
non-functional dehydrase (DH) domain. The simplified domain organization 
of module 1 and the presence of inactive catalytic domains (i.e. KR in module 
2 and DH in module 3) have precedence in bacterial systems (Aparicio et al, 
1996; Donadio et al, 1991). Nevertheless, several features of the pyoluteorin 
PKS such as the absence of a loading or thioesterase (TE) domain and  a 
single module within PltC, are attributes normally associated with fungal 
PKSs. 
ACP-1  ACP-2 
P1tB  KS-1  AT-1  KS-2  AT-2 
a 
1 
module 1  module 2 
ACP-3 
pltc Ili  KS-3  Naval  AT-3 
I  400 aa 1 
module 3 
Figure 3-4. Modular organization of the functional domains identified in 
P1tB and PltC. The individual domains within each of the three modules are 
designated by open boxes and are labelled according to their assigned function.
Stippled boxes represent the non-functional  KR and DH domains. 
Interdomain regions are represented by solid lines.  Abbreviations are as 
follow: KS, ketosynthase; AT, acyltransferase; CLF, chain length determining
factor; KR, ketoreductase; ACP, acyl carrier protein. 60 
Catalytic domains within the pyoluteorin PKS. Catalytic domains were 
identified within the pyoluteorin PKS modules using ProfileGap analysis as 
well as multiple sequence alignments for identified domains within known 
PKS and FAS sequences (Figure 3-5). Well-defined modules  such as KSs 
could be identified by either method. However, poorly defined regions or 
regions in which diagnostic sequence motifs were not found could be identified 
only by using a statistical analysis of the Profile Gap alignments. Active-site 
motifs and the invariant residues within the protein sequence could be 
identified only by using multiple sequence alignments. The C-terminal and 
N-terminal limits to any given domain also differed depending on whether 
multiple sequence alignment or Profile Gap analysis was used to define the 
domain (data not shown). It was not possible, therefore, to define the precise 
length of each domain within the pyoluteorin PKS. Although the statistical 
capability of Profile Gap analysis does not take into account all statistical 
properties of biological sequences (Lipman et al, 1984),  when used in 
conjunction with multiple sequence alignments, this alignment tool was 
invaluable in identifying regions of limited similarity  within poorly 
characterized domains. 
A KS domain of approximately 415 as is present within each of the three 
modules of the pyoluteorin PKS. An active-site Cys  residue within the 
sequence motif GPxxxxxxxCxSxL (Cortes et al, 1990) is present roughly 170 
residues from the N-terminal start of each KS domain.  Two His residues 
found to be invariant in both Type I and Type II PKSs (Aparicio et al, 1996) 
are also present within the KS of modules 1, 2, and 3. It has been suggested 
that one of these His residues may increase the reactivity of the active-site 
Cys by acting as a general base (Aparicio et al, 1996). 
Active-site serine residues exist within the PxxxxGHSxGxxxA sequence 
motif (Cortes et al, 1990) for each of the pyoluteorin PKS AT domains. The 
AT domain of module 3 exhibits a Pro)Ala substitution within this sequence 
motif. Also present within the AT domains of modules 1 and 3 are specific 
His, Arg, and Gln residues that have been identified in all Type I PKSs and 
FASs (Aparicio et al, 1996) and that are involved in the active-site structure 
of the malonyl-CoA:acyl carrier protein transacylase of  E. coli (Serre et al, 
1995). In contrast to modules 1 and 3, the assigned AT region of module 2 
exhibits limited similarity to the  sequences of known AT domains and 61 
Figure 3-5. Deduced peptide  sequence alignment for the three PKS
modules encoded by pltB and pltC. Each functional domain is delimited by
a solid black bar above the aligned sequences. The dashed regions of this bar 
designate the approximate boundaries for each domain. Profile  sequences
surrounding active-site regions within each identified domain are also located 
above the aligned sequences. The  consensus sequence located below the
aligned pyoluteorin PKS modules was generated from conserved residues 
(identified by uppercase text) within each domain. A 464 aa region from P1tC
has been eliminated for clarity and is designated by the double headed arrow. 
Individual aa residues discussed in the text are in bold type. "
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possesses several anomalous features. The Pro and His residues found in 
the motif surrounding the active-site serine have been substituted by  Ala 
and Phe residues, respectively. Furthermore, of the His, Arg, and Gln residues 
mentioned above, only the Arg is present in the deduced protein sequence. 
Two sequence insertions of 8 and 64 amino acids C-terminal to the active-site 
Ser are also apparent from the multiple sequence alignment with known 
AT domains. 
The enzymatic function of all ACP domains requires covalent attachment 
of 4'-phosphopantetheine to the Ser residue within an LGxDS sequence motif 
(Cortes et al, 1990). The Gly and Ser residues of this motif are present within 
the C-terminal regions of modules 1, 2, and 3, but substitutions for the Leu 
and Asp residues are present within the assigned ACP domains. In both 
modules 1 and 2, an Asp -*Ser substitution has occurred. Additionally,  a 
Leu>Met substitution has occurred in module 2  as well as a Leu -*Tyr 
substitution in module 3. Apparently these substitutions do not compromise 
enzymatic function, because based on the model for polyketide biosynthesis, 
functional ACP domains are an absolute requirement of the PKS. Consistent 
with this conclusion, it is generally recognized that  sequences flanking the 
ACP active site motif do not exhibit noticeable sequence similarity among 
PKSs. 
A KR domain was identified within a 178 amino acid region between 
the identified AT and ACP domains of module 3. The invariant GxGxxGxxxA 
motif, which is found in all functional KR domains (Aparicio  et al, 1996) 
and is believed to form part of the binding site for the cofactor  NADP(H) 
(Scrutton et al, 1990), is present in the module 3 KR domain. In contrast, an 
analogous region within module 2 of PltB exhibited very limited similarity 
to the C-terminal region of a KR profile sequence. Extensive substitutions of 
conserved KR amino acid residues within this module 2 region make  it 
unlikely that this domain is functional within the pyoluteorin PKS. Therefore, 
the pyoluteorin PKS appears to contain only  one functional KR domain 
residing in module 3. 
Within module 3 of the pyoluteorin PKS, a 558 as region between the 
AT and KR domains was examined for the presence of DH domain. Statistical 
analysis of the alignments between this region and a DH profile sequence 
suggests that limited sequence similarity does exist. Although DH catalytic 64 
domains are located typically between AT and KR catalytic  domains in Type 
I FASs (and some PKSs), DH domains are not well characterized, and it is 
difficult to identify a DH domain on the basis of sequence homology alone. 
No TE domain was identified within either P1tB or PltC. Although TE 
domains are not strictly required within Type I PKSs, those that have been 
identified are located at the C-terminal end of the last ORF (Donadio and 
Katz, 1992; Swan et al, 1994; Yu and Leonard, 1995). It is unlikely that a TE 
domain exists at the end of PltC since only 30 nt exist between the C-terminus 
of the ACP and the translational stop codon. 
Non-catalytic regions of the pyoluteorin PKS. The differences in lengths 
of the interdomain regions (IDRs) within P1tB and  P1tC accounts for the 
variable module sizes within the pyoluteorin PKS. Whereas the IDR between 
the KS and AT within modules 1 and 3 are approximately 100 residues in 
length, the same region within module 2 contains  248 aa residues. The 
KS/AT IDR of modules 1 and 3 align with the N-terminal portion of the 
KS/AT IDR of module 2. The AT and KR domains of module 3 are separated 
by 558 aa and the AT to ACP distances in modules  1 and 2 are 90 and 260 
residues, respectively. A qualitative, composite alignment derived from the 
individual pair-wise alignments for the C-terminal  IDR of each module 
suggests limited sequence similarity immediately preceding the ACP domains. 
However, the disparity among the C-terminal IDR for modules  1, 2 and 3 
precludes further comparison. 
The pyoluteorin PKS does not possess a loading domain. Initiation of 
polyketide assembly requires formation of an enzyme-substrate complex 
between an activated starter unit (e.g. acetyl CoA) and the first KS domain. 
Within bacteria, enzyme-substrate complex formation was attributed initially 
to a loading module comprised of an extra AT and ACP domain  located 
between the N-terminus of module 1 and the first KS domain (Donadio et 
al, 1991). Characterization of the rapamycin PKS indicates, however, that 
N-terminal loading modules are not restricted  to AT and ACP catalytic 
domains (Aparicio et al, 1996). In the rapamycin PKS, three catalytic domains, 65 
a carboxylic acid:CoA ligase, an enoyl reductase, and an ACP, are located at 
the N-terminus of the first PKS module and are likely involved with activation 
and reduction of the initial substrate (Lowden et al, 1996). The activated 
starter unit is then transferred directly to the first KS domain for polyketide 
assembly. In contrast to the bacterial PKSs, loading modules  have not been 
reported within fungal Type I enzymes. Furthermore, the heterologous 
expression of 6MSAS in the bacterium Streptomyces  coelicolor A3(2) (Bedford 
et al, 1995) implies that polyketide initiation can occur through an alternative 
mechanism within fungal Type I PKSs. Although no evidence for a loading 
module within the pyoluteorin PKS was found, this enzyme may possess an 
inherent, but as of yet unidentified, transferase activity  required to initiate 
polyketide biosynthesis. It is also possible that the initial substrate is directly 
transferred from another protein functioning earlier in the pathway. A gene 
encoding a CoA ligase within the pyoluteorin locus has  tentatively been 
identified (N.L. Chaney and J.E. Loper, unpublished) and may be involved 
in the activation and subsequent transfer of the starter unit onto the PKS. 
Alternatively, the pyoluteorin PKS may utilize the transferase activity from 
a distinct, yet related pathway. The suggestion that a malonyltransferase  is 
required for both fatty acid and polyketide biosynthesis  within two 
Streptomyces species (Reville et al, 1995; Summers et al, 1995) are of particular 
relevance to this possibility. 
Polyketide assembly of the pyoluteorin resorcinol moiety. The presence 
and organization of catalytic domains identified within the pyoluteorin PKS 
correspond to resorcinol ring formation within pyoluteorin. The addition of 
each C2 extender unit and modification of the resulting 13-carbonyl structure 
could be catalyzed by the combined activities within the individual modules 
of the pyoluteorin PKS (Figure 3-6). Although resorcinol ring synthesis within 
pyoluteorin requires dehydration at the 3-position, no functional DH domain 
was clearly identified. Therefore, dehydration may occur after release of the 
fully extended polyketide from the PKS. Tautomerization and the subsequent 
aromatization of I could very well be non-enzymatic processes due to the 
resonance stabilization energy resulting from this structural rearrangement 
(Armstrong and Patel, 1993). Release of the fully extended substrate from the 66 
PKS apparently does not require a dedicated TE domain, as none was found 
at the C-terminus of P1tC. However, a separate gene with similarity  to several 
TEs has been identified downstream of pltB and pltC and may terminate 
polyketide biosynthesis (N.L. Chaney and J.E. Loper,  unpublished). 
Alternatively the PKS alone may terminate polyketide biosynthesis  by 
cyclization (perhaps catalyzed by the unusual AT domain of module  2) as 
has been suggested for 6MSAS (Beck et al, 1990; Spencer and Jordan, 1992). 
PItB  PltC 
module 1  module 2  module 3 
..........
 
OH 0  H 
Pyoluteorin 
Figure 3-6. Proposed route for formation of the pyoluteorin  resorcinol 
moiety. The structure of the starter unit derived from proline is unknown 
and is designated as R. Condensation of each C2 extender  unit and the 
modification of the 0-carbonyl are catalyzed by each of the  three modules 
within the PKS. Release of the fully extended substrate is hypothesized to 
occur by condensation between the two carbon centers identified by the arrow. 
The aromatization of the resulting structure (conversion of I -4 II) is likely a
non-enzymatic reaction. 67 
3.2.3 Identification and sequence analysis of the pyoluteorin halogenases 
Nucleotide sequence analysis of pltA, pltD, and orf-S. Three ORFs in the 
pyoluteorin biosynthetic gene cluster, designated pl t A, pltD , and orf-S exhibit 
similarity to loci encoding chlorinating enzymes required for tetracycline 
biosynthesis (cts4) within Streptomyces aureofaciens (Dairi et al, 1995) and 
for pyrrolnitrin biosynthesis (prnC) within Ps. fluorescens (Hill et al, 1994). 
pitA (1.3 kb) and pltD (1.6 kb) were sequenced completely; both genes are 
transcribed in the same orientation as those encoding the pyoluteorin PKS 
(nucleotide sequences for pitA, pltD, and orf-S are in Appendices 4, 5, and 6, 
respectively). pitA and pltD are very closely linked to the PKS genes, and 
putative Shine-Dalgarno sequences are present immediately upstream of 
the start codon for each ORF. In contrast, a coding region exhibiting similarity 
to both pltA and pltD is located at the extreme 5' end of the pyoluteorin 
region (orf-S) and is transcribed divergently to the other  genes within the 
cluster. Because orf-S  is at the terminal end of the pJEL1938 cosmid insert, 
the complete nucleotide sequence was not determined. A Shine-Dalgarno 
sequence is not present within the orf-S sequence; however, the first four 
bases within this gene overlap the putative regulatory gene pltR (see Chapter 
4) suggesting that translation of the gene products may be translationally 
coupled. Transposon insertions within pitA and pltD inactivate pyoluteorin 
production (Figure 3-1) indicating a role for their translated products in 
pyoluteorin biosynthesis. 
Comparison of PItA, PltD, and Orf-S to halogenases involved in 
tetracycline and pyrrolnitrin biosynthesis. Dairi et al (1995) have identified a 
1.4 kb ORF (cts4) encoding the chlorinating enzyme required for tetracycline 
biosynthesis. An A+G rich region (AGAAGAG) between positions -20 to -14 
upstream from the postulated start codon was identified as the putative 
Shine - Dalgarno sequence of cts4. Several discrepancies between the nucleotide 
and deduced peptide alignments for cts4 , pltA, and pltD prompted a closer 
examination of the cts4 nucleotide sequence. In light of the unconvincing 
placement and sequence of the Shine-Dalgarno ribosomal binding  site 
proposed for cts4 and because the Pf-5 sequences aligned to a region extending 68 
approximately 300 nts 5' of cts4, it was considered likely that the beginning 
of the cts4 ORF was incorrectly identified. Indeed, codon preference analysis 
of the tetracycline biosynthetic gene cluster revealed that the reported sequence 
contains a frame shift error (data not shown).  Therefore, the Cts4 protein 
has had an additional 100 amino acids appended to the N-terminal region 
for all subsequent sequence alignments. 
PrnC  megkspane. hclarthFDVII
  10e3maGtql4 gaiLkIgAft
  VliiEessbP RftICHtas/P WralmnriIa dRYgIrildh itsfystgry VasSt.Gittr
 Cts4 mtdttadqtr hgdrpYDVVI
  ialsGlaGtmL geiLAIChgfr
  ImILDgahhP RfaV0ItstIr cOlvvLrlIs dRYgc.Xian lasfgdylan Vssah.GgSs
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Figure 3-7. The deduced peptide sequence alignments for the putative
halogenases PitA, PltD, and Orf-S with PrnC and Cts4. Residues in UPPER 
CASE letters signify conserved substitutions. Those in BOLD UPPER CASE 
letters are invariant among the available sequences (only the N-terminal
151 residues are available for Orf-S). The consensus sequence was calculated
with a plurality of 4. Residues involved in forming necessary secondary 
structure for binding NAD co-factors are indicated by asterisks (*) within the
the boxed region. 69 
Multiple sequence alignment of the Cts4 and PrnC halogenases with the 
three putative halogenases of the pyoluteorin gene cluster show a considerable 
amount of similarity throughout the protein sequences (Figure 3-7). Of the 
78 conserved residues among the deduced proteins, the  majority are 
concentrated in the N-terminal region. The most intriguing aspect of these 
sequences is that, with the exception of P1tD, they each possess  a core 
GxGxx(G/A) sequence believed to form the 13a--f3 secondary  structure 
required for NAD co-factor binding within many oxidoreductases (Scrutton 
et al, 1990). The NAD co-factor binding site had not been recognized previously 
within the reported halogenase sequences. This result suggests that the 
halogenases are a subclass of the oxidoreductase enzymes. 
Speculation on the parameters of biological halogenations. While  there 
appear to be no obvious mechanisms that would account for biological 
halogenations, it is possible to consider some of the chemical parameters for 
the enzyme substrates that may guide future research. These points are merely 
speculative at this point; although the genes have been identified, subcloned, 
and theoretically can be easily expressed, it is virtually impossible to undertake 
any mechanistic studies without knowing the substrate requirements of the 
enzyme. 
The solvation of chloride (i.e. C1) within protic solvents generally makes 
it a fairly poor nucleophile. Therefore, chlorination is likely to occur via an 
electrophilic addition or substitution mechanism. Such a reaction would 
require the electrophilic equivalent of a chloronium species (i.e. Cl'). Although 
results from previous research involving the haloperoxidases suggest this 
species might be HOC1, this conclusion is probably not biologically relevant 
because in vitro halogenation of a susbtrate requires the use of high H202 
concentrations. Within biological systems, reactive oxygen compounds like 
1-1202 are efficiently eliminated; therefore, it is unlikely that H202 could reach 
sufficient concentrations in  vivo to effect halogenation. Alternatively,  a 
chloronium electrophile may arise directly from metal-catalyzed  reaction 
with molecular oxygen. 
If the halogenation reaction does involve  an electrophilic addition or 
substitution, the substrate necessarily must be a good nucleophile. As a ic­70 
excessive heterocycle, pyrrole is quite facile at undergoing electrophilic attack. 
Furthermore, the aromaticity of the pyrrole carbon skeleton allows charge 
delocalization throughout the ring and could conceivably assist in stabilizing 
reactive intermediates and accounting for adding of chlorine atoms at the l­
and the 3-positions on the ring. Within the pyoluteorin pathway, therefore, 
halogenation is likely to occur after the pyrrolidine moiety has been oxidized 
to the pyrrole. 
3.3 CONCLUSIONS 
Several loci have been identified within the Pf-5 pyoluteorin biosynthetic 
gene cluster by sequence analysis, and the function for each of the encoded 
gene products serves either in a biosynthetic or a regulatory capacity. PltB 
and PltC encode a Type I PKS required for assembly of the pyoluteorin 
resorcinol moiety. Because many PKS sequences have been analyzed and the 
catalytic mechanisms of these enzymes are well understood, there is little 
doubt as to the assigned function of PltB and PltC. Nevertheless, the absence 
of a loading domain and the unusual AT domain make this PKS worthy of 
further study. 
It appears that three loci within the pyoluteorin gene cluster potentially 
encode halogenases. Furthermore,  sequence alignment of PltA, PltD, and 
Orf-S with two known halogenases has identified a potential NAD co-factor 
binding region that may play a role in catalytic activity. The presence of 
three halogenases in the pyoluteorin region is quite surprising because only 
two chlorine atoms are present within pyoluteorin.  Several possible 
explanations might account for this observation: i) Pf-5 may produce several 
(but as of yet unidentified) pyoluteorin homologues that differ only in the 
extent of halogenation. ii) One of the halogenases may be required for the 
biosynthesis of the presumed P1tR co-inducer. iii) One  of the halogenases 
may be non-functional. iv) There may be a cryptic chlorination involved in 
pyoluteorin biosynthesis. v) Several alternative routes to pyoluteorin may 
exist requiring chlorination of various precursors. vi) orfS may not be 
involved in pyoluteorin biosynthesis,  as no mutants in this region have 
been derived. In the midst of this speculation however, it should be stressed 71 
that the catalytic functions for Orf-S, PltA, and PltD have been assigned 
tentatively since this class of enzymes is relatively unknown  (nucleotide 
sequence data has been reported for only two other halogenases). In light of 
the novelty of these enzymes, characterization of the halogenation reaction 
required for pyoluteorin biosynthesis promises to be very exciting. 
3.4 EXPERIMENTAL METHODS 
Nucleic Acid Manipulations. Six DNA fragments from  the cosmid 
pJEL1938, which contains the genomic pyoluteorin biosynthetic region of Ps. 
fluorescens Pf-5 (Kraus and Loper, 1995), were subcloned into pUC19 using 
the restriction sites identified in Figue 3-3 and transformed into Escherichia 
coli DH5a using standard methods (Sambrook et al, 1989; Ausubel et al, 
1992). E. coli strains were routinely cultured in Luria-Bertani medium at 37 
°C (Sambrook et al, 1989). Double stranded DNA was isolated for automated 
sequencing by either QlAprep -Spin plasmid mini-prep  kits (Qiagen, 
Chatsworth, CA) or by Promega Wizard maxi-prep kits  (Promega, Madison, 
WI) and quantified by UV spectrophotometry. 
DNA Sequence Analysis. Sequence analysis of each subcloned region 
was initiated from the pUC primer sites and subsequently completed by 
"primer walking" in each direction across the entire length of the subclone. 
Automated DNA sequence analysis and primer synthesis were performed by 
the Center for Gene Research Central Services Laboratory  at Oregon State 
University and by Macromolecular Resources Sequi-net Division at Colorado 
State University using dideoxynucleotide chain-termination (Sanger et al, 
1977) on Applied Biosystems models 373A and 377 sequencers. Compilation, 
manual editing, and analysis of the  sequence data were done using the 
University of Wisconsin Genetics Computer Group (Genetics  Computer 
Group, 1991) programs (GCG). Open reading frames were identified within 
the DNA sequences by codon usage analysis utilizing the codon preference 72 
frequencies compiled for Ps. aeruginosa (West  and Iglewski, 1988). Protein 
functions were initially assigned on the basis of sequence similarity detected 
upon comparison to the Gen Bank or EMBL databases using BLAST (Altschul 
et al, 1990) and FASTA (Pearson, 1990) algorithms, respectively. 
Deduced protein sequence analysis. The catalytic  domains within P1tB 
and P1tC were identified by multiple sequence alignments (Pile Up) and by 
profile sequence alignments (Profile Gap) using standard parameters. The 
alignment analysis used various domain  sequences from the following 
representative Type I polyketide and fatty acid synthases (Gen Bank accession 
numbers are in parenthesis): the erythromycin PKS of Saccharopolyspora 
erythraea (M63676 and M63677), the rapamycin  PKS of Streptomyces 
hygroscopicus (X86780), the soraphen A PKS of  Sorangium  cellulosum 
(U24241), the mycocerosic acid synthase of  Mycobacterium tuberculosis 
(M95808), the 6-methylsalicylate synthase of Penicillium  patulum (X55776), 
and chicken fatty acid synthase of Gallus gallus (J04485). Interdomain sequences 
within the modules of P1tB and P1tC were manually aligned after comparison 
of several Gap generated alignments for these regions. 
Statistical analysis of the alignment between the domains in either P1tB 
or P1tC and the profile sequences above was performed using the  Best Fit 
algorithm with the RANDOMIZATION command  option. Scores were 
calculated for each alignment and compared to the  average alignment score 
for ten random sequences that maintained base composition and length. 
Scores that were 5 standard deviations above the mean were considered 
indicative of significant similarity. Those scores that were 1-5 standard 
deviations above the mean were considered of limited similarity. 
Conserved residues were identified within PltA, P1tD, and Orf-S by 
multiple sequence alignment with Cts4 of St. aureofaciens (D38214) and PrnC 
of Ps. fluorescens (U74493). The putative NAD co-factor binding site was 
identified manually. 73 
Chapter 4. Nucleotide Sequence Analysis of a Putative Transcriptional
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4.1 INTRODUCTION 
Secondary metabolite production is regulated by many factors including 
cell growth rate, extracellular signalling metabolites, and nutritional factors 
such as carbon, nitrogen, and phosphate sources (Demain et al, 1983; Grafe, 
1989; Liras et al, 1990; Horinouchi and Beppu, 1992; Vining,  1995). These 
regulatory factors do not necessarily operate independently, nor does each 
factor elicit an identical response for each antibiotic pathway that may exist 
within a single organism. For example, S. coelicolor A3(2) cultures containing 
nitrate as the sole nitrogen source exhibit differential production  of the 
pigments undecylprodigiosin and actinorhodin in late log  phase and 
stationary phase, respectively (Hobbs et al, 1990). The complex regulatory 
networks affecting antibiotic production appear to operate on two distinct 
levels. Global regulatory loci have pleiotropic effects that can either directly 
or indirectly regulate antibiotic production, whereas regulatory loci directly 
linked to biosynthetic genes generally mediate  gene transcription within 
that gene cluster (Martin, 1992; Hutchinson et al, 1993). 
Antibiotic production within Pf-5 is globally regulated, in part, by the 
sigma factor RpoS (as), which controls the transcription of many genes in 
response to starvation or the onset of stationary phase (Kolter et al, 1993; 
Lange and Hengge-Aronis, 1994; Hengge-Arronis, 1996).  Inactivation of the 
rpoS locus within Pf-5 results in the over-production of  both pyoluteorin 
and the antifungal metabolite 2,4-diacetylphloroglucinol (Sarniguet, et al, 
1995). Concurrent research involving a Ps. fluorescens strain that is strikingly 
similar to Pf-5, has demonstrated that increasing the gene dosage of the 
essential "housekeeping" sigma factor RpoD (a') also resulted in the over­
production of both antibiotics (Schnider et al, 1995). Both results support the 
hypothesis that RpoS and RpoD act in concert to regulate secondary 
metabolism possibly via competition for RNA polymerase. 
Antibiotic production within Pf-5 is also globally regulated by a two-
component regulatory system involving the  sensor kinase ApdA (Corbell 74 
and Loper, 1995) and the response regulator GacA (Laville et al, 1992). Within 
the two-component paradigm, an ATP-dependent auto-phosphorylation of 
ApdA (the sensor kinase) occurs in response to an environmental stimulus. 
Subsequently, ApdA phosphorylates GacA (the response regulator) which in 
its activated form, is capable of interacting with the target gene sequences to 
induce gene transcription (for general reviews of two-component regulatory 
systems, see Albright et al, 1989; Stock et al, 1990; Parkinson and Kofoid, 
1992). Mutations within either apdA or gacA result in several pleiotropic 
effects including complete loss of antibiotic production. Although both ApdA 
and GacA are necessary for gene expression in Pf-5, neither the environmental 
stimulus nor the genes targeted by GacA have been identified. 
Antibiotic pathways within other Pseudomonas spp. are locally regulated 
by gene products that are translated concurrently with the required biosynthetic 
genes (see Chapter 1, section 1.2). Recently, the gene cluster responsible for 
2,4-diacetylphloroglucinol production in Ps. fluorescens Q2-87 has been 
characterized (Bangera and Thomashow, 1996), and a 6.5 kb DNA fragment 
was shown to confer 2,4-diacetylphloroglucinol production within 
heterologous hosts. However, larger fragments containing flanking DNA 
sequence were unable to transfer antibiotic production. A linked gene encoding 
a 23 kDa repressor protein has since been identified via sequence analysis 
and accounts for the lack of expression in heterologous hosts (Thomashow 
et al, 1996). 
In the course of sequencing the pyoluteorin biosynthetic  gene cluster, 
an ORF was identified that is divergently transcribed from and located 
upstream from the pltABCD loci. The similarity of this gene to the LysR 
family of transcriptional activators (Henikoff et al, 1988; Schell, 1993) and the 
presence of a putative operator region upstream of pltA provides compelling 
evidence at this time for the role of the translated protein in the regulation 
of the pyoluteorin biosynthetic genes. Unfortunately, there is no experimental 
evidence that inactivation of pltR negatively affects pyoluteorin production 
within Pf-5. Therefore, the conclusions discussed below are tentative pending 
further genetic analysis of pltR. 75 
4.2 RESULTS AND DISCUSSION 
4.2.1 Nucleotide sequence analysis of pltR 
A 1.0 kb ORF (pltR), divergently transcribed from p1tABCD (Figure 4-1), 
was identified within the Pf-5 pyoluteorin gene cluster (nucleotide sequence 
of pltR is in Appendix 7). The translation initiation site as well as a possible 
Shine-Dalgarno sequence (positions -11 to -8 relative to the start codon) were 
identified 766 nt upstream of pltA. An alternative  start codon and Shine-
Dalgarno sequence exist approximately 60 nt upstream of the  identified 
initiation site, but it is unlikely that this is the site of translation initiation 
due to the presence of an in-frame stop codon 12  nt downstream. No 
alternative start sites are present within 100 nt downstream of the identified 
initiation site. Codon preference analysis detected an atypical codon usage 
and low G+C bias patterns within the first 500 nt of pitR. Whereas other 
genes within the pyoluteorin cluster exhibit G+C bias in the range of 75-85%, 
G+C bias for the pltR 5' region was approximately 35-45%. The low G+C 
content within pltR may have a regulatory  consequence for pyoluteorin 
production (via infrequently used tRNAs) or it may simply reflect a residual 
structural motif that is required for regulatory function. 
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Figure 4-1. Genomic region required for pyoluteorin production and the 
regulatory gene identified by nucleotide analysis. All  transposon insertions
are numerically labelled. Tn5 insertion locations are designated by black 
diamonds. The orientation of a Tn3nice reporter insertion (4366) is is indicated 
by the open flag. Shaded ORFs were described in Chapter 3. 76 
4.2.2 Similarity of P1tR to LysR-type transcriptional activators 
The deduced P1tR peptide sequence (344 aa) exhibits significant similarity 
to amino acid sequences of more than 20 members of the LysR  family of 
transcriptional regulators (Henikoff et al, 1988; Schell,  1993). LysR-type 
regulators influence an extremely wide range of phenotypes and have several 
common features: i) They generally act as transcriptional activators and require 
a co-inducer for activity. ii) The gene encoding a LysR homolog is often 
closely linked to and transcribed divergently from the regulated target gene(s). 
iii) A highly conserved N-terminal domain containing  a helix-turn-helix 
(HTH) motif, a somewhat variable co-inducer binding  domain, and a 
conserved C-terminal domain are present within all LysR-type regulators. 
iv) LysR regulators generally recognize  target promoters containing an 
inverted repeat within the -75 to -55 region (relative to the transcription 
initiation site). v) Expression of lysR- homologs is often negatively auto-
regulated. Despite these similarities, there  are no consistent biochemical 
relationships between either the required co-inducers or the proteins encoded 
by the regulated target genes. 
Based on the initial database search results, the highly conserved N-
terminal domain that is characteristic of all LysR-type proteins was readily 
apparent within P1tR (Figure 4-2). Further analysis using a calibrated weight 
matrix (Dodd and Egan, 1990), predicted with absolute certainty that a HTH 
motif exists between residues 20-41 within the N-terminal region of P1tR. In 
addition to the N-terminal domain, a co-inducer binding and a C-terminal 
domain were assigned via comparison of the P1tR sequence with a 70% 
consensus sequence for each of the three domains common to LysR-type 
proteins (Schell, 1993). Furthermore, many amino acid residues along the 
entire length of a profile sequence compiled from ten LysR-type proteins 
representing several phylogenetic groupings (Schlaman et al, 1992) also were 
conserved within P1tR. 77 
Figure 4-2. Gap alignment of P1tR and a LysR profile sequence. Identified
domains are indicated by bars above the sequence alignment. Domains were
identified from the 70% consensus sequences described by Schell (1993) as
shown. The helix-turn-helix motif (residues 20-41) within the N-terminal 
region was calculated using the method of Dodd and  Egan (1990). The
consensus sequence was calculated from the PltR-LysR profile alignment 
and adheres to the following conventions: Amino acid residues in UPPER 
CASE are identical within both sequences. Conservative substitutions are
designated as follows: g, hydrophobic residues (F, W, Y,  V, I, L, M); f,
hydrophilic residues (N, D, E). 78 
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4.2.3 A putative PltR binding site within the pyoluteorin gene cluster 
Promoters targeted by LysR regulators contain  an inverted repeat 
sequence centered near the -65 promoter region that exhibits a conserved 
TNTNA-N7-TNANA motif (Schell, 1993) and is essential for transcription 
mediated by LysR-type activator proteins (Ebright, 1986). An inverted repeat 
containing the TNTNA-N7-TNANA motif  was identified within the 
pyoluteorin gene cluster and is centered 45 nts 5' to the translation  start 
codon of pltR (Ebright box; Figure 4-3). It should also be noted that sequences 
flanking the identified Ebright box are particularly A+T rich, an attribute of 
some LysR-regulated promoters (Vale et al, 1991 and references therein). 
The proximity of the putative PltR binding region to the presumed 
pltR promoter region may serve to auto-regulate expression of PltR, as is 
characteristic of LysR regulons. Other potential PltR binding regions within 
the pyoluteorin gene cluster were identified by partial similarity to the 
TNTNA-N7-TNANA motif; however, these sequences did not possess the 
symmetrical inverted repeat characteristic (data not shown). 
ATCAATTTTCCCAAAGCCAACTAATCATGGCCCCAGCACTGCTTGACAAACAAAAAGCCT 
TAGTTAAAAGGGTTTCGGTTGATTAGTACCGGGGTCGTGACGINACTGTIrTGTTTTTCGGA 
pl to  -10 
AGCCGTACTAAGGAGGCTGTCATGATCTATTT GTAAT TT GC CTT TACK-1AAATAAGACAC 
TCGGClaiTGATTtCTCCGACAGTACTAGATAAACATTAAACGGAAATGTTTTTATTCTGTG 
-35 
RB S 
TAAAAATTCTAAAAGGATTTAGGAATGAAGGCGCTAGGCGTTGTCAATGACATAGACCTT 
ATTTTTAAGATTTTCCTAAATCCTTACTTCCGCGATCCGCAACAGTTACTGTATCTGGAA 
PltR 
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Figure 4-3. The putative promoter region of pltR. The identified Ebright
box containing the conserved motif TNTNA-N7-TNANA is in bold type.
The ribosomal binding site (RBS) and the N-terminal sequence of PltR are
also shown. Tentative -35 and -10 promoter regions for the pitA transcript
are also indicated by the boxed nucleotides. 80 
The presence of the Ebright inverted repeat  sequence has tentatively 
allowed identification of the pltA promoter region (Figure 4-3).  Although 
the -35 and -10 RNA polymerase recognition sites within the pltA  promoter 
region do not conform strictly to known Pseudomonas promoter regions 
(Deretic et al, 1989), the identity and positioning for 7 out of 12 nts within 
the pitA promoter regions are identical within three a"-dependent promoters. 
Nevertheless, it must be stressed that in the absence of  functional 
characterization and identification of the pitA promoter sequences, presumed 
similarities within the tentatively assigned -35 and -10 regions are speculative. 
4.2.4 Models for PltR-dependent regulation of pyoluteorin biosynthesis 
Identification of P1tR as a putative transcriptional activator is a significant 
contribution when viewed in the context of the global regulatory loci known 
to influence pyoluteorin production. In addition to the global regulators 
ApdA, GacA, RpoS and RpoD described above, a La protease has been identified 
recently as a negative regulator of pyoluteorin production (C. Whistler and 
I.E. Loper, unpublished). La protease induction is often associated with the 
heat shock response (Neidhardt and VanBogelen, 1987) and is involved in 
the proteolytic regulation of cellular development (Gottesman and Maurizi, 
1992). Although secondary metabolism is not formally  viewed as a 
developmental stage within bacterial metabolism, it is, nevertheless,  closely 
coupled with transition into stationary phase. It is possible that the identified 
Pf-5 La protease may regulate pyoluteorin biosynthesis via P1tR degradation. 
Recent studies also suggest that ApdA and GacA influence  the 
accumulation of RpoS (C. Whistler and J.E. Loper, unpublished); however, 
it  is unlikely that this two-component system regulates  pyoluteorin 
biosynthesis via RpoS because both ApdA- and GacA- mutants fail to produce 
pyoluteorin. Alternatively, ApdA and GacA may be required for production 
of the P1tR- binding co-inducer. Because pyoluteorin biosynthesis is also 
affected significantly by available carbon sources (Nowak-Thompson et al, 
1994), ApdA and GacA may exert their control either by  sensing carbon 
sources or by regulating co-inducer biosynthesis in response to an unknown 81 
signal. In light of the number of regulatory loci required for pyoluteorin 
biosynthesis and the many possible interactions between their gene products, 
it is apparent that pyoluteorin biosynthesis is controlled by  a complex 
regulatory network, an understanding of which is in its infancy. 
4.3 CONCLUSIONS 
The divergent orientation of PltR in relationship to the other pyoluteorin 
biosynthetic genes, the identified LysR-type domains (especially the N-
terminal HTH motif), and the presence of the inverted  repeat promoter 
binding region strongly suggest that PltR is  a LysR-type regulator. Because 
pltR is also closely linked to p1tABCD, it is likely that pyoluteorin biosynthesis 
is regulated by PltR. 
Whereas several global regulatory loci controlling  pyoluteorin 
production have been identified, this is the first report of a possible pathway-
specific regulatory mechanism. In keeping with the LysR regulatory model, 
PltR most likely requires a co-inducer to effect transcription of the pyoluteorin 
gene cluster. The absence of this co-inducer within other Ps eudomonas species 
could account for low transcription levels of the gene cluster within 
heterologous hosts (B. N.-T., J. Kraus, and J.E. Loper, unpublished  results). 
Because the biocontrol properties of Pf-5 are, at least in part, dependent upon 
pyoluteorin production and since transcription of the pyoluteorin gene cluster 
varies with respect to the plant host, the discovery of the pltR  locus holds 
great promise for improvement of biocontrol activity. 
4.4 EXPERIMENTAL METHODS 
The methods used for nucleic acid manipulations and  DNA sequence 
analysis of pltR were identical to those described in Chapter 3, section 3.4. 
Deduced protein sequence analysis. The described domains within PltR 
(see section 2.3) were identified via Profile Gap using standard  parameters. 
The LysR-profile used was constructed from the following  representative 82 
LysR-type regulators (Gen Bank accession numbers are in parenthesis): PtxR 
(U35068) and TrpI (X51868) of Ps. aeruginosa  ,  TcbR of an unidentified Ps. 
species (M80212), RcbR of Chromatium  vinosum (M64032), NahR (J04233) 
and CatR (U12557) of Ps. putida  ,  LysR (J01614), LeuO (J03862), and IlvY 
(M14492) of E. coli, and G1tC of Bacillus subtilis (M28509). The presence of a 
helix-turn-helix motif was confirmed using the program Helix-turn-helix v. 
1.0.5 (December, 1993) available via anonymous ftp from the ebi.ac.uk server. 
The putative P1tR promoter sequence was identified using the search routine 
in the GCG sequence editor (SeqEd). 83 
Chapter 5. Concluding Summary 
5.1 PYOLUTEORIN BIOSYNTHESIS 
The results of the work described herein have demonstrated that proline 
is the primary precursor leading to formation of the dichloropyrrole moiety 
of pyoluteorin. Although other putative intermediates were tested, the lack 
of incorporation of these labelled compounds into pyoluteorin have precluded 
any assessment of the biosynthetic pathway. Nevertheless, identification and 
characterization of several genes residing within a genomic region that was 
previously found to be required for pyoluteorin production (Kraus and Loper, 
1995) has provided some insight as to the assembly of pyoluteorin, as well as 
establishing this region as the biosynthetic gene cluster. 
The Type I polyketide synthase (PKS) encoded by pltB and pltC  contains 
several functional domains that each catalyze a single reaction required for 
forming the resorcinol moiety of pyoluteorin. Some structural  features of 
the pyoluteorin PKS were unexpected; namely the absence of both a loading 
and a thioesterase domain. With the exception of the rapamycin PKS (Aparicio, 
1996), most Type I PKSs possess each of these domains, which are responsible 
for the initiation and termination, respectively, of polyketide assembly. 
Although these domains are not absolutely required for PKS activity, their 
absence makes it difficult to otherwise reconcile polyketide chain initiation 
and termination. Concurrent work in our lab has identified and partially 
characterized genes encoding a CoA-ligase and  a thioesterase within the 
pyoluteorin gene cluster (N. Chaney and J. Loper, unpublished). The CoA­
ligase exhibits similarity to many amino acid activating synthetases that are 
required for antibiotic biosynthesis in a variety of organisms and may function 
in the initiation of polyketide biosynthesis by transferring the activated starter 
unit (perhaps prolyl-CoA) to the pyoluteorin PKS. Likewise, the thioesterase 
also shares similarity to a variety of thioesterases found within  several 
biosynthetic gene clusters and may catalyze the release and cyclization of the 
terminal PKS substrate. Nevertheless, future research must be directed at 
verifying their presumed functions, because the proteins encoded by these 84 
genes were identified based on sequence similarity alone. 
In contrast to the polyketide portion of pyoluteorin, the transformation 
of proline to the dichloropyrrole moiety is not easily discerned from gene 
sequences within the biosynthetic gene cluster. Three loci have been identified 
that encode halogenases that are likely responsible for the chlorination of 
one or more  pyoluteorin pathway intermediates. It is not immediately 
obvious, however, why three halogenases exist within a pathway that resolves 
to a dichioro- functionality. Nevertheless, chlorination is required for the 
biological activity of pyoluteorin (B.N.-T., unpublished result),  suggesting 
that these genes are required for the antifungal properties of pyoluteorin. 
Prior to this study, only three other halogenases had been identified, making 
this a poorly characterized class of enzymes. An NAD co-factor binding site 
was identified tentatively via protein sequence alignment of the halogenases 
described herein, suggesting that a formal oxidation or reduction may be 
required for halogenation. In light of the fact that chloride ion is a poor 
nucleophile, halogenation most likely occurs electrophilically via covalent 
bond formation between a chloronium equivalent (i.e. CI+)  at an electron 
rich carbon center. Therefore, oxidation of the proline-derived pyrrolidine 
moiety to the pyrrole may be a prerequisite to chlorination due  to the ability 
of pyrrole to undergo electrophilic reactions. 
One chemically feasible mechanism that accounts for the formation of 
the pyrrole and the subsequent halogenation is based on the identification of 
a gene encoding an acyl CoA-dehydrogenase within the pyoluteorin gene 
cluster (N. Chaney and J. Loper, unpublished). It is possible that this enzyme 
may catalyze the initial oxidation of the pyrrolidine ring to the A2-pyrroline 
derivative, 5.1 (Scheme 5-1). In a subsequent NAD+-dependent reaction 
catalyzed by either PltA or Orf-S, the A2-pyrroline would be further oxidized 
to 5.2, introducing the chlorine atom at C5 via proton abstraction from C4. 
Addition of the C4 chlorine atom would occur analogously via C5 proton 
abstraction mediated by PltD. Removal of the second proton from C4 would 
afford the 4,5-dichloropyrrole moiety of pyoluteorin, 5.3. 85 
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5.2 REGULATION OF PYOLUTEORIN BIOSYNTHESIS 
The translated gene production of the pltR locus, which has been identified 
within the pyoluteorin biosynthetic gene cluster, exhibits sequence similarity 
with other LysR transcriptional regulators. The divergent orientation of pltR 
from the pltABCD gene cluster, the identification of a helix-turn-helix motif 
within the N-terminal region of P1tR, and an inverted repeat sequence within 
the presumed promoter region of the pltA locus also suggest that P1tR is a 
LysR-type regulatory protein. The proximity of pltR to several pyoluteorin 
biosynthetic genes further implies that P1tR specifically  regulates the 
transcription of the biosynthetic gene cluster. Because most LysR-type proteins 
regulate transcription only in response to a co-inducer molecule, it is likely 
that pyoluteorin production also requires an as of yet unknown, co-inducer. 
This is possibly the first report of a LysR-type regulatory gene controlling 
antibiotic biosynthesis (Doull and Vining, 1995). Future studies will be directed 
towards demonstrating the function of the  gene product as in relationship 
to pyoluteorin production. 86 
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Appendix 1. Production of 2,4-diacetylphlorogiucinol by the biocontrol 
agent Pseudomonas fluorescens Pf-5 
NOTE: The material presented within this appendix was written under 
joint authorship with Drs. J. Kraus, J.E. Loper, and S.J. Gould and was published 
in Can. J. Microbiol. (1994) 40:1064-1066. B.N.-T. was the principal author of 
this work and responsible for the isolation and structural  confirmation of 
2,4-diacetylphloroglucinol and assisted in the quantitative  analysis of 
antibiotic production. Dr. J. Kraus identified bioactivity attributed to 2,4­
diacetylphloroglucinol production and was responsible for the quantitative 
analysis of antibiotic production within this strain. 
Antibiosis has been established as an important mechanism of biological 
control against plant pathogens through the application of modern genetic 
techniques (Lugtenberg et al. 1991; O'Sullivan and O'Gara 1992; Weller and 
Thomashow 1993). Current research has focused on metabolites produced by 
fluorescent pseudomonads and has implicated oomycin A (Howie and Suslow 
1991), phenazine-l-carboxylate (Pierson and Thomashow 1992; Thomashow 
and Weller 1991), 2,4-diacetylphloroglucinol (Keel et al. 1992; Vincent et al. 
1991), pyoluteorin (Maurhofer et al. 1992), and hydrogen cyanide (Voisard et 
al. 1989) as factors contributing to the suppression of  plant disease. 
Pseudomonas fluorescens strain Pf-5, originally isolated  from a cotton 
rhizosphere, is an effective biocontrol agent against Pythium damping-off of 
cotton (Howell and Stipanovic 1980) and cucumber (Kraus and Loper 1992) 
and Rhizoctonia damping-off of cotton (Howell and Stipanovic 1979). Pf-5 
also inhibits ascocarp formation by Pyrenophora tritici-repentis on wheat 
straw residue (Pfender et al. 1993). The antibiotics pyrrolnitrin and pyoluteorin 
have been isolated from cultures of Pf-5 and, when these metabolites were 
applied to seed surfaces, seedling damping-off caused by Rhizoctonia solani 
and Pythium ultimurn was suppressed (Howell and Stipanovic 1979, 1980). 
In addition to these metabolites, Pf-5 produces hydrogen cyanide, ammonia, 
a pyoverdine siderophore, and a previously uncharacterized antibiotic (A3), 112 
which inhibits growth of R. solani and P. ultimurn (Kraus and Loper 1992). 
We report herein the isolation and identification of A3, the effect of various 
carbon sources on A3 production, and its antibiotic activity  against several 
phytopathogenic organisms. 
Antagonism of P. ultimum by Pf-5 in culture was attributed earlier to 
the production of pyoluteorin (Howell and Stipanovic  1980). Pf-5 mutants 
deficient in pyoluteorin production, however, inhibit growth of P. ultimum 
on glucose-supplemented nutrient agar (NAG1c) (Kraus and Loper 1992), on 
which Pf-5 produces A3. Cultures of Pf-5 grown on NAG1c were extracted 
with aqueous acetone (80% v/v acetone), and A3  was partially purified by 
thin layer chromatography (TLC) (silica gel developed in chloroform/acetone, 
9/1, v/v). Because 2,4-diacetylphloroglucinol (Phl) is produced by many strains 
of P.fluorescens that exhibit biocontrol activity (Defago 1993; Harrison et al. 
1993; Levy et al. 1992; Shanahan et al. 1992) and inhibits mycelial growth of 
P. ultimum (Keel et al. 1992), we considered it a likely candidate for the 
identity of A3. A synthetic sample of Phl co-migrated with A3 on TLC and 
both compounds formed a brilliant yellow derivative when TLC plates were 
visualized with diazosulfanilic acid. Furthermore, analysis by C18 reverse 
phase HPLC (0.8 x 10 cm Waters Nova-pak radial compression  cartridge 
eluted with H20/MeCN/Me0H, 45:30:25 at 1.5 mL/min) revealed that both 
compounds exhibited identical retention times (6.4 min)  and possessed 
identical UV spectra (UV., 270 nm). 
To identify the structure of A3 unequivocally,  we isolated a sufficient 
quantity of the compound for spectroscopic analysis from a Tn5 mutant of 
Pf-5 (JL3985) that over-produced A3 regardless of the carbon source present 
in culture media (Pfender et al. 1993; Sarniguet et al. 1994). The bacterium 
was cultured in 1.5 L of glycerol-Phytone medium (5.0 g/L glycerol, 20 g/L 
Phytone Peptone (Becton and Dickinson, Cockeysville, MD), 1.5 g/L K2HPO4, 
1.5 g/L MgSO4 7 H2O, pH 7.0) at 20 °C with agitation (200 rpm). After 48 h, 
the culture supernatant was acidified to pH 2 with 3M HC1, extracted with 
ethyl acetate (3 x 150 mL), and the crude extract (0.5 g) was fractionated on a 
flash-silica gel column (5 x 15 cm) eluted with toluene/acetone (3/1, v/v). 
The fractions containing A3 (250 mg) were combined and re-chromatographed 
on a flash-silica gel column (2.5 x 15 cm) eluted with chloroform/methanol 
(9/1, v/v). Fractions containing pure A3 (180 mg) were combined and analyzed 113 
by standard 1H and 13C NMR spectroscopy. The chemical shifts in both the 1H 
and the 13C NMR spectra of A3 were identical with those observed for authentic 
Phl. (A3 was recrystallized from acetone/water: mp 173-174°C (lit. Strunz et 
al. 1978, 168-172°C); 1H NMR (400 MHz, acetone-d6) 8 16.30 (br s, 1H), 5.85 (s, 
1H), and 2.60 (s, 6H); 13C NMR (100 MHz, acetone-d6) 8 204.56, 172.69, 170.06, 
104.67, 95.62, and 32.76.) 
The spectrum of antibiotics produced by Pf-5 was affected by the carbon 
source composition of the culture medium (Table 1).When Pf-5 cultures 
were grown in nutrient broth (Difco Laboratories, Detroit, MI) supplemented 
with glucose (20 g/L), Phl was produced almost exclusively. This was consistent 
with the earlier observation that antibiotic A3 is produced on NAG1c. This 
result contrasts with the report by Shanahan et al. (1992) that Phl production 
by P. fluorescens F113 was reduced in response to glucose in culture media, 
and may reflect either differences in medium formulation or a fundamental 
difference in the regulation of Phl production between the two Pfluorescens 
strains. In contrast to Phl, pyoluteorin and pyrrolnitrin production  by Pf-5 
was diminished if nutrient broth was supplemented with glucose but 
enhanced if the medium was supplemented with glycerol  (Table 1). The 
differential regulation of antibiotic production within a given strain of 
Pseudomonas sp. is not without precedent and has been described for P. 
fluorescens strain HV37a (James and Gutterson, 1986). 
Table 1. Concentrations of antibiotics produced by P. fluorescens
 
Pf-5 in culture.
 
Antibiotic concentration 
(ggimL culture) 
2,4-diacetyl-

Culture medium  phloroglucinol  pyoluteorin  pyrrolnitrin
 
Nutrient broth  <0.02  0.50  <0.09 
Nutrient broth + 2% glycerol  <0.02  5.75  2.07
 
Nutrient broth + 2% glucose  16.60  0.19
  <0.09 
NOTE: Five mL cultures were incubated at 20°C for 48 h with shaking, acidified with 
HC1 to pH=2 and extracted twice with 5 mL ethyl acetate. The ethyl acetate fractions 
were concentrated and analyzed by photo-diode array HPLC in comparison with authentic 
standards. The values presented are an average of three replicate cultures. 114 
The profound effect of carbon source on Phl production by Pf-5 in culture 
media suggests that the chemical composition of habitats that the bacterium 
occupies in the spermosphere or rhizosphere will also effect Phl production. 
Phl has been detected in the rhizosphere of gnotobiotic plants inoculated 
with P. fluorescens CHAO (Keel et al. 1992), indicating that the rhizosphere is 
conducive to the production of Phl, at least under certain conditions. However, 
not all occupied sites or environmental conditions may be conducive to the 
in situ production of this metabolite at the time or in the concentrations 
needed to suppress a fungal pathogen. Although the role of Phl in disease 
suppression by Pf-5 has not yet been investigated, isolates of plant pathogens 
that are suppressed by Pf-5 are sensitive to Phl in culture. Inhibition of P. 
ultimum N1 (Kraus and Loper 1992), R. solani J1 (Howell and Stipanovic 
1979), and P. tritici-repentis 6R180 (Pfender et al. 1993) were observed at Phl 
concentrations of 128 ug/mL in potato dextrose agar (Difco), and Erwinia 
carotovora subsp. carotovora W3C105 and E. carotovora subsp. atroceptica 
W3C37 (Xu and Gross 1986) were inhibited at 250 ug/mL of Phl in nutrient 
yeast broth (Stanisich and Holloway 1972). These data are in agreement with 
previously reported inhibitory activities of Phl (Keel et al. 1992; Levy et al. 
1992). 
Indirect evidence for the in situ production of antibiotics by Pseudomonas 
spp. and evaluation of these metabolites in disease suppression is usually 
obtained by comparing the biological control activities of antibiotic-deficient 
mutants to that of a parental strain. Identification of mutants defective in 
antibiotic production has commonly been attempted by screening mutants 
for loss of inhibition in culture. The array of inhibitory metabolites produced 
by Pf-5, however, necessitates the use of chemical analysis to screen mutants 
because the presence of an unidentified but biologically-active compound, 
such as Phl, could mask the existence of a biosynthetic mutant blocked in a 
single antibiotic pathway. The case-in-point is  a study conducted in our 
laboratory (Kraus and Loper 1992) in which individual culture extracts from 
several thousand Tn5 insertion mutant cultures were assayed by TLC for 
pyoluteorin and pyrrolnitrin production. Pyoluteorin-deficient  mutants did 
not inhibit P. ultimum on certain media but  were inhibitory against the 
fungus in other culture media, including NAGlc, which we now know to be 
conducive to Phl production by Pf-5. The ability of Pf-5 to produce Phl may 115 
explain our initial failure to obtain pyoluteorin or pyrrolnitrin non-producing 
mutants by screening for loss of inhibition of P.ultimum or R. solani. Indeed, 
the common approach of screening mutants by inhibition assays can not 
successfully detect biosynthetic mutants if the phenotypes of such mutants 
are masked by the production of an unsuspected antibiotic(s). 116 
Appendix 2. Nucleotide Sequence and Translated Product of pltB 
CCCAGTCGAAGGAGATGACTGAATGGATGCTCGTGCGCCCATGGATTTTGAACCCATTGC
 
1  MDARAPMDFEPIA
+ 60
 
AATCATCGGGAGTGGATGCCGCTTTGCCAAAGGTGCATCGACCCCCGAGGCATTCTGGGA
 
61  + + +
  + +
 IIGSGCRFAKGASTPEAFWE
+ 120
 
GCTCCTTCGTGCTGGGACCGAiiiiGTCGGACCGGTTCCCGCAGAGCGCTGGGACACAGC
 
121  +
  +  +  + +
 L LRAGTDFVGPVPAERWDTA
+ 180
 
GGCGATCTACGATGAGAGCGCTGCTGAAACCGGTACGACCTACAGCAAGGTGGGGGCGTT
 
+  + + + +
 181  AIYDESAAETGTTYSKVGAF
+ 240
 
CCTCGAGCACATCGATCGCTTCGATGCGCATTACTTTGGCATCTCGGCCTCTGAAGCCAA
 
+ + + + +
 241  L EHIDRFDAHYFGISASEAK
+ 300
 
GGAAATGGACCCCCAGCAGCGCCTGCTGCTGGAGGTCGCCTGTGAAAGCGTGGCCCGTGC
 
301  + + + + +
 E MDPQQRLLLEVACESVARA
+ 360
 
CGGCCTGACCCGCGAGCAGCTCAAAGGCAGCAGGACCGCGGTCTATGTCGGCATGCTGGG
 
361  + +
  + + +
 G LTREQLKGSRTAVYVGMLG
+ 420
 
CATGGATTACCTGGCACTGCACTCCCGCGAGGCCGGCATCGAACAGATCAACCCCTACTA
 
421  + +
  + + +
 MDYLALHSREAGIEQINPYY
+ 480
 
TGCCGCCGGCAAGGAATTCAGCTTCGCCGCCGGGCGTATTGCCTACCACCTGGGTGTTCA
 
481  +
  + + +  +
 AAGKEFSFAAGRIAYHLGVH
+ 540
 
TGGGCCGGCAATGACCGTGACCACTGCATGCTCTTCTTCCCTGGTGGCCATGCACCTGGC
 
541  + + +  +
 +
 G PAMTVTTACSSSLVAMHLA
+ 600
 
CTGTCGCGCCTTGCAGGCAGGGGAGGCGGACATGGCCCTGGCCGGAGGGGTGAACCTGAT
 
601  + + +  +
 +
 CRALQAGEADMALAGGVNLM
+ 660
 
GCTGGCGCCGGACCTGACGATCTACATGAGCCAGATCAGGGCGATCTCGCCCAGTGGTCG
 
661  +
  +  + + +
 L APDLTIYMSQIRAISPSGR
+ 720
 117 
CTGCCGGGTATTCGATGCGGCGGCCGACGGGATCGTCCGGGGCGAAGGCTGCGGGGTCAC
 
721  +
  +  +  +  + + 780
 
C R V F D A A A D G  I V R G E G C G V T
 
GGTGCTCAAGCGCCTGGCAGATGCCCTACGCGATGGCGATCCGATCCAGGCGGTGATCAG
 
781  + + +
  +  +  + 840
 
L K R L A D A L R D G DP I  Q A V  I  R
 
GGGCTCGGCGATCAACCAGGATGGCGCCAGTGCCGGCCAGACCGTGCCCAACGCCAATGC
 
841  +
  + +
  +  +  + 900
 
G  S A INQ DG A S A GQ T V PN AN A
 
CCAGGCTGCAGTGATCAGCCAGGCCCTGAAAGTGGCCGGCTTGAGCGTGGACGACATCGA
 
901  + + +
  +  +  + 960
 Q AAV I S Q A  L K V A G LSVDD I D
 
CTATGTCGAGGCCCACGGCACCGGTACGCCCCTGGGCGATCCGATCGAACTCTCTTCGCT
 
961  +
  +  +  +  + + 1020

Y V E A H G T G T P L G  D P I IEL S SL
 
GGACAGTGCCTTCCAGGGGCGTGAGCGGCCGCTGTGGGTGGGCTCGGTCAAGGCCAACAT
 
1021  + +  + + +
  + 1080
 
D S A F Q G R E R P L W V G S V K A N M
 
GGGCCATCTGGATGCGGCCGCCGGAATGGCCAGCGTGATCAAGACCATGATGGTTCTCAA
 
1081  +
  +  +  +  + + 1140
 
G H L D A A A G M A S V  I K TMMV L K
 
GCACGCCGAGGTGCCTGCGCAACTGCATCTTGCACAGTTGAACCCACTGGTGGACTGGAA
 
1141  +
  +  +  +  + + 1200
 H A E V  P A Q  L H L A Q L N P LVDWK
 
GCGTTCCCGGCTGGCGGTGCCCACGGCGATCGAGTCGTTGCCCGACCGGCCGCGCCTGGC
 
1201  + +  +
  + +
  + 1260
 
R  S R L A V  P T A IESL PDR PR L A
 
TGGAATCAGTGGTTTCGGGCTCAGTGGCACCAACGTCCACATGATTCTCGAAGATGCCAG
 
1261  + +  +
  + +
  + 1320
 
G  I S G F G L S G T N V H M  I L E D A S
 
CGTCTATCGGCAGGCACAGCCGCAGCAGGAACGATCGGCACAGGGCCGGCCCTGGGTCCT
 
1321  + +  +
  +  +  + 1380
 Y R Q A Q  P Q Q E R S A Q G R P W V  L
 
GCCGGTATCGGCCAGGTCCGCGCAGGCCGTGGTGGAGCAGGCCAGGGCCTATGCCGTTCA
 
1381  + + + + +
  + 1440
 
P V S AR S A Q A V V EQ AR A Y A V  H
 
TCTGCCGCAGCAGGACGATGGGCAATTGCAAGCCTTTGTCGCCAGCGCCATTCATCGTCG
 
1441  +  + +
  +  +  + 1500
 L PQQDDGQLQAF VA S A IHRR
 118 
TGATCACTTTCCCTACCGGTCGGCCGTGGTGGGTGCGAACGCCGGGCAATTGAAGAGCCA
 
1501  + + + + +
  + 1560 
D H F  P  Y R S A V V G A N A G  Q L  K  S  Q 
GCTGGAGCAGCTGCCGGCCCCGACCTTGGCCTGCACGACGGACGAAGAGGATCGGCGCGG
 
1561  + + + + +
  + 1620  L EQL PAP T  L AC T TDEEDRR G
 
GCCCGTGCTGGTGTTTACCGGGCAGGGCGCCCAGTGGGTGGGAATGGGCCGCGACCTGCT
 
1621  + + + + +
  + 1680  P V L V F  T  G Q G A Q W V G M G R D L  L 
TGAACGGGAGCCGGCCTTCCTGGCGATGATCCGGCGTTGCGACCAGGCGCTGGCCCAGTG
 
1681  +  + +
  +  +  + 1740 
C 
GGCAAGCTGGTCGGTGGAGGCCGAGCTGCGCAGCGACGCCAGTGGGTCCCGCCTGCACCT
 
1741  + +
 
E  R E  P A F  L A M  I  R R  D Q A LAQW 
+  +  +  + 1800 
A S W S V E A E L R S D A S G S R L  H L 
GACCGAATTTGCCCAGCCCTGCATCTTTGCCATCCAGGTGGCGATCAGTGAATGCCTGCG
 
1801  +
  +  +  +  + + 1860 
F P  A T  E  A Q  C  I  F  I  Q V A I SECLR 
CCAGTGGGGTGTGATCCCGGCGGCGGTGGTCGGCCACTCCATGGGGGAAGTGGCCGCGGC 
1861  +  +  +  +  +- + 1920 Q W G V  I  P A A V V G  S  M G  E V A A A H 
CTATTGCGCCGGAGCACTGGACCTGGAGTCGGCGGTGCGGGTCATCCACCATCGGGCCCA
 
1921  +  + + + +
  + 1980  Y C A G A L  D  L E  S A V R V  I  H  R A Q H 
GGCCATGAAGGACACCCTGGGGCAGGGGCGGATGCTGGTGGTGGGCTTGCCCGCGCCGAC 
1981  + + + + +  + 2040  A M K D T  L G Q G R M L V V G  L  P A  P  T 
GCTCCAGTCGCGTCTGGCGAACAACCCGCAACTGGAACTGTCGGTGGTCAACAGTCGAAA 
2041  + +  + +  +  + 2100 L Q  S R L A N N  P  Q  L  E  L S V V N S RN 
CAGCTGTGTGGTGTCCGGTAGCCCGCAGGCTGTACAGGCTCTGGATCAGCAACTGCGTGA 
2101  + +  + +  +  + 2160 S CVVSGS PQAVQA LDQQLR  D 
CGAAGGCATCTTCACTTACCTGATGCCGGCGGAATATGCCTTCCACTCCTGCCAGATGGA 
2161  + +  + + + E G IF T YLMPAEY AFHSCQMD
+ 2220 
TGAGTGCCTGACGCAGATCCGCGCGGGGCTGGAGGATTTGCCGGTGGTTGCCGCGCACAC 
2221  +  +  +  +  + + 2280 
E  C L  R A G L E E  D D L L P V V A A H T 119 
2281  + + + + +
  + 2340 
+ 2400
 
GCCCTGGATTTCCACCAGCGCGATGCCCGAGGAGCCGATCCTGGCAGATGCCGACTACTG
 
P W I S  T S A M  P  E  E  P I L A D A  D Y W 
GGCGAGGAATGCCCGTGGCATCGTGCGCTTCGATCGCGCCATCGAACAGTTGATCGAGCA 
2341  ARNARG IVRF DR A IEQL I  E Q 
GGGGCACCGGCTGTTCGTCGAGATCGGCCCGCACACCGTGTTGGCGGCGTCGATCAACCA
 
2401  +
  +  +  +  + + 2460
 G H R L  F V E  I  G  P  H T V L A A  S INQ 
2461  + + + + +
  + 2520 A L A D K  G  T  Q  G L V C G A  L H K Q G  D 
+  +  +  + 2580
 A A L E L A  S I V A R L  Y E W G A G  P  D 
+  +  +  +  + + 2640
 
W Q  A  F  Q  P R E A A L  E  L  P A Y P WQQ 
2641 +  +  + +  +  + 2700
 E R F W F A  P A P  R P  Q P A G L V  S  Q L 
GGCCCTGGCCGACAAGGG'AACCCAGGGACTGGTGTGCGGCGCCTTGCACAAGCAGGGCGA
 
CGCCGCCCTGGAGCTGGCCAGTATTGTTGCCCGCCTGTACGAGTGGGGCGCAGGTCCCGA
 
2521  + +
 
CTGGCAAGCCTTCCAACCCAGGGAGGCGGCGCTGGAGCTGCCGGCCTATCCCTGGCAGCA
 
2581
 
GGAGCGTTTCTGGTTTGCCCCGGCGCCGCGGCCGCAGCCGGCAGGGCTCGTGTCCCAGCT 
GCGGGCGCAGGTACTGGTGTATGACGCCCAGGGCAATCTCTGCGCCCAGGCCAACGATGT
 
2701  + +
  +  +  +  + 2760
 R A Q V L V Y  D A Q  G N L  C A Q A N D V
 
GGCGCTGAGCGTGCCGCAGCTGGCACAAGTCGCTGTGCCGGCACCGGCCAAGGTGTCCGC 
2761
  +  +  +  +  + + 2820
 A L  S  P  L A Q V A V P A  P A K V S A V Q 
AGCGGCGCAGCCGGTGGGGGATGTGCGGGCGCAGATTGGTGCACTGCTGACGCAGATCAT
 
2821  + +  + + +
  + 2880 A A Q P V G D V R A Q  I G A  L  L  T  Q  I  I
 
Tn5 insertion
 
mutant 4296
 
CGGCGTGGCCTGTGCC GACCCGGACCCGGATCGAGGCTTCTTCGAACTGGGCCTGAGCTC 
2881  +2940 G V A C A  P  D P  D R  G F F E L GL S S D 
GATTTCCCTGGTTGAATTCAAGCGCATGCTGGAGCGCCAGTTCGCCCTCAAGCTGTCGGC 
2941  + +  +  +  +  + 3000 
S  L V E  F K R M L E R Q  F A L  L  S K  A A 120 
GACCGTGGGCTTCGACTATCCCACCATCAACCGGCTGGGCCAGTACCTGGAAGGGCTGCT 
3001 +  +  + +  +  + 3060 T V G  F  D  Y  P  T INRLGQYLEGL L 
GTCCCGGGAGCCGGCCAGCACCCCGGTAACGGTCGATGCCGGGGCGACCGACGCCGCGGG 
3061  + + +  + +  + 3120 
S  R E  P A  S  T  P V T V D A G A T  D A A G 
GAGCGTCGCCGTGGTGGCCATGGCGTGCCGGTTTCCCCAGGCCGACAGCCCCGAGGCACT 
3121  + + + +  +  + 3180 S V A V V A M A C  R F  P Q A D  S  P  E A L 
CTGGAAGCTGATGCTGGAACAGACGGACACCGTGGGGCCGGTACCGCCGTCCCGGCTCGC 
3181  +  + +  +  +  + 3240 W K L M L E Q T  D T V G  P V P  P  S  R L A 
CGGCGCTAAGCCGGAGGAAACCTTCCCGCGGTTTGCCAGCCTTATCCAGCGCCCCGAAGG 
3241 + + +  + +  + 3300 G A K P E E T F P R F A S L I  Q R  P E  G 
GTTCGACGAAGCGTTCTTCCGCATTTCCCCCAAGGAAGCCCGGAGCATGGAC.CCCCAGCA 
3301  +  +  +  +  + + 3360 
F  D E A F F R I  S P K E A R S M DPQQ 
ACGGCTGTTGCTGATGGTGGCCTGGGAGGCTCTGGAACGGGCCGGTATCCCTCAGGAGAA 
3361  + +  + + +  + 3420  R L  L  L M V A W E A L  E R A G  I PQEK 
GCTGCTGGAACAGAGGGTCGGGGTGTTTGTCGGGGCCAACTCCCACGACTACGAAACCCG 
3421  +  + + +  +  + 3480 
L  L E  Q R V G V F V G A N  S  H  D  Y E T  R 
GGTCCTGGGTAGCGCGCAAGGCGTGGATGCCCACTACGGCACTGGCAGTTCGTTTTCGGC 
3481  + +  + + + + 3540 
L  G  S  A Q G V D A H Y G  T  G  S SF S  A 
GATCTGCGGGCGCCTCTCGCA1 rri CTCGGCGTGCGTGGGCCGAGCCTGACGGTGGACAC 
3541  + +  + + +  + 3600 
1  C G R L  S  H  F L G V R G  P  S  L T V D  T 
CGCATGCTCGTCATCGCTCACGGCCATCCATCTGGCGTGCAACAGCTTGCGTGCCGCGGA 
3601  + +  +  +  +  + 3660 A C S S S L T A  I  H L A C N S L R A A E 
GTGCGACATCGCGATTGTGGGTGGGGTGAATGTCATCGCCTCGGCGTCGATCTTTCAATC 
3661  + +  +  +  +  + 3720 
C  D I  A I V G G V N V  I  A  S  A S IF QS 
CATGGGGCAGGCCGGCGCATTGGCCCCGGACGGCATCAGCAAGGCCTTCGACGACAGTGC 
3721  + + +  + +  + 3780
M G Q A G A L A  P D G I  S K A F D D S A 121 
CGACGGTTACGGTCGAGGGGAGGGCTGCGGCGTGGTCATTCTCAAGCGCCAGGCCCAGGC 
3781  +  +  +  +  + + 3840 
D  G  Y G R G E  G  C  G V V I  L K R Q A Q  A A 
CGAGCGGGAGCGTGACCCGATTGTCGCGACGATTCTCGGTTCGGCGGTCAATCACGACGG 
3841  +  + + +  +  + 3900 E R E  R D  P IVA T IL G  S AVNHDG 
TGCCTGTGCCGGGCTGACAGTGCCCAATGGTCCGGCGCAAGAGGCGCTGATCAGCGAAGC 
3901  +  + + +  +  + 3960 A C A G  L T V  P N G  P A Q E A L  I S EA 
ACTGGCCAACGCCGGCGTGCATCCGGGGCAAGTCAGCTACGTGGAGGCCCATGGCACCGG 
3961  + + + +  +  + 4020 L A N A G V H  P  G Q V  S Y V E A  H  T  G G 
CACGGTGCTGGGTGACCCCATCGAGCTCAACGCCCTGCACAACGCCTATCGCCAGGCCAG 
4021  + +  +  +  +  + 4080 T V L  G  D  P I  E L N A  L  H N A Y R Q A A  S 
CCCCGACAGTCCGCCGCTGACGGTGGCCTCGGTCAAGGCCAATATCGGGCACCTCGAGGC 
4081  +  +  +  +  + + 4140 
P  D  S  P  P LTVA A  S V K A N IGH L  E A 
GGCAGCGGGCATCGCTTCGCTGATCAAGGCCTGCCTGGTGGTGGAGCACGGCCGGATTGC 
4141  +  +  +  +  + + 4200 A A G I A S L  I  K  R I IA 
CCCGCAAGCCCATCTGCAGCGGGCCAACACCCGTGTCGACTGGGCGGCCATGAACCTCAA 
4201  +  +  +  +  + + 4260 
P  Q A H  L  Q R A N T  R V D W A A M N L  K 
GCTGGCGCATCAGGCCATGGACTGGCCGGGCCGGCCGGAGTCGCGGGTGGCCGGGGTCAG 
4261  + +  + + +  + 4320  L A H Q A M D W  P  G  R  P  E  S R V A G V  S 
TGCCTTTGGTTTCACCGGGACCAACGTGCATGTGCTGCTCAAGGGCTATACGGCGCCCGC 
4321  +  + + + +  + 4380  A F  G  F  T  G T N V H V L  L K G Y T A P A 
GACAGCGCCTTTGCCACCCGCCACAGCACCAGTGGCCTTGTGCCTGTCCGCGGCCACCCC 
4381  + + + +  +  + 4440 T A P L P P A T A P V A  L  C L S A A T P 
GGCGGCATTGGCGGAGCTGGCCCAGCGCTATGTGTCCTTCCTGGGCGCTACCGAGCACTG 
4441  + +  +  +  +  + 4500 A A L A  E L A Q R Y V  S  F  L G A T  E  H  C 
CCCACAGACCATCTGCTACAACGCGCTGATGCGGCGCACGGCG1 i CAAGGAACGCCTGGT 
4501  +  +  +  +  + + 4560 
P  Q  T I  C Y N A  L M R R T A  F  K  E  R L V 122 
CGTCCACGGCCAGGATTGCCGCGAGCTGGCTCAGGCACTACAGGCCTGGCTGGCCGGTAG 
4561  +  +  +  +  + + 4620 
H  G  Q  D C R E L A Q A L Q A W L A  G S 
CCCCATCGCCAATGACCGCAAACCCGCGGCCGGCGAACCCTGGGCAACCCTGGCCGAGGC
 
4621  +  + +  +  + + 4680
 
P  I  A N  D R K PAAGE P W A T  L A  E A 
CTTTGGCCGCGGCGCCCAGTCGCCGGGCCCCGAGCGCTTGCCGGACGGCTGTCAGGCCAT
4681  + + + + +  + 4740 
F G R G A Q S P G P E R L P D  G C Q A I 
CGGGTTGCCCACCTATCCCTGGCAGCTCAACGACTACTGGATCGATGCTGGCCAGCCGGC 
4741  + + +  +  +  + 4800 
G L  P  T  Y PWQLNDYW IDA G  P A Q 
TACGGCGGTGCAGCCCGCCCGGGCAGCCTCGGGCCATCCTTGCCTGCAGGGGCTGGTACG 
4801  + +  +  +  +  + 4860 T A V Q P A R A A  S  G  H  P  C L Q G L V R 
GCCGGCCGGGCAGCTCTGGTACTGGTCGGGGGCTCTCGCTCCCCAGGCCGGGCATTACGA
4861  +  +  +  +  + + 4920 P A G  Q  L J W Y W S G A L A  P Q A G  H  Y  D 
CCCGCTGGGCGAGCAGGGGTACAGGGTCAAGACTCACCTGTTGCTGGATGCCGTGCTCCA
4921  +  +  +  +  + + 4980 
P L  G E  Q  G  Y R V K T  H L L L D A V L  Q 
GGCGGTGCGGGAAACACCACGGGGCGTGCAGCAGATCCGCGACTTGCAGATTGCCCAGCT 
4981  +  + + +  +  + 5040 A V R E T PRGVQQIRDLQ I  A Q  L 
GCGCCTGCGCGGCGAACAGCACCTCACTTCGCACCTGAGCATCCACCTCACCCAGGCGCC 
5041  + +  + + +  + 5100 
R L R G  E Q H L T S H L S I H L T Q A P 
TGACGCCTGCTTCGAACTGGCCTTGCAAGGGGCCGGCGACGAGCGCCGCCAGGTCTGCAT 
5101  + + + + +  + 5160  D A  C  F  L A L Q G A G G  D E R R Q V C  M 
GAGCGGAACCCTGGTTGACTGTGCAGCGCAGTTGCAGGAGGAAACCCTGTGCGGGGTGTC 
5161  + +  +  +  +  + 5220 
S  G T  L V D C A A Q L Q E E T  L  C  G V S 
GATGCTCGATGAGCCTTCACCGCCGGCGCCGGACGTTGGCCTGTGCCCATGGTCCGGGTG 
5221  + +  +  +  +  + 5280
M L D E  P  S  P  P  A  P D V G  L C PWSGC 
TGCGGCCACGGGCGGGCAGCGGGCCTTGTACCGTTTTGCCCACTCCCTGACGGCGGCCGA 
5281  +  +  +  +  + + 5340 A A  T  G  G Q R A  L Y R F A H  S  L T A A  E 123 
GCGCCAGACCCAGTTGCTGGCCAGTGTGGTCGAGCTGTTTGAAGGCGCCCACGCCGCCGC 
5341  + + +  + +  + 5400 R Q T Q  L  L A S V V E  L F E G A H A A A 
GCTGGTCGGGTTCTCCGGGCTCCAGGTATGGGCAGACCTGCCGGCGCAGGTATGGATTGT 
5401  + + + + +  + 5460  L VGF SGLQVWADL PAQVW  I  V 
GCTGGCCGGCCATGACGCCGACAAACCCGACAGCCTGCAGGTAGTGGATGCCCGGGGTTG 
5461  +  + + +  +  + 5520 
L  D A  D  K  P  D  LQVVDARGC GC 
CCAGCTGGCGCTGTTCGAAGGTCCGCAGTTTGGCCATCCTGGTTCGTGGTACTTGCCCGA
 
5521  + + + + +
  + 5580 
Q L A L F E  G P  Q  F  G  H P  G S W Y L PD 
CCTCCAGACCGCACCCCTCGACCTGCCGATGATCGCTCGCCAATGGCAGGACTATCCGAT 
5581  + + + +  +  + 5640 L QT A PLDL PMIARQWQDY  PM 
GCCGGGCGAGGGCGCTCGGCAACGCGAGGGCTACTGGATGGTGCTGGCCTGGAGCACTGC 
5641  + +  +  +  +  + 5700 P GEGARQREGYWMVLAWS  T A 
CGAGGTCCAGCCACTGGCTGCGGCGTTTGCGGCTGAACAGCGTCCGGTTGAAGTCATCGA
 
5701  + +  + +
 +  + 5760 E V Q  P L A A A  F A A E  R  P V E V  E Q  I I 
GCTGCACGCCGGGCAACAACCTCTGGCCCGCAAACTGTCCTCGGCGTTGCGCGGGGCAGT
5761  +  +  +  +  + + 5820 
L  H A G Q Q  P  L A R K L  S  S  A  L  R G A V 
GGCCGATCCGTCCTGCCTGGGGGTGATCGTTGCCGGCGTTGAGGCTCAGGAGGCCGACGG 
5821  + +  + + +  + 5880  A D  P  S  C  L  G V  I  V A G V E A Q E A DG 
CCTCGGTATATCCCTGGTGGCCTCTGCGGCGCTGGTACAGGCCTTCGCCGGTGCGATTGC
 
5881  +  +  +  + + + 5940
 L G  S  L V A S A A L V Q A F A G A A  I  A 
CAGCGTCGGAACACCGGCAAAGCCGGTCTGGTTCGCCCTTCATGCCAGTGATGCTGCGTC 
5941  + + +  + +  + 6000 S V G  T  P A K P V W F  A  L H A S DA A  S 
GCCGGCCATGGCCGCTGTCCAGGCCACCTGGCAGGGCGCCGCGCATATCTTCGCCCTGGA 
6001  +  +  + + +­ + 6060  P A MA AVQ A T WQG A A H IF  A L E 
GCATCCTGCCTGGTGGGGCGGTCTGGTGACTTTGCAGGGCAGCGACAGAAGAAGCTACGC 
6061  + +  +  +  +  + 6120 
H P A W W G  G L V T  L  Q G  S D R R  S  Y A 124 
CAGCCTCTGCCGGCTGTTGCACGGCCAACCTGGCCATGATCACTTTGCGATCAGCGGCGC
 
6121  +  + + +
  +  + 6180
 S LCRLLHGQPGHDHF A I SG A
 
CCGGGTCGAGGTGCAATACCTGGTGGAGGATCAAGCCGACCCGCTACAGCGTCTGGAGCC
 
6181  + + + + +
 RVEVQYLVEDQADPLQR LE P
+ 6240
 
GCCGGCGCTGAACGGAACCGTTGTGCTGCATGCCGTCCCGGGATCTGACCTGGAGACTGT
 
6241  + + +  +
 +  + 6300
 
P A L N G T V V L  H A V P  G  S  D  L  T V
 
GCTGACGGCGCTCGGGCAGCGGGGTGTGCAGCGTGTGCTGCTGCTCTGCGAGGCCCCCGG
 
6301  +
  +  +  +  + + 6360

L T A L G Q R G V Q R V L L L C E A  P  G
 
GCAACTGCACATGCCTGAGCGGATGCCCGAAGCGATGGCGATCAGCAGCCTCTCGGACCT
 
6361  + +
  +  +  +  + 6420
 Q LHMPERMPEAMA IS SL SDL
 
GAGCCGGGAAAACCTGGCTGACACCTTCGCGACGCTGCGAGCGCAAGACCGCATCGCCGG
 
6421  + + +  +
 +  + 6480
 
L A D T  F A T L R A Q D R G
 AQDR I A
 
CTTTATCCACCTCGATCTTGACTGGCGCACGGTTGCGCTCAAGGAGCCAGAGTTTGTCGT
 
6481  +
  +  +  +  + + 6540
 
F  H  L  D  L D W R T V A  L K E  P  E  F V V V
 
Tn5 insertion
 
mutant 4128
 
GCGAATGCAGGAAGGCGTTCGGCC GCTTGAGGTCTTGCAGCAGGTTCACCAGCTGATCGA
 
6541  + +  + + +
  +6600
 
R M Q  E G V R  P  L E V  L  Q Q V H  Q L ID
 
TGACCCTGAAGCGTTCTTCCTGATCCTGGGCAGCGTGTCTTCCCTGCTTGGCGGGGCCGG 
6601  +  + 4- +  +  + 6660 D PEAFF L ILGSVSSLL G G A G
 
CTTCGCCCGCTCGGCGATTGCCGATGCATATGCCTTGTGGGTGCATGCACAGCGCCGGCG
 
6661  + + +  +
 +  + 6720
 
F A R  S  A  I A D A Y A L W V H A Q R R R
 
CCAGGGGTTGAACTGCCAGCTGCTGCACCTGACGCAGAGCGAACAGGAGCTTGAGCAGGA
 
6721 +  +
 +  + +
 Q GLNCQLLHL TQSEQELEQD
+ 6780
 
CGCCGCAGCCCGCACGGCCATGCAAGGCAGCGGCCTGCAGCCTTTGCAGCGCTCGCAGAT
 
6781  +
  + +
  +  +  + 6840
 
A A A R T A M Q G S G L Q P L Q R S Q  I
 125 
AGTGCAGGCCATAGCCCGCGTGCTGGGTGGCCAGGGCCAGTGCGGGCTGCTCAATGTCGA
 
6841  +  + + + +
  + 6900
 
Q A  I A R V L G G Q G Q C G L L N V D
 
CTGGCAACAACTCAAAGGGCTGTACCTGAGCGTGCTGCCCTGGCCCTTGCTCGAACACCT
 
6901  + + + + +
 W QQLKGL YLSVLPWPLLEHL
+ 6960
 
GGGTGCAGCGGATAGCGCAGCGGATCAGCGTCTGGCCGAGCTGATTGGCCTGCCACCGCT
 
6961  + + + + +
  + 7020
 
G A A  D  S A A D Q  R L A  E  L  I  G L PPL
 
GCAGCAGCGCCGGGCCATGCAGGCGCTGGTCTGCGAGGTAGTGGGGCAGGTGTTCGGCGT
 
7021  + + + +
  +  + 7080
 
Q Q R R A M Q A L V C E V V G Q V F G V
 
TGCCGATGGCCTGGAGCTCGATGTCAGGAAGGGCTTCTTCGACATGGGCATGTCCTCGGT
 
7081
  +  +  +  +  + + 7140
 
A D G L E L D V R K G F F D M G M  S S V
 
CATGTCGCTGGACCTGCGCTCACGGCTGGGCCGGGCGTTGAGCATCGACCTGCCTTCGAC
 
7141  + + +
  +  +  + 7200
 MSLDLRSRLGR AL SIDL P S
 T
 
CTTCGGCTTCGAATACACCTCCATCGAACAGGTCACGGACTACCTCATGGGCCAGCTCCT
 
7201  + +
  +  +  +  + 7260
 
F G F E Y T
 TSIEQV TDYLMGQL L
 
GGCGCCTGAAACCCGGGAGCCGGTGGCGGCGCCCGAACCTGTGTCGCCAGCGTCGCGGCA
 
7261
  +  +  +  +  + + 7320
 
A P E T R E P V A A  P E P V S PASRH
 
TCAGGACCTGCATGAACTGTCACGGGCCGAGCTGATTGGTGCTCTCGAAGACGAGCTGCG
 
7321  + + +  +
 +  + 7380
 
Q  D  L  H  E  L  R A E EL IGALEDELR
 
CGATATCGCCAATTACTAGCCCTGGGGCTGGATGACAACTGCCAGAGAATCACTGATCGA
 
7381  + + + +
  +  + 7440
 
D  I A N Y  *
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Appendix 3. Nucleotide Sequence and Translated Product of pltC 
CCrGGGGCTGGATGACAACTGCCAGAGAATCACTGATCGAGGCCTTTATGGATAACGATG
 
1  W GWMT T ARES L IEAF MDN D V
+ 60
 
TCCGCGATGTAAGCAAGGAACAGCTGCAAGAGAGTCTTGCTCAGGCAATCACTACCATCC
 
61  + + + +
  +  + 120
 
R D V S K E Q L Q E S L A Q A I T T  I R
 
GTGCGCTCAAGGAAAAGGTGGCCGGCAAGAGCTCGGCGCCTGTCGAACCGATCGCCGTAG
 
121  + + +
  + +
  + 180
  A L K E K V A G  K S SA PVEP I A V V
 
TGGGCCTGGGGTGCCGGCTACCGGGCAGTGCCGACACACCGAAGCGGCTGTGGAGCCTGC
 
181  + + +
  + +
  + 240
 
G  L G C R L  P G S A D T  P K R L W S  L L
 
TGAAACATGCCACCGATGCGGTGGGCGACATGCCCAGCGACCGTCTGTACGGCACCGACT
 
241  + +
  + +
  +  + 300
 
K H A T D A V G D M  P  S D R L  Y  G  T  D  Y
 
Tn5 insertion 
mutant 4274 
ATTACCATCCTGATCCCCAGGCACCCGGCAAGG CCTACGTCATGCGCGGTGGCTTCATCG
 
301  +
  + 360
 
Y H P D P Q A P G K A Y V M R G G F  I E
 
AGGGGGTGGATCAGTTCGACCCGGGCTTCTTCGGCATTTCGCCCAAGGAAGCCGAAGGCA
 
361  + +
  +  +  +  + 420
 G V D Q F D P G F F G  I S P K E A E G M
 
TGGACCCCCAGCAGCGCCTGGCCCTGGAGGTTGCCTGGGAGGCCCTGGAGAACGCCGCGA
 
421  +
  + +
  +  +  + 480
 
D  P Q Q R L A L E V A W E A L E N A A  I
 
TCGCCCCCGACAGCCTGCATGGCAAGAAGCTCGGCGTGTTCATGGGGGTCAGTACCAATG
 
481  + +
  +  +  +  + 540
 
A  P D S L H G K K L
 G V F  M G V S TN D
 
ATTACGTGCGCCTGCGCCAGCAGTTGGGCGCGGTCGAGGACGTCAACGCCTACCAGTTCT
 
541  + +  + + +
  + 600
  Y V R L R Q Q L G A V E  D V N A Y Q  F
  Y Y
 
ATGGCGAAACCAGCTTCGTGGCCGGGCGCATTGCCTACACCCTGGGCTCCAGGGGCCCGG
 
601  + +  + +
  +  + 660
 
G E T  S F V A G R  I A Y T L G  S R G P A
 
CGGTGGTGCTCGACACCTCCTGCTCCTCATCCCTGGTGGCCCTGCACCAGGCCTGCAACA
 
661  + +
  +  +  +  + 720
 
V L D T S C S S  S L V A L H Q A C N S
 127 
GCCTGCGCAGCCGCGAGAGCGAGCTGGCGCTGGCCGGTGGGGTCAACCTGATCCTGTCGC 
721  +  + +  +  + + 780 
L  R  S R E  S  E L A L A G G V N  L I  L  S  P 
CCTACGGTTTCATCCTGGTCAGCAAGCTGCGGGCCGTGGCCCCCGATGGCCGCTGCAAGA 
781 +  + + +  +  + 840 
K Y  G  F  I  L V  S  L R A V A PDGRC K  T 
CCTTCGACGCGGCGGCCGATGGCTACGGGCGCGCCGAAGGCTGCGTGATCCTTGCGCTCA
841  + +  + + +­ + 900 
F  D A A A D G  Y G R A E G  C V  I  L A L  K 
AGCGGCTGAGCGATGCGGTACGCGACCAGGACCCGGTGCTGGCCGTGATCGAGGGTAGTG 
901  +  + + + +  + 960 
R  L  S D A V R D Q  D P V L A V  I  E  G  S  A 
CGGTCAACAACGACGGCGCCAGCAGCGGCATCACCGTGCCCAACATCCACGCCCAGGAAG 
961  +  + + + +  + 1020  N N D G A  S  S  G  I T V P N  I H A Q E E 
AGGTGATCAGGCTGGCGCTCGGCCAGGCCGGGCTCCAGGGCAGCGAGGTCGACTATGTCG
1021  + + + + +  + 1080  I R L A  L  G Q A G  L  Q  G  S E V D Y V E 
AGGCCCATGGCACCGGCACCGCGCTGGGCGACCCGATCGAACTGCACGCCCTGCATGCGG 
1081  + + + + +  + 1140  A H G T G T A L  G DP I  E  L  H A  L  H A V 
TACTGGGCAAGCAGCGGCCCGTCGATGCACCGCTGCTGGTGGGCTCGATCAAGGCCAACA 
1141  + + + +  +  + 1200 
L  G K Q R  P V D A  P  L L V G  S  I K ANM 
TGGGGCATCTCGAACCGGTCGCCGGGGTGACCGGGCTGGCCAAGGTCCTGCTGTGCCTGC
1201  + + + + +  + 1260  G HL E PV A G V T  L AK V  L  L  C  L  Q G 
AACAAGAGGCCCTGGTGCCCCAGGTGCACTTCAACACGCCCAACCCGCGGATCGAATGGG 
1261  + +  + + +  + 1320 
Q  E A  L V P  Q V H  F  N T PNPR I  E W  D 
ATCGCCTGGCCCTGAAGGTGGTCACCGAATCCACGCCCTGGCCACGCCAGGGCAAGGCGC 
1321  + +  + + +  + 1380 
R L A  L K V V T  E  S  T  P W  P R Q  G K A R 
GGCACGCCGGTGTCAGTTCGTTTGGTGTCACCGGCACCAACGCCCATGTGCTAGTGGGCG
1381  + +  + + +  + 1440  H A G V S  S  F  G V T  G T N A H V L V G  D 
ACGCGCCGCTGCGCGAACGTGCCCAGGGGCGCGACAACCCCTGGCAGCTGATCACTCTGT
1441  + +  +  +  +  + 1500 
A  P L R E R A Q  G  R D N P W Q  L I  T  L  S 
CGGCCAAGGGCGAGACGCCCCGGCGCCAGATTGCCGGACGCTATGAACGTTTTATCGCCG 
1501 +  +  + +  +  + 1560 A K  G  E  T  P R R Q  I A G R Y E R F  I A D 128 
ACAACAGCCAGCTCGAACTCAAGGACCTGTGCTACACGGCGAACGTCGGGCGGGCGCACT
1561  +  +  +  +  + + 1620 
C 
TTGGCCATCGTTTCGCGGCCGTGGCCGATAGCCGTGAGGGGCTGCGCGAGCAACTGGCAG 
N S Q L E L K  D L  Y T A N V G R A  H F 
1621  + + + +  +  + 1680  G H R F A A V A D  S  R E G  L R E Q  L A A 
CCTATGCGTCACGCAAGGTCGTGGGGCATGTATTCGAAGGGCGCTGCCAGGGAGCGGCGG
1681  +  +  +  + + + 1740 Y A SRK VVGHVF EGRCQG  A A A 
CGCCGCTGGTGATGCTCTTTCCGGGGCAGGGCTGCCAGTACCGGGCAATGGCCCAGGCAC
1741  + + + + +  + 1800 
C 
TGTATGACAGCGAACCATTCTTCAAGGCGCAGATCGATGAATGCCGCGCCCTGTTGCAGC 
P  L V M L  F  P  G Q G  Q  Y R A M A Q A  L 
1801  + +  +  +  +  + 1860 
Y  D S E P F  F  K  IDECRALLQ LQ P 
CGCTGATGGACGTGGACCTGCTGACCCTGGTGCTGGACGCGGGTGCGGCCAGTGACAGCT 
+  +  +  +  + + 1920 1861
L M D V D  L  L  T L V  L D A G A A  S  D  S  Y 
ACCTGCAACAGACCCGCTATGCCCAGCCGGCGATATTCGCGGTCGAATATGCCCTGGCGC 
1921  +  +  +  + + + 1980 L Q Q T R Y A Q  P A  I  F A V E Y A L A R 
GGTTGTGGATGCATTGGGGGGTCGCTGCCGATGCGCTGTTCGGACACAGTTTCGGCGAGA
1981  + +  + + +  + 2040  L W M H W G V A A D A  L  F  G  H  S  F G E I 
TCAGTGCAATCTGTGTAGCCGGGGCGGTATCCCTGGCTGACGCGCTGCGTATGGTGGAGG
2041  + +  + +  +  + 2100 
C S  A  V A G A V  L A  D A  L  R M V E A S S 
CGCGTGGGCGCCTGGCCCAGCAACTGATGACGGCCGGCGGCGCGATGTACGCACTGGGCA
2101  + +  +  +  +  + 2160 
R  L  A Q  Q  L M T A G  G  A M Y A L  GM G M
TGAGCGAGGCGCAACTGCTGGAGCTGCTCAAGGACCGGCCCGGCAGCGCGATCGAACTGG
2161  + +  + +  +  + 2220 
S E A Q L L E L L  K D R P  G S A I E L A 
CGGCGGTCAACAGCCCGCAGGACGTGGTGGTGGCCGGGCCGCAAGCCGAGGTCCAGGCGC
2221  + +  + + +  + 2280  A V N S PQDVVV A G PQA E  V Q A  L 
TGGCCGAAGCGGCGCTCGCCAGCGGTTGCAAGGTCAAGAAGCTTGCGGTTTCCCATGCCT
2281  + +  +  +  +  + 2340 A E A A L A SGCK VKK L A V  S  H AF 
TCCATACCGCAGCCACCGAGCCGATGCTTGAAGCGTTCCGCCAGACGGTGGCGCAGATCA
2341  + +  +  +  +  + 2400 
H  A T A A T E  P  M L  E  F R Q T V A  Q Q I  T 129 
CCTTCAGCGAGCCGCGCTTGCCGGTCATCAGCAGTGTCACTGGCCGGGTGCATACGCTCT
 
2401  +
  +  +  +  + + 2460
 F SEPRLPVISSVTGRVHT
  L S
 
CCAGCCTGAGCTCGCCCGATTACTGGTGTACGCACACCCGCCAGGCCGTGAGGTTCTGCG
 
2461 +  +
 +  +  +  + 2520
 
S
 L SS PDYWC THTRQAVRF CE
 
AAGGGGTCAACACCCTGATCGCAGAGCTGGGGGTGAAAACCTTCCTTGAAGTGGCCTCCG
 
2521  + + +
  +  +  + 2580
 G VNTLIAELGVK T F LEV A  S
  D
 
ATGCTGTGTTGACGCCGCTGATCGGCCGTCACCCCCTGGCGGACGGCAGCCTGGTCCTGG
 
2581  + + + +
  +  + 2640
 A V  L  T  P  L  L A ADG SLVL A
 
CCAGCCTGCGCCGGGCCGGCGATCCGTCCAGGGACCTGCGCCTGGCCGCCGCGCAGCTCT
 
2641  + +
  +  +  +  + 2700
 
S L R R A G D  P  S  R D L R L A A A Q  L Y
 
ACGTGGGCGGCCATAACCTCGACTGGGCCCGGCTGCACGAGCATGACGGGGCCTTGCGCC
 
2701  + + + +
  +  + 2760
 G G H N L D W A R L H EHDG A LRQ
 
AGGCCTTGCCCGGGTATGCGTTTCAGCGCCAGCGCTACTGGTTCGACAACGCCAGCGGCT
 
2761 +  +
 +  +  +  + 2820
 A L  P G Y A F Q R Q R Y W F DNA SG S
 
CGCCCCTGCAACAGGTCGCTGCGGGAGCGGTCGGCCGGCTGCTGGGGCATTC.C4GTCAATG
 
2821  + +  + + +
  + 2880
 
P  L Q Q V A A G A V G  R  L  L  G  H  S V N A
 
CACCCACTCCGGCATTCGAGTCGACGCTCGATAGCGCGCTCCTGCAGGTTGTGGGCGGCG
 
2881  + + +
  + +
  + 2940
 
P
 T P A F E  S T  L D  S A  L  L Q V V G G E
 
AGATCCGCGATGACCTGGCGCTGCTGCGTCCTGACCGGTTGCTGGCAGCCCTGAGCGATG
 
2941 +  +
 +  +  +  + 3000
 RDDLALLRP P DRL LA AL SDE
 
AGCTGGCCGGCCACTTGCAGCTGGACACCTATGGGGTGAGCCTCGCCAGCATCACCCCGG
 
3001  + + + + +
  + 3060
  L A G H L Q L D T Y G V S L A S  I T PA
 
CCCTGGCGTTCCATGTCGATGACCAGTTGCATCTGTTCACCGAACTCAAGCCGCTGTCCG
 
3061  + +  +
  +  +  + 3120
 L A F H V D D Q L H L F T E L K  P L  S G
 
GGGCGGCCTGGGAGGTCAACTGTTCGGCCCTGAGCGCAGCGGCCAAGGTTGCCGGTGCCG
 
3121  +
  +  +  +  + + 3180
 A A W E V N  C  S  A  L  S A A A K V AG AD
 
ATTGGCAGCCGGTCCTGTCGCTGACCCTGGAAGGCCTGCCGGCGGCTGTCCGGGGCGGCC
 
3181
  +  +  +  +  + + 3240
 W Q P V L  S L T L  E G L P A A V R G G L
 130 
TGCCGGACCCGGGCCATGCCGCCACCCAGGACGCAGGCTTTGTCTACCACATGCAGTTGC
 
+  + +  + +
 3241  P DPGHA A TQDAGF VYHMQL 
+ 3300
P
 
CGGCAGAACCCGATCCGCACGGCAATCACCTTGGGCAGGTCCTCGAGTACCTGGGGCAGG
 
3301 +  +
 + +
  +  + 3360
 A E  P  D  P H G N H L G Q V L  E  Y  L  G Q A
 
CGGTGCCGGGCGATGCGCCGGGCTCGATAAGCGGCATCCGCCGCTGGGTCGCCAGCCGGT
 
3361  + + +
  + +
  + 3420
 PGDAPGSISGIRRWV A SR S
 
CCGCTTCGCCCCGGGCACAAAGCCTGGTGATTGCCACGAGCCAGGCACATCCGCAGCAGT
 
3421  + + + +
  +  + 3480
 
A
 S  P R A Q  S L V  I  A  T  S Q A H PQQF
 
TCGACTGCGCCTTGTACGATGCGCACGGCCAGTGTGTAGGCAGCCTGGAAGGGCTGACCC
 
3481  +
  +  +  +  + + 3540
 D C A L  Y  D A H  G  Q C V G SLEGL T L
 
TGGCTGCCGCCCCGAGTGAGGAGGCGCTGCGTGGCATGCTTTACCAGCCCGACGTGCTCT
 
3541  + + +
  + 3600
  A A A  P  S  E E A L R G  M  L
+
Y Q  P
+
D V L  Y
 
ACAGCCTGGATTGGCTCGAACGCCCTCGCCAGCGCGCCGAAGTGCCGCAGCAGGACCGCT
 
3601  + + +
  +  +  + 3660
 S LDWLER PRQRAEVPQQDRL
 
Tn5 insertion 
mutant 4175 
TGTTCACCCTGGTCAGCCGCTCGCCGGAGACCGCCGCTCCCCT GGTCGAACACCTGCAGC
 
+3720
 3661 
F  T L V S R S  P E T A A PL VEHLQR
 
GTGGCGGGCATCGTGCCCGGGTCCTGTGCCCGCAGCAGTTGCTCGATAGCGCGCGGAGGG
 
3721  +
  +  +  +  + + 3780
 G G H R A R V L C  P Q Q L L D S A R R V
 
TGCTGGCCCAGGACCCGAGCCAGGCATTGACCGATGAAGGCGAGGCCTTGGCCGCCGATA
 
+
 3781  +  +  +  + + 3840
 L AQDPSQAL T DEGEAL A A DI
 
TCATCGTGCTCGATGGCAAAGACATCGAGGATGCCGGCTCGACCACGCTGCAGAGCCTGT
 
3841  + +
  +
  +  +  + 3900
 IVLDGKDIEDAGS T T LQSLS
 
CGAGCCTGCAGGCGACACTGTTCCACCCGTTGCTGGAGATGGTCCAGGCGCTCATCGAAC
 
3901  +
  +  +  +  + + 3960
 S LQA TLFHPLLEMVQAL IEL
 
TGGGCCCGCGCGGTGGCCGGTTGTGGCTGGTGACCCAAGGGGCAAACCCTGTTGGCCTGG
 
3961  + +  +
 +  +  + 4020
 
G  P R G G R L W L V T Q G A N P VG L D
 131 
ATCGCGACCAGCCCCTGCAAGTGGCGACCGGGCCGTTGTGGGGGCTGGGCAAGACGCTCG
 
4021  + + + + +
  + 4080
  RDQPLQVA TGPLWGLGK T L A
 
CCCTGGAGCACCCCGAACACTGGCGCGGGCTGATCGACCTGGCCCCCGACGATCCTCACT
 
4081  +  + +
  +  +  + 4140
 
L  I D
 IDL AP DDPHW
 
GGGCAAGGGCGCTGGCCGAAGAAGTCAGCGACTCCGATGGCGACGACAAGATCTGCCTGC
 
4141  + +
  +  +  +  + 4200
 A R A L A E E V S DSDGDDK IC L R
 
GCCCGGGCAAGCGTTATGTCCAGCGCCTGAACCATTTCAGCGCTGCGCAGTTGCCAGCAC
 
4201  + + +  +
 +  + 4260
 P GKRYVQRLNHFSAAQL P  A Q
 
AGGCCTATGCACCTTGCCCGCAGGGCAGTTACCTGATTACCGGCGGCATGGGTGGAATTG
 
4261  + +  + + +
  + 4320
  A Y A PC PQGSYL I T GGMGGIG
 
GCCTGGCCATGGCCCAGTGGCTTCTGGATAAAGGCGCGGGCGCTGTGCTGATCACCGGCC
 
4321  + + +  +
 +  + 4380

L A M A Q W L  L  D  K G A G A V L ITGR
 
GGCGGCCACTGGAGGATGTCGCCACGGGCCTGGAGCGCTTCGGCGCTGCGGCATCGCGGG
 
4381  + + + + +
  + 4440
 
R  P  L  E D V A T  G  L  E R F G A A A  S R V
 
TGAGTTACGTCCAGGCCGACATCACCTCGCCCCAGGACATGCAGCGGCTGTTCTGCGGTC
 
4441  + + + +
  +  + 4500
 S YVQADI T SPQDMQRLF C G
 L
 
TGGAGGCGTCGGGCGCGAGCCTGAAGGGCATCTTTCATGCCGCCGGGATTTCAATTCCGC
 
4501  + +
  +  +  +  + 4560
 E A  S  G A  L  K G GIF HAAG IS I PQ
 
AGGATCTCAAGGACGTCGACCGTGACAGTTTCGACCAGGTGATGCGGCCCAAGGTCGAGG
 
4561  + + +  +
 +  + 4620
 
D  L  K D V D R D  S  F D Q V M R  P K V E  G
 
GCACCTGGTTGTTGCACGAACTGTCCCTGGGGCTGGACCTGGACTTCTTTGTCCTGTGTT
 
4621  + +  + + +
  + 4680
 TWLLHELSLGLDLDFF V LC S
 
CGAGCATCGCCAGTGTCTGGGGTTCGCAGCATGTCGCCAGCTACGCAGCCGCCAATCAGT
 
4681  + + + + +
  + 4740
  S IA S V W G  S  Q H V A  S Y A A A N Q  F
 
TCCTCGACAGCCTGGCGTGGCAGCGTCGGGCCATGGGCCTGAGTGCCCTGGTGATCGACT
 
4741  + +  + +
  +  + 4800
 L DS L AWQRRAMGL SA L V I DW
 
GGGGGCTGTGGGCCGGCGGCAGTCACCTGTTCGACGAGCAGGTGCTGAATTTCCTCACCA
 
4801  + + +  +
 +  + 4860
 
G L W A G G S H L F D E Q V L N F L T  S
 132 
GCGTTGGCTTGAAACAGATCGCCCCGGTACAGAACGTCGGCCTGCTGTCGCGGATTCTGG
4861  +  +  +  +  + + 4920 
G  L  K  Q I  A P V Q N V G  L  L  S R IL A 
CCAGCGAGCTGCCCCAGATGGTGGTGTCAGGGGTGGACTGGAATCGCTTCAAGCCACTGC 
+ 4980  4921 
S  E  L  P Q M V V S  G V D W N R F  K PL L 
TCGAATCCCGCGGCCCGCAACCGCTGCTGCAGTACATCCGCAGCCAGGCTCCGACCGCCA 
+ 5040 
E S 
4981  R G PQPLLQY IR S QA P  T  A R 
GGGCCGGCGACAGCAGCAACGTGGAGATCCTGCAGCAACTGGCGGGCGCCGATGAAGCCG 
+ 5100 
A 
CTGCCCTGGCATTGCTGGATGACTACGTGTGGGAGCAGTACGCGCAGTTGCTCGGGGTCA 
5041  G DS SNVEILQQL A G A DEA A 
5101  + +  + +  +  + 5160 A L A  L  L  D  D Y V W E  Y A Q  L L G V K Q 
AGACCGAACAGGTGCGGGCCAAGCTCGAGGATGGCGGCAGCCTGATGGACTACGGCCTGG 
+ 5220  5161 
T  E  Q V R A K  L  E  D  G  G SLMDY GL D 
ACTCGCTGCTGGTGATGGACATGGTCGCCCGCTGCCGGCGCGATCTGAAGCTGGAGATCA 
+  +  +  +  + + 5280 
S 
AGGCCCGCGAGTTTCTTGAGTGTCCGGGCCTGATGTGGCCGGACTTCCTGGCCCGTTCGA 
5221  L L V M D M V A R C RRDLK L  E  I  K 
5281  + +  +  +  +  + 5340 A REF LECPGLMWPDF L AR S  I 
TAAAGGAACAGGGCTGCGTGGCCGAGGCCTGACGGGCCGCGGGCAGTGCAA 
5341  +  +  +  + +- 5391 K E Q  G  C V A E A  * 133 
Appendix 4. Nucleotide Sequence and Translated Product of pltA 
AAGACCTGAATGCAATATCCAGGACTGTCGAGCAACTAAAGGCCGAGTGCGCCTAACAGG
 
1
  + 60
 
GAGTGGGCAATGAGCGATCATGATTATGATGTAGTGATTATCGGTGGCGGGCCGGCGGGT
 
61  + + +
  +  +  + 120
 
I
 M  S  D  H D Y D V V  I GGG PA G
 
TCGACCATGGCCTCCTACCTGGCAAAAGCCGGTGTCAAATGCGCGGTGTTCGAAAAAGAA
 
121 +  +
 +  +  +  + 180
 
S T M A  S  Y L A K A G V K C A V F E K  E
 
CTGTTCGAGCGCGAGCATGTTGGCGAGTCGCTGGTACCGGCCACCACTCCGGTGCTGCTG
 
181
  + + +  +  + + 240
 
L  F  E R E H V G E  S L V P A T T PVL L
 
GAAATCGGGGTGATGGAAAAGATCGAGAAAGCCAACTTCCCGAAGAAGTTCGGCGCTGCC
 
241  + + +  +
 +  + 300
 
E  I G V M E K  I E K A N F  P K K F G A A
 
TGGACCTCGGCAGATTCCGGCCCCGAAGACAAGATGGGCTTCCAGGGGCTGGACCACGAT
 
301  + + +
  +  +  + 360
 
W T S A D  S G P E D K M G F Q G L D H D
 
TTCCGTTCGGCGGAAATCCTCTTCAACGAGCGCAAGCAGGAAGGGGTCGATCGCGACTTC
 
361 +  +
 +  +  +  + 420
 
F  R  S A E  L F N E R K Q E G V D R D
  F F
 
ACGTTCCACGTCGACCGCGGCAAGTTCGACCGCATTCTTCTGGAGCACGCAGGTTCGCTG
 
421  + + + + +
  + 480
 
T  F H V D R G K  F D R  I  L  L E H A G  S  L
 
GGGGCCAAGGTCTTCCAGGGCGTGGAGATCGCTGACGTCGAGTTTCTCAGCCCGGGCAAT
 
481  + +  + + +
  + 540
 
G A K V F  Q G V E  I A D V E  F  L  S P GN
 
GTCATTGTCAATGCCAAGCTGGGCAAGCGCAGCGTGGAGATCAAGGCCAAGATGGTGGTG
 
541  + + +
  +  +  + 600
 
I V N A K L  G  K  R  S V E  I K A  K M V V
 
GATGCCAGCGGTCGCAACGTGCTGCTGGGCCGCCGGCTGGGCTTGCGAGAAAAGGACCCG
 
601  +
  +  +  +  + + 660
 
D A  S  G R N V L  L G R R  L  L R E  K  D DP
 
GTCTTCAACCAGTTCGCGATTCACTCCTGGTTCGACAACTTCGACCGCAAGTCGGCGACG
 
661  +
  +  +  +  + + 720
 
F N Q F A  I  H  S W F D N F D R K  S  A  T
 134 
CAAAGCCCGGACAAGGTCGACTACATCTTCATTCACTTCCTGCCGATGACCAATACCTGG
 
721  + +
  +  +  +  + 780
 
Q  S  P D K V D DY IF I H  F L PM TNT W
 
GTCTGGCAGATCCCGATCACCGAAACCATTACCAGCGTGGGCGTGGTTACGCAGAAGCAG
 
781  +
  + + + +
  + 840
 
W Q  I  P  I T E T  I T S V G V V T Q K Q
 
AACTACACCAACTCCGACCTCACCTATGAAGAGTTCTTCTGGGAAGCGGTGAAGACCCGG
 
841  +
  +  +  +  + + 900
N Y T N  S D L T Y E E F F W E A V K T  R
 
GAAAACCTGCATGACGCGCTGAAGGCATCGGAGCAGGTCCGCCCGTTCAAGAAAGAGGCG
 
901  + + +  + +  + 960 
E N L  H D A L K A S E Q V R PF K K E A
 
GACTACAGCTACGGCATGAAAGAAGTCTGTGGCGACAGCTTCGTGCTGATCGGCGATGCC
 
961 +  +
 +  + +
  + 1020
 
D Y  S Y G M K E V C GDSF V L  I  G D A
 
Tn5 insertion 
mutant 4236 
GCACGGTTCGTCGACCCGATCTTCTCCAGCGGCGTCAGCGTTGCACTCAAC AGTGCGCGC
 
1021  +- +  1080 A R F V D  P  I  F  S  S G V  S V A L N  S A R
 
ATCGCCAGCGGCGACATCATCGAGGCGGTGAAGAACAACGACTTTAGCAAGTCCAGTTTC
 
1081  + + + +
  +  + 1140
 
I A S G D  I I E A V K N N D F S K S S F
 
ACTCACTACGAAGGCATGATCAGGAATGGCATCAAGAACTGGTATGAGTTCATCACGCTC
 
1141  + + + +  +  + 1200  T HYEGMIRNG IKNWYEF  I
  T L
 
TATTACCGCCTGAACATCCTCTTCACCGCGTTCGTTCAAGACCCACGCTACCGCCTGGAC
 
1201  + +  + +  +  + 1260 Y Y  R L N  L  F T A F V Q QDPR Y  R  L  D
 
ATCCTGCAATTGCTGCAAGGGGACGTCTACAGCGGCAAGCGCCTGGAAGTGCTGGACAAG
 
1261  + + + +  + +  1320 
I L Q  L L Q G D V Y  S G K R  L E V  L D K 
ATGCGCGAAATCATCGCTGCGGTTGAAAGCGACCCGGAACACCTCTGGCACAAGTACCTG
 
1321  + +  +
  + +
  + 1380
  M R E  I IAAVE S DPEHLWHK Y L
 
GGCGACATGCAGGTTCCTACCGCCAAACCCGCGTTCTAAACACTAAACACCCAGTCGAAG
 
1381 +  +
 +  + +
  + 1440
  DMQVPTAK K P A F*
 135 
Appendix 5. Nucleotide Sequence and Translated Product of pltD 
CGCGGGCAGTGCAACCCAGACCCATGATCTGTGATTGAGGTGGTTATGAACGATGTGCAG
1 + +  +  + + +  60
MN DV Q 
TCTGGCAAGGCGCCAGAGCATTACGACATTCTCTTGGCGGGCAACAGCATCAGCGTGATC
61 +  + + +  +  + 120 S GK A PEHY DI L  L AGNS I  S  V  I 
ATGCTCGCCGCCTGCCTGGCCCGGAACAAGGTCCGGGTCGGTTTGTTGCGCAACCGGCAG
121 +  + + +  + +  180 M L A A C  L A R N K V R V G  L RNR Q L 
ATGCCCCCCGACCTTACCGGTGAGGCGACGATTCCCTATACCTCGATGATTTTCGAGCTG
181 + + + +  + +  240 M P  P  D L T G E A T  I  P  Y T  S M IF EL 
ATTGCCGACCGCTATGGCGTGCCGGAAATAAAGAATATCGCCCGCACCCGGGATATCCAG
241 + + + +  + +  300 I  A D R Y G V  P  E I K N I A R T  R  D  I  Q 
Tn3-nice insertion 
mutant 4366 
CAGAAGGTGATGCCGTCTTCCGGGGTCAAGAAGAACCTCGGGTTC ATCTATCACCAGCGC
301 +  +  +  +  + - -- + 
Q  K V M  P  S  S  G V K K N  L  G  F IYHQR 
360 
AGCCGGGCGGTGGACCTGGGCCAGGCGCTGCAATTCAACGTGCCCTCCGAGCATGGCGAG
361 + +  +  + +  +  420 
S  R A V D L G Q A L Q  F  N V P SEHGE 
AACCATCTGTTCAGGCCCGATATCGATGCCTATCTGCTGGCGGCGGCCATCGGTTATGGC
421 + + +  +  + +  480 N HL F  R PD I DA Y  L  L A A A  I  G Y  G 
GCGCAGCTGGTGGAGATCGATAACAGCCCAGAGGTGCTGGTCGAGGACAGCGGGGTCAAG
481 + + + +  + +  540 A Q L V E  I  D N  S  P E V L V E  S CVK D 
GTAGCTACGGCACTGGGGCGCTGGGTCACTGCCGATTTCATGGTTGATGGCAGCCAGGGC
541 + +  + +  +  + 600 A T A  L  G R W V T A D  F M V D  G SQG 
GGCCAGGTGCTGGCGCGGCAGGCTGGCCTGGTCAGCCAGGCTTCGACGCAGAAGACCCGG
601 + + +  +  +  +  660 
G Q V L A R Q A G L V S  Q A  S  T  Q  K  T  R 136 
ACCCTGGAATTCTCCACTCATATGCTCGGGGTGGTGCCGTTCGATGAGTGCGTGCAGGGC
 
661 + + + +  + +
 
T L E F S T H M L G V V P F DEC VQG 
720
 
GATTTTCCCGGCCAGTGGCATGGCGGCACTCTGCATCACGTGTTCGATGGGGGCTGGGTG
 
721 +  +  + +
  +  +  780
 
D F
 P GQWHGG T LHHVF DG GW V
 
GGGGTCATCCCGTTCAACAACCATCAGCACTCGCGCAACCCTTTGGTCAGCGTGCTGGTT
 
781 + +  + + +
  +  840

G V  I P
 F N N H Q H  S R N  P L V S V L V
 
TCACTGCGTGAGGACCTCTGCCCGAGCATGGACGGCGACCAGGTCCTGGCCGGCCTGATC
 
841 +  +  + +
  +  +  900
 
S  L  R E  D  L  C PSMDGDQVLAGL I
 
GAGCTGTACCCCGGCCTGGGGCGGCACCTGTCCGGCGCCCGGCGGGTGCGCGAGTGGGTG
 
901 +  + + +
  +  +  960
 
E L Y  P  G L G R H L SGARRVREWV
 
CTGCGCCAGCCGCCCCGGCAGGTCTATCGCACGGCGCTCGAACGCCGCTGCCTGATGTTC
 
961 +  + + +  +
 +  1020
 L R Q  P P R Q V Y R T A L E R R C LMF
 
GACGAGGGCGCCGCGAGCAACGATCTGTTGTTCTCGCGCAAGCTGTCCAATGCTGCGGAA
 
1021 +  +  +
  +  +  +  1080
 D E G A A S N D L L F  S R K L  S N A A E
 
CTGGTTCTGGCCCTGGCGCACCGGCTGATCAAGGCGGCGCACAGCGGTGACTACCGCAGC
 
1081 +  +
  + + + +  1140
 L V L A L AHRL I K A A  H  S G  D Y R  S
 
CCGGCCCTGAATGATTTTGTCCTGACCCAGGACAGCATCATCAGCTTGAGTGACCGGATC
 
1141 +  + + + +  +
  1200
 
P A L N D F V L T Q D S  I  I S L S DR I
 
GCCTTAGCGGCTTATGTGTCGTTTCGCGACCCCGAGTTGTGGAATGCCTTCGCCCGTGTC
 
1201 + +  + + + +
 
A L A A Y V  S  F R D  P  E L W N A  F A R V 
1260
 
TGGCTGCTGCAGTCGATTGCCGCCACCATCACCGCGCGCAAGATCAACGATGCCTTTGCC
 
1261 +  +
  + +
  +  +  1320
 W L LQS IAA T  I T ARK INDAF A
 
AAGGACCTGGACCCGCGAGTGTTCGATGAAATCGACCAGCTCGCAGAGGACGGTTTCTGG
 
1321 +  +
  + +
  +  +  1380
 K DLDPRVF DE IDQL A E DGF W
 
ATGCCTCTGTATCGGGGGTACAAGGATATTCTCAACACTACGCTGGGCCTTTGTGATGAC
 
1381 +  +  +
  +  +  +  1440
 M P L Y R G Y K D  I L N T T L G  L C DD
 137 
GTCAAAAGCGCCAAGGTCTCTGCTGCGCACGCGGCGAGCAGCATCTTTGCGGAGCTTGCC
 
1441 +  +  + +
  + +
  1500
 
K  S A K V S A A H A A  S  S  F A E  L A A
 
AACGCCAGTTTTGTTCCGCCTATTTTTGATTTTGCTAATCCTCACGCTCGTGTCTATCAA

1501 + + +  + +  +  1560 N A  S F V  P  P  I  F D F A N  P H A R V Y  Q
 
CTGACCACCTTGAGAAAGCTCAAGGCGCTCTGGTGGGGCCTGATGCAAGTGCCCTCAGAG
 
1561 + + +  + + +
  1620
 
L  T  T L R K L K A L W W G L M Q V  P  S  E
 
GTCGGACGGCTGATTTTCTATCGATCCTTCAGAAAACCTTCCCTGCGCAAGGAGAGTTGA
 
1621 + + +  + +
  +  1680 
G R L I F Y R S F R K P S L R K E S  *
 
AATGGACTTCAACTACGACGATACCCAGAAAAAACATGCGGCCATGATCGCCCAGGTGTG

1681 +  +  + +  + +  1741 138 
Appendix 6. Nucleotide Sequence and Translated Product of orf-S 
GCGACCACCTTGCAAGACAAGAGCCAGACATCATGAATCAGTACGACGTCATTATCATCG 
1  + 60 MNQYDV I I
  I G
 
GTAGTGGTATCGCCGGCGCGCTGACCGGCGCCGTCCTCGCGAAGTCCGGGCTGAACGTTC
 
61  +  + + + +
  + 120
 
S G  I A G A L T G A V L A K S G L N V L
 
TGATCCTCGACTCGGCCCAGCACCCACGATTCTCCGTCGGCGAAGCGGCGACACCGGAAA
 
121  +
  +  +  +  + + 180
 
I  L  D S A Q H P R F S V G E A A T PE S
 
GCGGTTTTCTGCTGCGTTTGCTCTCAAAGCGCTTCGACATCCCTGAAATCGCCTACCTCT
 
181  +
  +  +  +  + + 240
 
S D
 G F L L R L L  K R F  I P E IAYL S
 
CGCACCCCGACAAGATCATCCAGCACGTCGGTTCGAGCGCCTGCGGGATCAAGCTGGGCT
 
241  + + +
  + +  +  300 
S
 H  P D K  I  I  Q H V G  S A C G IK LGF
 
TCAGTTTTGCCTGGCATCAAGAGAACGCGCCGTCGTCCCCCGACCACCTTGTGGCCCCGC
 
301  + + +  +  +  + 360 
S
 F A WHQENA PSS PDHL 4 A
 P P
 
CGCTGAAGGTGCCGGAAGCCCATC ii ri CCGGCAGGACATCGACTATTTCGCCCTGATGA 
361  + + + +  +  + 420
 
L K V P E A H L F R Q D I D Y F A L M  I
 
TTGCCCTGAAACACGGCGCCGAATCCAGACAGAACATCAAGATCCGTCGACCTGCAGCCA
 
421  + + +
  +  +  + 480
 
A L K H G A E  S  R Q N  I  K  I R R PAAK
 
AGCTT
 
481  485
 
L
 139 
Appendix 7. Nucleotide Sequence and Translated Product of pltR 
AGCCGTACTAAGGAGGCTGTCATGATCTATTTGTAATTTGCCTTTACAAAAATAAGACAC
 
1
  + 60
 
TAAAAATTCTAAAAGGATTTAGGAATGAAGGCGCTAGGCGTTGTCAATGACATAGACCTT
 
61  +
  + +
  +  +  + 120
 M K A LGVVN D I  D L
 
TATATATCCGTAACTAAAACGGGTAGTTTCTCCGAAACAGGAAGACTACTTGGCATCCCA
 
121  + +
  +  +  + -- + 180
 
Y  I S V T K T G S F S E T G R L L
 G I P
 
CCTTCTTCGGTGATGCGCAGAATCAATAGCCTCGAAAAAGAACTTGAAACCTGTCTATTC
 
181  +
  +  +  +  + + 240
 
P S SVMRR IN S LEK E L E T C LF
 
AATCGATCGACAAAATGCTTGATACTTACCGAAACAGGCCTGCTCTTTCTCGAACATGCA
 
241  + + +  +
 +  + 300
 N R S T K C L  T E T
 L  G GLLF L EH A
 
AAGAACATCTCGAGATGCATTGGGCATGCTAGATCAGAAGTAAAAGAACACACTGCATCG
 
301
  +  +  +  + 360
 K N  I 
+
S R C  I
+
G H A R  S E V K E  H T A  S
 
ACCCTTGGCGTTCTCAAGGTTTCAGCACCCGTGGCCTTTGGACGGCGCCATGTAGCGCCT
 
361
  + + + +
  +  + 420
 
T L G V L K V  S A P V A F G
 R R H V A  P
 
TTATTGAGCAGAATACTGAACCATCATCCCGGTTTGAAAATTGAATTCTCGCTTAACGAC
 
421  + + + +
  +  + 480
 
L  L S R
 I LNHHPGLK IEF S LND
 
AAAGCTCTCGACCCCAGCATCGATAACGTCGATATCTGTATCAAGCTGGGCATATTGCCG
 
481  + + +
  +  +  + 540
 K A L D P S I D N V D I C  I K L G IL P
 
GACAGTAATCTGATTCCAACGAAACTTGCGGATATGCGGCGCGTGCTCTGCGCAAGCCCG
 
541  + + + +
  +  + 600
 
D S N L  I P T K L A D M R R V L C A S P
 
GAATACATCCGGCAACACGGCTGTCCGCAAACTCTTGAAGACCTGTACCAACATGCCTGC
 
601  +
  +  + +
  +  + 660
 E Y  I R Q H G  C  P Q T  L E D L Y Q H A C
 
CTGATCCACAGCACCTGCAGCAACTTCTCACTGACCTGGCAATTCAAGGTCGATGGCCTG
 
661  + + +
  +  + 720
 
L  I H S T C S N F S L T W Q
+
F KVDG L
 140 
CTCAAGAAGCTCATGCCCAGCAGCCGGCTATCGGTCAACAGTTCCGAGTTGCTGGTGGAC
 
721  +
  +  + + +
  + 780
 
L  K K  L M
  P  S S R L S V N  S  S E L L V D
 
GGCGCCCTTCAGGGCATAGGAATCATCCACGCGCCCACCTGGCTGGTGCATGAACAGATC
 
781  + + + + +
  + 840
  G ALQG I G  I  I H A  P T W L V H EQ I
 
GCCAGCGGCCAACTGGTGTCGCTGCTCGACGAATATTGCGAGGCCGATCCGCAACAGGGA
 
841
  + + + +  +
  + 900
 
A  S  G  Q L V  S  L  L D E Y  C E A D P QQG
 
GCGATCTACGCACTGAGGGCACGCAGCAGCGTTGTCCCGGCCAAGACCCGCCTGTTCATC
 
901  + + +
  +
  +  + 960
 
A  I Y A L R A R  S S V V  P A K T R L  F  I
 
AATGAGTTGAAACGCTCGATCGGCAGCACGCCTTACTGGGACTTGCCGTTTGAAAAGGAA
 
961  + + + + +
  + 1020
  N E L K R S  I G S T P Y W D L P F E K E
 
ATACCGCAGACCCTGGCCACCCTGCATTTCGATACCGCAATGCATTCAGCGC'i 11CCAGA 
1021 +  + + +  +  + 1080 
I P Q T L A T L H F D T A M H S  A  IJ  S R 
GCGACCACCTTGCAAGACAAGAGCCAGACATCATGAATCAGTACGACGTCATTATCATCG
 
1081  + + + +
  +  + 1140

A T T L Q D K S Q T S  *
 
GTAGTGGTATCGCCGGCGCGCTGACCGGCGCCGTCCTCGCGAAGTCCGGGCTGAACGTTC
 
1141
  + 1200
 